An electrical microcytometer for portable blood analysis in global health applications by Watkins, Nicholas
c© 2012 Nicholas Noel Watkins
AN ELECTRICAL MICROCYTOMETER FOR PORTABLE BLOOD




Submitted in partial fulfillment of the requirements
for the degree of Doctor of Philosophy in Electrical and Computer Engineering
in the Graduate College of the
University of Illinois at Urbana-Champaign, 2012
Urbana, Illinois
Doctoral Committee:
Professor Rashid Bashir, Chair
Professor Brian Cunningham
Professor Kanti Jain
Adjunct Professor William Rodriguez, Harvard Medical School;
CEO, Daktari Diagnostics
ABSTRACT
For three decades the AIDS (Acquired Immune Deficiency Syndrome) pan-
demic has killed millions and currently affects tens of millions around the
world. It has especially crippled resource-poor regions in the world such as
sub-Saharan Africa, which contains two-thirds of the world’s people living
with AIDS. Antiretroviral therapy (ART) to combat the human immunod-
eficiency virus (HIV) has become more accessible to patients in these re-
gions over the past several years, and has shown to improve the quality of
their lives. However, the lack of objective diagnostics—CD4+ T lymphocyte
counts—to determine when to start ART and to monitor its success hinders
the effective use of treatment in these regions. The industry standard of
flow cytometry to obtain CD4+ T cell counts is too taxing on the debili-
tated healthcare infrastructure of undeveloped nations because of its high
cost, technical demands, and lack of portability. Therefore, there is an ur-
gent need to develop a portable, robust, and affordable point-of-care (PoC)
CD4+ T cell counter that can reach all HIV/AIDS patients, regardless of
geography or socio-economical situation.
This dissertation addresses this great need through investigation of a minia-
turized, portable PoC platform that can provide CD4+ T cell counts in less
than 15 minutes. Standard microfabrication techniques have been used to
create a microfludic biochip, which uses electrical impedance sensing to ana-
lyze small sample volumes (∼10 µL) of blood. The biochip progressively gains
more functionality during the study. First, a chip was designed to confirm
that the electrical impedance pulse counting technique was a viable method
to enumerate CD4+ T cells. Three-dimensional hydrodynamic focusing was
used to take advantage of the laminar flow regime found in microfludics and
increase the counting accuracy of the device. Second, a differential counting
stage was added that selectively counted CD4+ T cells from leukocyte (i.e.,
white blood cell) populations using immunoaffinity chromatography meth-
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ods. Total leukocyte counts were obtained before and after the cells flowed
through a CD4+ T cell depletion chamber. The difference between these two
counts proved to be an accurate representation of the number of captured
cells when verified with an optical control. Third, an erythrocyte (i.e., red
blood cell) lysis module was added, with which to perform accurate counts
on unprocessed blood samples, verified with flow cytometry controls. The
success of this final stage suggests that the technology described is a viable
answer to bringing PoC CD4+ T cell counts into resource-poor regions. An
advantage of this label-free technology is that it can be readily expanded to
diagnose other diseases and conditions simply by altering the specificity of
its depletion chambers to other cell types.
Although this dissertation focuses on the specific application of PoC AIDS
diagnostics, it also addresses the fundamentals in microfluidic cytometry.
The impedance responses of cells under various conditions were studied, in-
cluding living cells, dead/dying cells, and cells undergoing chemical modifi-
cation. Leukocyte subsets were distinguished based on their electrical prop-
erties found using multiple AC interrogation frequencies, confirming state-
of-the-art findings in the literature. This multiple frequency technique gave
a better understanding of the morphological and electrical characteristics of
leukocytes, such as cell volume and membrane capacitance. Different electri-
cal sensor designs were investigated to increase sensitivity and signal integrity,
and to know cell flow direction through the counter. Various sensing channel
designs were explored to determine the optimal balance between counting
accuracy and fabrication complexity.
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The need for a portable AIDS (Acquired Immune Deficiency Syndrome) di-
agnostics platform is a crucial problem. Since its discovery in the early 1980s,
AIDS has grown from a few isolated incidents to a pandemic that is currently
affecting the lives of over 33.4 million people around the world. Sub-Saharan
Africa has been hit hardest by the AIDS pandemic: it comprises 67% (22.4
million) of all infections and 70% (1.4 million) of annual deaths [1]. One of
the major reasons for these staggering statistics besides the lack of educa-
tion on the disease (e.g., its symptoms, how it is transmitted1, and how to
protect against transmission) is poor healthcare infrastructure from poverty.
The governments within this region do not have the financial resources to pay
for expensive equipment, facilities, and labor hours required to accurately de-
tect and analyze the progression of HIV in millions of potential patients. In
addition, only 3% of the world’s healthcare workers are in this region, which
contains 25% of the world’s global burden of disease [2]. This problem is only
compounded by the fact that 2 out of 3 inhabitants live in rural areas, unable
to travel to urban sites that would provide these facilities and services [3].
The current situation is bleak: understaffed single-room facilities with inad-
equate equipment, resulting in inaccurate tests for only a fraction of those
patients who need them. Antiretroviral therapy (ART) that uses a cocktail
of drugs has been shown to improve the quality of life for those infected with
the Human Immunodeficiency Virus (HIV), and global efforts increased the
accessibility of such treatment 30-fold in sub-Saharan Africa between 2003
and 2008 [4–6]. However, the lack of objective diagnostic tests to determine
when to start ART and to monitor its success hinders the effective use of
treatment. Absent appropriate diagnostic tests, clinicians may rely on less
accurate assessments, ranging from self-described symptoms or insensitive
1Known methods of HIV transmission: sexual intercourse, blood transfer, sharing nee-
dles, perinatal, and breast feeding.
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laboratory tests. For example, patients undergoing treatment are asked a
series of questions regarding how they feel to determine the effectiveness of
the drug combination and how severe are the side effects—so-called “clini-
cal monitoring.” A quantitative test that is administered more frequently
is necessary to maximize the effectiveness of the treatment and minimize
detrimental side-effects.
An important quantitative HIV/AIDS diagnostic procedure is to obtain a
patient’s CD4+ T lymphocyte count [7–9]. CD4+ T lymphocytes, or sim-
ply CD4+ T cells2, are a subset of leukocytes (i.e., white blood cells) whose
concentration has been shown to be inversely proportional to the progression
of HIV in human patients. Flow cytometers using laser light scattering and
laser-induced fluorescence principles are the current gold standard to pro-
vide accurate CD4+ T cell counts at high throughputs. However, the cost
($40,000 to over $125,000), technical operator and maintenance requirements,
and lack of portability of such instruments are too taxing for the debilitated
healthcare infrastructures of resource-poor regions.
A complementary approach to flow cytometry is to obtain the concentra-
tion of HIV RNA in human blood, known as a viral load test. This test,
in conjunction with the CD4+ T cell count test, gives healthcare providers
a better look at the current and future state of a patient’s immune system,
allowing for optimal secondary prophylaxis with ART. However, viral load
tests demand the same resources as mentioned for the flow cytometers, and
have also failed in penetrating developing regions of the world.
This problem has led to the investigation, detailed in this dissertation, of
a miniaturized platform that would complement sub-Saharan Africa’s (and
any resource-poor region’s) healthcare infrastructure: a portable, hand-held
CD4+ T cell enumeration device that could be easily transported and op-
erated by minimally trained workers even in the most desolate regions in
Africa. This is realized using industry-standard microfabrication methods to
create a microfluidic biochip that electrically counts the cells using samples
only the size of a drop of blood (∼10 µL). An initial biochip was developed
to test whether electrically counting cells in a microfluidic environment was
feasible. An improved biochip was then developed that showed the feasibil-
ity of selectively counting CD4+ T cells from a heterogenous population of
2Other common names for CD4+ T lymphocytes are CD4+ T cells and helper T cells.
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leukocytes. A third and final chip was developed to selectively count CD4+
T cells from whole blood samples with the addition of a sample preparation
module. The module, integrated within the chip, created a purified popula-
tion of leukocytes by selectively lysing all erythrocytes (i.e., red blood cells),
which is crucial for accurate electrical CD4+ T cell enumeration.
This document is comprised of six chapters, including this introduction.
Chapter 2 gives a succinct background on the mechanics of HIV/AIDS,
the theory behind current methods and technologies used to diagnose and
treat the disease. It then examines current trends in point-of-care (POC)
HIV/AIDS diagnostics, focusing on microfluidic technologies with emphasis
on electrical sensing methods. Figure 1.1 illustrates the content of the re-
maining chapters. Chapter 3 details the initial approach in portable HIV/AIDS
diagnostics via a microfabricated electrical cell counter that uses 3-dimensional
hydrodynamic focusing to increase the accuracy of the cell counts for purified
CD4+ T cell populations. Chapter 4 shows the steps used to realize a chip
that can selectively enumerate CD4+ T cells from purified leukocyte popula-
tions using an electrical differential counting technique. Chapter 5 provides
the details in designing, fabricating, and testing the final chip design that
enumerates CD4+ T cells from 10 µL whole blood samples via an additional
erythrocyte lysis module—suggesting the differential counting technique is
a valid approach to POC HIV/AIDS diagnostics. Future work, describing
improvements on and expansion of the final differential counter, is listed in
Chapter 6. Expansions considered are multiplexing the differential count-
ing technique to simultaneously provide CD4+ and CD8+ T lymphocyte
counts and to provide a complete blood count (CBC) of all major blood cell
populations.
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Figure 1.1: Graphical illustration of content covered in Chapters 3 – 6,
showing the starting sample and subsequent on-chip processing to obtain
CD4+ T cell counts. Chapter 6 proposes the expansion of the device
described in Chapter 5 to realize a CD4+ and CD8+ T cell counter and a
complete blood counter (CBC).
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CHAPTER 2
METHODS IN AIDS DIAGNOSTICS
2.1 Introduction
This chapter provides a brief summary behind the mechanism of HIV in-
fection and its deleterious effects on the human immune system. Current
industry standards for AIDS analysis are discussed, followed by the most
recent research in microfabricated lab-on-a-chip (LOC) systems, with special
emphasis placed on electrical methods. A brief history of and theory behind
electrical impedance sensing in fluidics will also be explored.
2.2 Composition of Human Blood
Blood is the essential substance in an organism that provides the necessary
functions to sustain life through its circulatory system. Some of its most im-
portant functions include supplying oxygen and necessary nutrients to and
removal of waste products from tissues and organs, regulating body tempera-
ture, supplying a chemical messaging pathway (e.g., hormonal secretion), and
providing immunological response to pathogens, such as viruses and bacteria.
These various functions make blood an extremely complex fluid: 55% is com-
prised of serum that contains thousands of different proteins that range in
concentrations across 9 orders of magnitude (mg·mL−1 to pg·mL−1) [10] and
the remaining 45% contains various blood cells of varying size, function, and
concentrations. Table 2.1 notes the several different types of blood cells and
their concentrations in healthy adult blood. Erythrocytes, or red blood cells
(RBCs), are by far the most numerous of the blood cells and help transport
carbon dioxide and oxygen to and from the lungs, respectively. Thrombo-
cytes, or platelets, help stop bleeding by forming clots around wounded blood
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vessels. Leukocytes, or white blood cells (WBCs), form the immune system,
the body’s dynamic and multi-layered defense system which protects against
disease by attacking pathogens such as viruses, bacteria, fungi, and any other
foreign entity. Special attention is directed toward one particular leukocyte,
the helper T cell, which will be the main focus for the remainder of this
chapter.
Table 2.1: Cell content of human blood. Concentrations and % total WBCs
data are for healthy adults.







Erythrocytes (RBCs) transport O2 and CO2 5x10
6 6–8 —
Thrombocytes (platelets) initiate blood clotting 3x105 2–3 [13] —
Leukocytes (WBCs) immune defense 4–11x103 7–21 —
Neutrophils phagocytose and destroy
invading bacteria
5x103 10–12 54–62% [14]
Eosinophils destroy larger parasites
and modulate allergic in-
flammatory responses
2x102 10–12 1–6%
Basophils release histamine in cer-
tain immune reactions
4x101 12–15 <1%




Lymphocytes (see below) 3x103 7–8 25–33%
B Cells make antibodies 2x103 7–8 16–22%
T Cells kill virus-infected cells
and regulate activities of
other leukocytes
1x103 7–8 8–11%
Natural Killer Cells kill virus-infected cells
and some tumor cells
1x102 7–8 0.8–1.1%
Helper T cells play a crucial role in the adaptive nature of the immune
system by activating and directing other leukocytes toward a particular
pathogen. Pathogens such as viruses and bacteria express particular pro-
teins on their surfaces (antigens) that may be recognized by complemen-
tary proteins (antibodies) distributed throughout the blood. The antibodies
specifically attach to the antigens, neutralizing the pathogens’ attack method,
eventually leading to the elimination of the pathogens by the immune system.
If an invading pathogen containing antigens not known to the immune sys-
tem, antigen presenting cells (APCs), such as macrophages, dendritic cells,
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or B cells, engulf and digest (a process called phagocytosis) the pathogen
and present the pathogen’s epitope (portion of its antigen that is recognized
by the immune system) to immature T cells within the lymph nodes. This
activation process requires the use of two surface proteins on the T cell mem-
brane, the T cell receptor (TCR) and the CD4 (cluster of differentiation 4)
co-receptor, which amplifies the sensitivity of the interaction between the
TCR and the epitope presented by the antigen presenting cell [15]. Through
this process, the T cells learn about new pathogens, mature into helper T
cells, and proliferate to effectively memorize the antigen to prepare for future
invasions. Already mature Helper T cells (also called CD4 T cells because
of their aforementioned CD4 co-receptors) will recognize this antigen on the
surface of a B cell and activate the B cell to start producing antibody to the
antigen.
2.3 Mechanisms Behind HIV/AIDS
HIV, more specifically HIV-11, is a retrovirus that is transmitted via bodily
fluids (e.g., unprotected sexual intercourse, blood, breast milk, and vertical
transmission from mother to child at birth). Once it enters the bloodstream,
it targets the CD4 proteins expressed on leukocytes, such as macrophages,
monocytes, dendritic cells, and especially helper T cells, which express sub-
stantially more of the protein on their surfaces. Figure 2.1 illustrates how
HIV infects a CD4 T cell and uses the cell to replicate for viruses. Initially,
an HIV virion attaches to the surface of the cell via the virus’ gp120 protein,
which complements the cell’s CD4 receptor. This interaction facilitates fur-
ther interaction of gp120 with other cell surface proteins, called chemokine
receptors, creating a more substantial attachment. This allows HIV’s gp41
protein to penetrate the cell’s membrane. Subsequent folding of gp41 brings
the virion close enough to fuse to the cell’s membrane. This fusion delivers
the virus’ ribonucleic acid (RNA) and essential enzymes necessary for virus
replication by the cell. The reverse transcriptase enzyme creates complemen-
tary single-stranded DNA (cDNA, or complementary deoxyribonucleic acid)
1Currently, two strains of HIV have been discovered, but HIV-1 is more common
throughout the world and more heavily studied (HIV-2 is localized to West Africa as
it is less infectious [16]).
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Figure 2.1: Mechanism in which an HIV virus infects a CD4 T cell, causing
it to replicate more viremia [20].
which is then turned into double-stranded DNA (dsDNA) by the polymerase
enzyme. Integrase then transfers the viral dsDNA into the cell nucleus and
integrates it into the host cell’s genome. This hijacks the cell to translate the
viral genes through the same processes the cell uses to synthesize proteins.
The virus proteins and newly replicated RNA are reconstructed into viral
capsids that attach to the inner side of the cell’s plasma membrane. Eventu-
ally, the newly constructed virus buds out through the cell membrane, ready
to infect another CD4 T cell [17–19].
This process not only kills the host cells by increasing the likelihood of
apoptosis (programmed cell death), but also triggers an immune response in
the form of cytotoxic T cells, which kill the HIV-infected cells. The continual
decimation of helper T cells will eventually lead to death of the individual
because the essential role these cells have in the immune system. In reality,
HIV does not directly kill a patient, but weakens the immune system enough
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so that an opportunistic pathogen—that may be handled easily by a healthy
immune system—would eventually cause death. For this reason, the Centers
for Disease Control (CDC) defined AIDS as the point when the immune
system cannot support itself, specifically when a patient has less than 200
CD4 T cells per microliter (cubic mm) of blood [21]. Without aid, a patient
would soon die in the case of an opportunistic infection.
Figure 2.2 illustrates the relationship between the HIV viral load content
(concentration of viral RNA in the blood) and the number of CD4 T cells
throughout a patient’s life since HIV acquisition. CD4 T cells start decreasing
rapidly, even before the large spike in HIV viremia. Initially, the immune
system responds to the infection and causes a sharp decrease in the number
of HIV viremia. This results in a latent, chronic infection—a battle between
the virus and host immune system that generally is waged for 8 to 10 years.
Eventually, the helper T cell concentration becomes so low that the immune
system cannot defend against opportunistic infections. This, coupled with
rapid production of HIV viremia, causes death.
The availability of antiretroviral treatment (ART) continues to increase
throughout the developing world. These drugs have proven to have a dra-
matic impact on health by specifically hindering HIV’s aforementioned repli-
cation mechanisms [22]. For example, one drug may inhibit the attachment
of HIV to the cell membrane, another would prohibit the reverse transcrip-
tion of viral RNA into cDNA, and another may prevent the creation of viral
proteins that would construct the new viral capsid. As a result, it is necessary
to find the optimum combination of antiretroviral drugs to severely dampen
the proliferation of HIV. This requires periodic and quantitative monitoring
of a patient’s immune system, which is not currently feasible in developing
regions, especially sub-Saharan Africa.
2.4 Current AIDS Diagnostics Methods
Comprehensive diagnostic testing in HIV care involves three tests. A patient
who is in a high-risk group for HIV or may have been exposed to HIV is
screened for the presence of antibodies to HIV. These antibodies are cre-
ated by the immune system in response to the presence of HIV, and can be
detected in either blood or saliva. The antibodies may also be detected in
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Figure 2.2: Common pattern of relationship between the concentration of
CD4 (helper) T cells and HIV viral load over the life of individual.
Adapted from [23].
urine, but this has proven more difficult. The antibody test may be coupled
with other tests for confirmation, such as the Western Blot which uses gel
electrophoresis to sense the proteins, directly testing for the HIV p24 antigen,
and even a viral load test (see below) [24]. These tests serve as qualitative
methods to determine the presence of HIV, and cannot give more information
regarding the current state of a patient’s immune system.
Ideally, once it is confirmed that a patient has contracted HIV, two tests
are administered periodically: an absolute CD4 T cell count and a HIV viral
load count. These tests are usually run in tandem, giving clinicians valuable
quantitative information about the health of a patient’s immune system (Fig.
2.2), enabling them to provide a tailored and optimized ART regimen. The
following subsections detail each method.
2.4.1 Viral Load Test
A viral load test is used to estimate the concentration of circulating HIV in
blood. Since the goal of ART is to reduce the amount of HIV in a patient, a vi-
ral load test gives a direct look at the effectiveness of treatment. All approved
methods estimate HIV progression by quantifying the amount of viral RNA in
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a known volume of blood (usually in units of RNA copies per mL). Currently,
three proprietary methods exist: (1) using reverse-transciptase PCR (RT-
PCR) to amplify the RNA (Amplicor R© HIV-1 MonitorTMby Roche) [25],
(2) nucleic acid signal-based amplification (NASBA) using fluorescent bea-
cons that only fluoresce when attached to viral RNA (NucliSens R© HIV-1
QT by bioMerieux) [26, 27], and (3) specific immobilization of viral RNA
and subsequent attachment to branched DNA (bDNA) fragments linked
to light-emitting enzymes (Versant R© HIV-1 RNA by Bayer) [28]. It has
been reported that the aforementioned tests have the following detection
limits: (1), 200 copies·mL−1 [27]; (2), 176 copies·mL−1 [29]; and (3), 500
copies·mL−1 [27]. These limits are the smallest detectable number of RNA
copies, and show that these tests are capable of detecting the progress of HIV
at its earliest stages and during effective ART.
The main reasons these testing systems have not penetrated the African
continent successfully are their high cost ($15,000–35,000 for equipment and
as much as $100 per patient test), need for special laboratory space, and
requirement of highly-trained personnel in molecular biology. These require-
ments cannot be met by resource-poor regions; as a result, viral load tests
are seldom used [30].
2.4.2 Absolute CD4+ T Cell Count
Helper T cells are enumerated using flow cytometers—the industry stan-
dard for cellular analysis—which use optical interrogation to analyze cell
populations a single cell at a time. Figure 2.3 illustrates the fundamental
components of a flow cytometer. Cell populations are hydrodynamically-
focused into a single-file line to ensure cells are individually analyzed. Each
cell is then optically interrogated by laser light as it passes through an aper-
ture. This passage causes a perturbation in the light which is quantified by
sensitive photodetectors through optical filters to determine a cell’s various
characteristics, which are saved in a data structure on a computer. Laser
light scattering (LLS) is one perturbation that can determine a cell’s size,
current phase in growth cycle, and DNA content by observing the amplitude
and direction that an applied laser light is scattered onto photodetectors [31].
For example, the amplitude of the forward scattering (FSC) photodetector
11
signal is generally proportional to a cell’s size, while side scattering (SSC)
signal from its photodetector determines the interior complexity of a cell
(e.g., nucleus and other organelles). Figure 2.4(a) illustrates how plotting
FSC vs. SSC can discriminate among different cell and particle populations.
Laser-induced fluorescence (LIF) is an important concept in flow cytometry
that can be used to complement LLS [32–35]. One or more lasers of different
wavelengths (colors) are used to excite fluorescent markers that specifically
attach to a particular cell’s surface receptor proteins. Each cell line has a
unique combination and concentration of these receptors on its surface (this
is similar to identifying a person via fingerprints). Therefore, a specific cell
type can be determined by the intensity and color of fluorescent markers that
specifically attach to a cell’s surface receptors. This is shown in Fig. 2.4(a),
where a helper T cell can be identified solely by fluorescence by three mark-
ers with three different colors. CD45 denotes the cell as a leuokocyte, CD3
narrows it down to a type of T cell, and CD4 ensures it is a helper T cell (or
CD4+ T lymphocyte). Figures 2.4(b–d) illustrate the concept of isolating
the helper T cell population using a combination of LLS and LIF gating:
(b) Lymphocytes are isolated using the FSC vs. SSC plot, (c) only CD3+
lymphocytes (T cells) are selected from the total lymphocyte populations,
and (d) helper T cells are identified as being CD4+ and CD14-. With the
addition of fluorescent counting beads of a known concentration, it is possi-
ble to find the concentration of helper T cells in whole blood. The standard
procedure for finding helper T cell concentration is to add fluorescent beads
of a known concentration to the sample, and compare the number of helper
T cell events to the bead events. A healthy adult will have approximately
600–1,000 helper T cells per microliter of blood, while someone infected with
HIV, if not receiving treatment, will have counts less than 500, and eventually
below 200—at which he or she would technically have AIDS.
Other forms of analysis can be performed to give an idea about a patient’s
health besides an absolute CD4 T cell count, such as finding the ratio of
CD4+ T cells to CD8+ T cells, and finding the percentage of CD4+ T cells
out of total lymphocytes or the entire white blood cell population. However,
the current standard set by the World Health Organization emphasizes the
absolute CD4 count.
Flow cytometry provides a versatile, accurate, and high-throughput plat-
form for the diagnostics of AIDS. However, like viral load testing methods,
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Figure 2.3: Components of a flow cytometer with laser light scattering and
laster-induced fluorescence capabilities. Adapted from [36].
flow cytometry requires resources that hinders its penetration in developing
nations [37]. They have a high initial cost (some approaching $125,000),
need periodic maintenance (contracts can be $10,000/year) and repair, re-
quire operation by a trained technician, and lack portability due to sheer
size, weight, and fragile optical components. Effort has been made to reduce
the complexity, size, and cost of these machines to be more amenable for
diagnostics in resource-poor regions. Table 2.2 lists some of the available
systems with their cost, estimated cost per test, estimated throughput, and
weight.
i+Med Laboratories offers a CD4+Select
TM
reagent which provides CD4+
T cell counts and percentages at ∼$7 per test. Although it does not need a
flow cytometer, it still requires the use of an automated hematology analyzer
which can have an average cost of ∼$10,000 and a similar size to the products
listed in Table 2.2 [39]. Depending on the analyzer used and number of
technicians available, the throughput could be as high as 480 samples per
eight-hour day.
Although an improvement, the listed systems still fall short in meeting the
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Figure 2.4: Concept of identifying helper T cells in whole blood samples
(with lysed red blood cells): (a) the unique combination of surface markers
coupled with fluorescent markers helps identify the helper T cell; (b)
different white blood cell subsets can be discriminated in the FSC vs. SSC
plot; (c) lymphocytes with CD3 marker attached are selected, denoting
them as T cells; (d) different subsets of T cells are discovered by plotting
CD4 vs. CD14 intensities, where helper T cells are CD4+ and CD14-.
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Table 2.2: Specialized CD4 T cell enumeration systems currently available.
Product/
Manufacturer
System Cost Cost/Test Tests/Day System Weight (lbs)
FACSCount/
Becton-Dickinson
$30,000 $5 300+ 57
EasyCD4/
Guava Tech.
$45,000 $3 100–150 35
PointCare NOW/
PointCare Tech.
$15,000–20,000 $10 75 26.5
CyFlow SL 3/
Partec
$22,000 $2 [38] 250 33
needs for the undeveloped healthcare infrastructure of sub-Saharan Africa,
as they are still too expensive, require maintenance and trained professional
operators, and are too bulky and fragile to be portable. As a result, a truly
mobile and accurate CD4 T cell enumeration platform that can reach all
patients, regardless of geography and economic status, does not exist.
Manual CD4+ T cell counting options have been available for several
years. Beckman Coulter offers a Coulter R© Manual CD4 Count Kit (i.e.,
“Cytospheres”) which specifically labels CD4+ T cells with beads that are
visible under a light microscope for ∼$11 per test. Invitrogen offers mag-
netic Dynabeads R© which specifically attach to CD4+ T cells. With the help
of an external magnet, the bead-cell complexes are separated from other
cells and are counted under a light microscope for a per test cost of ∼$4.
Although these tests are relatively inexpensive and provide CD4+ T cell
counts which reasonably correlate with the flow cytometry standard, they
still require a laboratory setting with a dependable electricity source (for the
microscope and refrigerated storage) and skilled technicians. In addition,
manual counting under a microscope is not only tedious and error-prone,
but the time-consuming activity also has a low test throughput [40].
2.5 Lab-on-a-Chip Platforms for Global Health
Diagnostics
For the past two decades, a promising solution to the predicament of not hav-
ing a truly mobile and inexpensive CD4 T cell counter has been emerging.
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There has been much interest in applying and modifying standardized inte-
grated circuit (IC) fabrication processes to create microfluidic lab-on-a-chip
(LOC) systems for point-of-care (PoC) diagnostics. LOC systems share the
same advantages of IC fabrication: high yield, throughput, and repeatability
via parallel fabrication of possibly hundreds of chips per substrate result in
lower manufacturing costs. Other advantages of LOC systems: (1) they have
an inexpensive per test cost because they require smaller reagent volumes
(µL vs. mL), (2) their highly specialized application makes operation sim-
ple, enabling their use by less specially-trained healthcare workers, (3) they
would have minimal, if any, operation and maintenance costs, (4) their small
footprint creates mobile platforms that could go directly into a high-needs
area, and (5) they would come in a one-time-use, disposable chip that would
reduce biohazards. These advantages make it possible for LOC systems to
penetrate undeveloped regions that do not have an established healthcare
infrastructure.
The aforementioned IC processes can be used to create fluidic channels
with dimensions much smaller than a human hair, creating a unique fluidic
environment. The dimensionless Reynolds number (Re) gives the ratio of






where ρ is fluid density, V is the mean fluid velocity, L is the characteristic
linear dimension of the fluidic interface, and µ is the fluid’s dynamic viscos-
ity. Generally, Re >4,000 denotes turbulent flow that is chaotic while a fluid
with Re <2,300 transitions into the laminar regime where fluid flow becomes
more “smooth” and predictable [41]. In the case of microfluidic channels,
L is small (micrometers), resulting in Reynolds numbers much lower than
unity. In this special case, viscous forces dominate inertial forces, and the
Navier–Stokes equation for fluidic motion can be greatly simplified into the
Stokes equations, which describe a fluid whose flow is independent of time,
meaning flow is highly consistent and predictable. This allows for the precise
spatial manipulation of microscopic objects, such as biological cells, through
networks of channels, chambers, and micro- or nanofabricated sensors that
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Figure 2.5: Microfluidic network for the long-term culturing of E. coli. (a)
Size comparison of chip with a dime (18 mm in diameter). (b) Magnified
view of fluidic network, which contains media supply channels, bacteria
growth loop, and valves, forming an integrated peristaltic pumping system.
Different channels are dyed with food coloring for illustration purposes.
From [44]. Reprinted with permission from AAAS.
have a much higher sensitivity than macroscopic methods. The Quake group
at Stanford University have pioneered and specialized in the manipulation of
fluids and microorganisms in the microfluidic environment using microfabri-
cated valves and pumps [42], sophisticated arrays for a microfluidic memory
storage device [43], and microfluidic bioreactors that automatically regulated
the cell density of Escherichia coli (E. coli) for long-term cell culture (see
Fig. 2.5) [44].
Figure 2.6 illustrates one method of rapid fabrication of a microfluidics
sensor: (a)–(d) shows the standard process for patterning microelectrode
sensors on the surface of an oxidized silicon wafer, while (e)–(g) shows how
a microfluidic channel is created by peeling off a cured polymer (such as
polydimethylsiloxane, or PDMS) that has conformed to a micropatterned
photoresist negative mold. The channel height depends on the thickness of
the photoresist, which can be made less than 1 µm or more than 1 mm
using different commercially available photoresists. The cured polymer and
electrodes substrates are aligned and bonded (Fig. 2.6).
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Figure 2.6: Rapid fabrication of a microfluidic sensor. (a) Photoresist is
patterned on an oxidized silicon substrate. (b) Acid is used to etch a
portion of the oxide, creating recesses. (c) Metal is deposited on the
substrate. (d) The patterned resist is removed, lifting off the undesired
metal, creating patterned electrodes. (e) A negative image of the fluidic
channel is patterned on a silicon substrate. (f) Uncured PDMS is poured on
the mold and cured. (g) The cured PDMS is pulled off the mold, and
fluidic ports are punched before (h) bonding it to the electrodes chip.
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2.5.1 Hand-held LOC Systems on the Market
One successful commercial LOC system for blood analysis is the Abbot Labo-
ratories i-Stat R© 1, which is a handheld unit ($10,000) that accepts one-time-
use, disposable cartridges ($8–$40 each). Several cartridges are available that
electrochemically test a few drops of patient blood for various factors, such
as blood gas content, electrolytes, coagulation, and cardiac markers.
Recently, hand-held cellular analysis tools have entered the market. Invit-
rogen’s Countess R© Automated Cell Counter (∼$5,000 head unit with ∼$1
per test cost) analyzes homogenous cellular populations for concentration and
viability using optics and image analysis algorithms. The Millipore Scepter
TM
resembles an over-sized micropipettor with single-use microfabricated tips
that use the Coulter principle to electrically provide cell concentration and
viability analysis. The Orflo R© Moxi ZTM (∼$3,000) is another handheld
Coulter counter unit which provides live/dead cell counts for less than $2
per test.
However, all aforementioned cellular analysis devices—intended to replace
tedious and time-consuming manual cell counting using hemocytometers—
require off-chip sample preparation and cannot differentiate among different
cell types. As a result, much work remains to be done to create a diagnostics
platform that can specifically enumerate cells in PoC situations (i.e., CD4+
T cells). The following section details recent advancements in research to
develop such a device.
2.5.2 Current Research in Cell Enumeration Systems
Many efforts have used fluorescent tagging and subsequent image processing
to automatically enumerate CD4+ T lymphocytes in microchambers. Some
designs relied on the even distribution of cells in a plastic chamber to produce
accurate counts [45]. Others have used a microfabricated membrane to filter
out erythrocytes, leaving leukocytes, which were fluorescently labeled [46].
Fluorescence detection was later enhanced by using quantum dots [47, 48],
forming the technology behind LabNow, Inc. Immunospecific paramagnetic
beads were used to bring fluorescently labeled CD4+ T cells into the focusing
plane for analysis, reducing counting error [49, 50]. Cheng et al. have inves-
tigated CD4+ T cell capture by controlling shear stresses at the chamber
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walls and enumerating cells using a cocktail of fluorescently labeled antibod-
ies [51, 52]. They improved their design by including a monocyte depletion
chamber to reduce the positive bias created at lower CD4+ T cell concentra-
tions [53]. Beck et al. have eliminated the fluorescence labeling step required
by the aforementioned methods by coating capture chambers with hydrogels
containing fluorescent antibodies and drying them for storage [54]. During
testing, blood enters the capture region, causing the hydrogel to swell and
release the antibodies, specifically labelling CD4+ and CD8+ T cells. Sub-
sequent fluorescent image cytometry is used to obtain the CD4+ and CD8+
T cell counts. The Alere Pima CD4 counter uses a similar method to label
CD4+ T cells using cartridges containing a lyophilized antibody pellet, and
has shown some success in field testing [54–57]. However, in some situations,
it has operational costs similar to or more expensive than standard lab flow
cytometric analysis [58].
The aforementioned optical methods require the use of lenses and focusing
to analyze samples, but this can increase the cost and decrease the portability
of the device. Gohring et al. quantified the antibody-mediated attachment of
T cells by the amount of shift in the whispering gallery mode of an optofluidic
ring resonator [59]. Moon et al. counted immobilized helper T cells by
their shadows cast over a charge coupled device (CCD) by a white light
source [60]. Wang et al. further simplified the optics by not requiring an
external light source: immobilized CD4+ T cells were labeled with CD3-
conjugated horeseradish peroxidase to facilitate a chemiluminescent reaction,
which was amplified and quantified by a photodetector [61].
Electrical methods for enumerating CD4+ T lymphocytes prove to be
promising due to the fact that they would not require optical components
such as lenses, filters, light sources, photodetectors, and CCDs, which can
be expensive, bulky, fragile, and require periodic maintenance. An electrical
PoC solution could require only solid state components to electrically inter-
rogate a sensing geometry, process sensor output, and provide input from
and results to the user.
Mishra et al. used three-electrode cyclic voltammetry to estimate the
number of CD4+ T cells that were selectively captured on a working electrode
[62]. Jiang et al. have used this design as a building block to create an array
of 200 of these electrochemical sensing regions, or pixels, conjugated with
CD4 antibody. A pixel would be considered on when a CD4+ T cell was
20
captured, and a total cell count was the total number of on pixels [63].
Cheng et al. enhanced their CD4+ T cell capture device ( [51,52]) by inte-
grating impedance spectroscopy sensing into the capture channel to monitor
the cell lysates [64]. T cells from whole blood were captured on-chip and
lysed in a low-conductivity buffer, releasing intracellular ions into the bulk
solution, thereby changing its conductance, which increased proportionally
with cell concentration. The authors were able to correlate cell concentra-
tion with channel conductance with a detection sensitivity of 20 cells·µL−1,
eliminating the need of a microscope and manual cell counting. Daktari Di-
agnostics, Inc., has developed the Daktari CD4 counting platform based on
this technology.
The lysate impedance method has shown to be the most promising tech-
nology to penetrate into resource poor regions, as it needs no off-chip sample
preparation, requires only electrical means of interrogation, and is simple
to operate. However, inherent drawbacks from measuring lysate impedance
may reduce its efficacy. This technology assumes every patient’s T cells con-
tain similar ion concentrations, which may not be true, resulting in counting
error. In addition, since the technology is sensitive to the concentration of
ions, contamination from the sensor chip’s materials and failure to wash away
excess ions may reduce the system’s counting resolution and dynamic range.
2.5.3 Microcytometry
A microfabricated flow cytometer (microcytometer) would combine the ben-
efits of flow cytometry with that of LOC systems, resulting in a powerful
AIDS diagnostics tool that could penetrate even the most impoverished re-
gions in the developing world. Cells are counted one at a time as they flow
through a small orifice, providing a counting accuracy that is superior to
bulk counting methods.
Microcytometers can be divided into two groups based on their sensing




The mechanism behind optical microcytometry is similar to its macroscopic
counterpart, and has been a research interest for many: LLS chips [65–68],
LIF chips that use imaging software to count cells [69] or directly convert
the fluorescence signal to an electrical signal using avalanche diodes [70–72],
photomultiplier tubes [73–79], or PIN photodiodes [80]. Chen et al. combined
LIF and LLS onto one platform using optical fibers, and could enumerate
and discriminate between fluorescing and non-fluorescing beads [81]. Son et
al. developed a method of detecting particles using a boron diffused resistor
(BDR) and infrared (IR) diode. The particles would block the IR light which
changed the effective resistance of the BDR [82].
Furthermore, others have used digital image processing to sort cells based
on their size via pattern recognition or through fluorescent labels and sensing
[83–85].
Wang et al. have developed a microfluidic chip which first labels CD4+ and
CD8+ T lymphocytes (from buffy coat samples) on-chip using pneumatic
vortexing before hydrodynamically focusing and LIF counting [86]. They
were able to produce CD4/CD8 T cell ratios similar to that found using
standard flow cytometry.
Electrical
We have chosen the electrical detection method for CD4 T cell enumeration
because it would most likely provide the best penetration into the developing
world. An electrical analog of optical microcytometers would likely prove
to be more portable, cost effective, and less complicated. This is mainly
due to the fact that an electrical microcytometer would provide both an
electrical stimulus and electrical feedback for analysis. This would create
a more streamlined setup that eliminates the need for expensive and bulky
lasers, optics, and photodetectors and the requirement of complex image
analysis software. The following is a brief history and theory behind the
electrical enumeration and interrogation of cells, followed by more recent
investigations in the microfabricated paradigm.
The invention of the Coulter Counter by Wallace and Joseph Coulter in
the 1950s was the first major step in the electrical analysis of cellular popula-
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tions. At the time, counting of biological cells and other particles was usually
performed using colorimetry (color density of solution correlated with con-
centration of particles) or by manual counting under a microscope with a
hemacytometer, which were somewhat inaccurate, time-consuming, and re-
quired highly-skilled technicians. The Coulter principle, illustrated in Fig.
2.7, allowed for automatic analysis of a particle population a single particle
at a time. A known volume of particles is pulled by suction through a small
aperture positioned between two electrodes with a constant voltage poten-
tial difference. This DC bias creates a Faradaic current that is temporarily
blocked by the passing of a particle through the aperture, creating current
pulses in time. The amount of current blocked (or the pulse peak amplitude)
is directly proportional to the size of particle, resulting in a system that
provides the size distribution of particle populations [87]. Equation (2.2) es-
timates the change in resistance, ∆R, caused by the passage of a particle of
rP through an aperture of cross-sectional area of AC , in a solution that has


















This not only can be used to obtain concentrations of populations, but also
can discriminate among subpopulations based on particle size, surface charge,
and mobility [89].
Microcytometers using the Coulter principle with DC voltage interrogation
method have been reported [88, 91–94], but size-based analysis alone is not
good enough to differentiate among different cellular populations of similar
size. For example, not only are CD4+ T lymphocytes indistinguishable from
other lymphocytes by size, but they are also similar in size to erythrocytes,
which outnumber the T cells by a ratio of 5,000:1.
As an answer to this problem, investigators have used alternating field
interrogation to differentiate among cell populations. H.P. Schwan’s pioneer-
ing work in the field of dielectric spectroscopy showed that an impedance
“signature” could be found for a particular cell population by varying the
applied voltage signal’s frequency and recording the resultant dielectric con-
stant and conductivity [95–100]. Fig. 2.8 illustrates how the dielectric con-
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Figure 2.7: Coulter principle. A suction system draws particles in solution
E through aperture A, causing a perturbation in the current flowing
between electrodes C and D. B is a highly insulating glass cylinder which
only allows current to pass through the aperture. A more detailed
explanation can be found at the source, [90].
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Figure 2.8: Relative permittivity, ε, and conductivity, σ, of blood cells,
erythrocyte ghost cells, and E. coli bacteria of similar volume fraction.
Respective dielectric dispersions are labeled (δ-dispersion is more subtle,
and denoted by the arrows). All three populations had similar dielectric
signatures, except in the α-dispersion regime, where all three populations
could be distinguished: upper and lower dashed curves correspond to E.
Coli and erythrocyte ghosts, respectively. From [99], used with permission;
c© 1983 Springer.
stant and conductivity of cellular populations are a function of frequency.
The four drops (three distinct, one more subtle) in permittivity correlate
with three different dispersion mechanisms from electrical relaxation phe-
nomena. α-dispersion may be used to understand a cell’s membrane con-
ductivity [97]; β for membrane capacitance [100]; δ and γ for intracellular
protein levels [95,98,99,101]. For example, in Fig. 2.8 suspensions of blood,
erythrocyte ghosts (internal contents replaced with buffer), and Escherichia
coli bacteria each showed similar impedance signatures, except in the alpha
dispersion regime, where they can be easily discriminated. Appendix A de-
tails how electrical characteristics of a cell can be extracted from its dielectric
spectrum.
Coulter and Hogg were the first to apply this principle to enhance the
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Coulter principle by simultaneously using DC and AC signals to distinguish
between two similarly-sized particles of different composition, initiating the
field of impedance flow cytometry [102]. Hoffman and Britt improved the
sensing system to have multiple AC signals in addition to the DC signal to
differentiate between plastic microbeads and mammalian cells [103,104].
The benefits of impedance flow cytometry are enhanced in the microfluidic
regime. Microfabricated electrodes and fluidic channels would decrease the
sensing volume and increase the system’s sensitivity to discriminate among
different cell types. The advancement in electrical instrumentation has en-
hanced impedance sensing to be able to interrogate individual cells at many
discrete frequencies. For example, Sun et al. simultaneously measured the
impedance values of particles at 512 different frequencies via the Maximum
Length Sequence (MLS) technique coupled with Fast Fourier transforma-
tions [105].
An understanding of the physics behind impedance microcytometry is nec-
essary to fully appreciate its advantages over a standard Coulter design that
only interrogates with a static field. Figure 2.9(a) represents a simplified
circuit model of a cell in a microfabricated sensing region. The cell mem-
brane is represented by capacitors (cm) in series with its cytoplasm resistance
(Rc). This agrees with the β-dispersion phenomenon previously described:
higher frequencies will “short out” cm, allowing the external electric field
to penetrate the cell’s interior, causing a sharp reduction in the cell’s total
impedance. Rsol2 represents the resistance of the media around the cell (that
was not displaced by the cell itself), Rsol1 denotes the resistance between
reference electrodes, and Rc is the cell’s cytoplasm resistance. All three re-





where ρsol is the solution resistivity (mostly dependent on ion concentration
and mobility), l is the length of the conduction path in the solution, and A is
the cross sectional area of the conduction path in the electrolyte. Cdl is double
layer capacitance created by the accumulation of charge at the electrode-
electrolyte interface, and is usually 20–50 µF·cm−2 (Fig. 2.10) [106].
Figure 2.9(b) illustrates the simulated complex impedance spectrum of
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Figure 2.9: (a) Simplified electrical model of a cell within a measurement
microchannel with reference electrodes. (b) Dependence of complex
impedance on frequency, revealing various electrical characteristics of the
cell. From [107] - Reproduced by permission of The Royal Society of
Chemistry.
a 10 µm cell within the sensing region illustrated in (a). This shows how
interrogating cells at different frequencies can potentially give valuable infor-
mation that could be used to discriminate among different cell types, discern
cell vitality, and observe cell growth cycles.
Impedance microcytometers have been developed to detect differences in
modified cells. Cheung et al. were able to differentiate between erythrocytes
and erythrocyte ghosts via impedance phase differences in addition to dis-
tinguishing between fixed and unmodified erythrocytes by observing changes
in opacity (ratio of high and low frequency impedances) [110]. Kuttel et
al. discriminated between healthy erythrocytes and those that were infected
with Babesia bovis. The parasite modifies the dielectric properties of the
cells’ cytoplasm, which can be detected by using an 8.7 MHz interrogation
signal [111]. Pierzchalski et al. could detect changes in the cell membrane
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Figure 2.10: Electrical double layer formed around a negatively-charged
electrode in ionic solution. Immediately upon electrode wetting, water
molecules, which have a partial positive charge at their hydrogen atoms,
form a barrier at the electrode-electrolyte interface, called the hydration
layer (specifically adsorbed ions can also attach to the electrode surface). A
second layer, called the diffuse layer, is comprised of hydrated ions that are
more concentrated toward the electrode, creating a charge density gradient
away from the interface. Applying an external potential to the electrodes
will result in a change in electrode charge that is matched by the opposite
charge in the electrolyte. Charge is accumulated and dissipated at the
surface, similar to charging and discharging of a capacitor. [108,109].
From [109], used with permission; c© 2001 John Wiley and Sons.
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potential of RN22 Schwann cells after modifying them in an ionophore solu-
tion [112].
Others have used impedance microcytometry to evaluate cellular processes.
Schade-Kampmann et al. distinguished between dormant and budding Sac-
charomyces yeast cells. They also could electrically differentiate between
healthy and apoptotic Jurkat E3.1 cells [113]. Pierzchalski et al. discrimi-
nated among live, necrotic, and apoptotic MCF-7 breast cancer cells based
on their membrane capacitances at 4 MHz [112]. Cheung et al. noticed a
decrease in impedance phase at 10 MHz correlated with cell death for ho-
mogenous populations of Saccharomyces cerevisiae yeast and Bacillus mega-
terium bacteria [114]. Sohn et al. monitored the life cycle of eukaryotic
cells by observing their capacitance at 1 kHz. They were able to determine
a cell’s current growth phase by observing a positive linear relationship be-
tween the change in capacitance and a cells negatively-charged DNA content
(Fig. 2.11) [115].
Differentiating among different cell types is critical to realize a practical
PoC diagnostic platform. Schade-Kampmann et al. discriminated blood
monocytes from differentiated dendritic cells in addition to 3T3-L1 fibrob-
lasts from differentiated adipocytes [113]. Benazzi et al. distinguished among
three algae (Isochrysis Galbana, Rhodosorus m., and Synechococcus sp.) us-
ing a dual frequency measurement system [116]. Cheung et al. were able to
discriminate among platelets and leukocytes from partially lysed erythrocytes
and also sensed a difference in the impedance of HL-60 myoblast cells and
differentiated macrophages [114]. Holmes et al. have developed an electrical
microcytometer that can differentiate between different leukocyte subtypes,
such as lymphocytes, monocytes, and neutrophils, solely on their impedance
characteristics at two different frequencies (Fig. 2.12) [117,118].
Although much advancement has been made in impedance microcytome-
try, it has still not proven to be sensitive enough to distinguish among differ-
ent cells that may have similar electrical characteristics (cell size, membrane
capacitance, cytosol conductivity, etc.). For example, CD4+ and CD8+ T
lymphocytes have similar morphology, but perform different roles in the im-
mune system. CD8+ T cells, or cytotoxic T cells, express the CD8 antigen on
their membranes and attack and kill cells that are damaged, dysfunctional,
or infected with a pathogen. CD4+ T cells, or Helper T cells, express the
CD4 protein and do not directly attack other cells, but lead the immune
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Figure 2.11: Growth cycle analysis of mouse myeloma cells (SP2/0) created
by flowing the cell population through a capacitance sensing region in a
microfluidic chip. The histogram shows the change in capacitance caused
by cell passage. The inset graph from a flow cytometer’s analysis of the
same population shows good correlation with the chip’s results. From [115],
c© 2000 National Academy of Sciences.
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Figure 2.12: (a) Low frequency impedance vs. opacity (high frequency
impedance / low frequency impedance) scatter plot illustrating electrical
differentiation among different white blood cells types. (b) and (c) are
impedance pulse height histograms for low frequency impedance and
opacity data, respectively. (d) Forward vs. side scatter plot from flow
cytometer for comparison. From [117] - Reproduced by permission of The
Royal Society of Chemistry.
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system’s response by activating and directing other leukocytes to the source
of the problem.
The few that have addressed this problem have enhanced the sensitivity of
electrical interrogation of heterogenous populations through immunoaffinity
assays. The highly specific affinity between a particular cell’s surface anti-
gen and its complementary antibody allows researchers to precisely target a
particular cell type, given its targeted surface antigen is unique.
Wang et al. integrated a commercial metal oxide semiconductor field ef-
fect transistor (MOSFET) with optical fluorescence detection to determine
the percent of CD4+ T cells among a total population of lymphocytes [119].
They have also created a similar system replacing the MOSFET with a two-
stage differential amplification system [120, 121]. However, the added com-
plexity of integrating both electrical and optical measurement systems may
be prohibitive for PoC applications.
Holmes et al. were able to enhance electrical differentiation of CD4+ T
cells from other leukocytes by specifically attaching 2.2 µm CD4 antibody-
cojugated latex beads to the T cells to modify their high and low frequency
characteristics (Fig. 2.13) [122]. They showed good correlation between
their electrical chip-based method and the flow cytometry standard for the
percentages of CD4+ T cells in white blood cell populations. However, the
off-chip bead labeling steps they used would need to be integrated into the
chip itself for this technology to be practical in resource-poor applications—
but is difficult to perform in the laminar flow regime found at the microscale.
Some have used antibodies immobilized onto microfludic channel surfaces
to facilitate a label-free method to distinguish cell types in heterogenous
suspensions. Carbonaro et al. discriminated between CD34+ murine ery-
throleukemia (MEL) cells and human U937 cells by coating the counting
channel with CD34 antibody [123]. The MEL cells interacted with the CD34
antibody, creating larger electrical pulse durations than the CD34- U937
cells that passed through the counter unaffected. As a result, the MEL cells
could be distinguished from the U937 populations based on pulse duration.
However, considerable overlap existed between the two populations, creating
error in detection sensitivity.
Capturing cells of interest may eliminate the inherent error from modi-
fying a cell’s electrical characteristics or passage velocity characteristics, as
both aforementioned methods could not distinguish the population of inter-
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Figure 2.13: The attachment of 2.2 µm latex beads modifies the low
frequency impedance and opacity (ratio of high and low frequency
impedances) of CD4+ T cells enough to separate them from the other
lymphocytes. Monocytes are also CD4+, but express it weakly and their
larger size distinguishes them from the T cells. From [122] - Reproduced by
permission of The Royal Society of Chemistry.
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est enough from other cellular populations for practical portable diagnostics.
Adams et al. developed a microfluidic platform which enumerated low con-
centrations of circulating tumor cells (CTC) using a chamber coated with
antibodies specific to the cells [124]. Whole blood spiked with the CTCs was
flown through the capture chamber, immobilizing the CTCs while the re-
mainder of the blood washed out. A custom buffer was then flowed through
the chamber to digest the antibodies and release the CTCs, which were then
counted one-by-one at a Coulter sensor at the chamber’s exit.
Chemical release of CD4+ T cells post capture has proven to be more dif-
ficult, as the cells may further bond to the substrate nonspecifically through
membrane adhesion molecules. Zhu et al. have shown the capture and re-
lease of CD4+ T cells using electrochemical reactions on microfabricated
electrodes; however some drawbacks are that some cell death occurs after T
cell release (∼10%) and agitation is needed to assist in electrochemical des-
orption, which is more difficult in the laminar flow regime found in a closed
microfluidic chamber [125, 126]. In addition, mass production may be hin-
dered by the fact that the capture region is limited to the area defined by
the electrodes, requiring a PEG gel passivation layer elsewhere to prevent
non-specific cell capture.
Gurkan et al. used a temperature responsive polymer to capture and re-
lease CD4+ T cells [127]. A capture chamber coated with poly(N-isopropylac-
rylamide) (PNIPAAm) was immobilized with CD4 antibody-Neutravidin com-
plexes at 37 ◦C—when the polymer is hydrophobic and prefers interactions
with the Neutravidin. CD4+ T cells are captured at the same tempera-
ture before washing away unbound cells and lysing erythrocytes. The CD4+
T cells are released by decreasing the chip’s temperature below 32 ◦C, when
the PNIPAAm layer becomes hydrophilic, releasing the antibody-Neutravidin
complexes and thereby releasing the CD4+ T cells. They were able to re-
lease 59% of captured CD4+ T cells with high viability (94%). This method
needs to address a few challenges before being a practical PoC device. This
includes ensuring surface chemistry is preserved from manufacture to test
(i.e., storing the chips at ∼37 ◦C) and improving the release efficiency for
accurate CD4+ T cell enumeration.
Instrument-Free CD4+ T Cell Diagnostics Since 2005, the Bill and
Melinda Gates Foundation has been funding a CD4 initiative (centered at
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Imperial College London) to create simple, power-free CD4+ T cell counting
technologies that would lessen the costs of the tests and increase their pen-
etration into resource-poor regions [128]. A semiquantitative immunochro-
matographic strip (ICS) being developed by The Burnet Institute compares
the intensity of gold particles that are specifically attached to CD4+ T cells
at a CD4 capture strip to a reference strip which has a similar intensity to a
known concentration of CD4+ T cells [129]. Therefore, one can tell whether
a patient has a CD4+ T cell count that is less than or greater than a crucial
concentration. For example, a 2009 World Health Organization guideline for
when to start ART is when CD4+ T cell concentrations become less than
350 cells·µL−1 [130]. Zyomyx has developed a device that uses the sedi-
mentation of high density CD4 antibody-conjugated beads to estimate the
concentration of CD4+ T cells from whole blood samples [129, 131]. These
beads specifically attach to the CD4+ T cells and are sedimented with the
help of a manually powered centrifuge. The height of sedimentation in the
column is proportional to the concentration of CD4+ T cells, and is viewed
through a window and compared to calibrated markings to give the CD4+ T
cell count. The device also contains a chamber which used CD14-conjugated








In this chapter, we present our initial approach in developing an electrical
helper T cell counter for resource-poor regions in the world. As mentioned
in Chapter 2, obtaining the concentration of human CD4+ T lymphocytes
(helper T cells) is a necessary method to diagnose patients for AIDS and to
give an accurate prognosis on the effectiveness of anti-retroviral drug treat-
ment (ART). Here, we couple the AC impedance interrogation technique
with 3-dimensional (3D) hydrodynamic focusing in a microfabricated flow
cytometer (microcytometer). We study the effectiveness of the 3D hydro-
dynamic focusing mechanism through fluidic simulations and corresponding
experiments to increase the signal-to-noise ratio of impedance pulses caused
by particle translocation and to give the most accurate representation of par-
ticle size distribution. Helper T cell counts from the microcytometer are then
compared with those found with the flow cytometer using sample volumes
approximately the size of a drop of blood (∼20 µL).
3.2 On-chip 3D Hydrodynamic Focusing
Figure 3.1(a) illustrates the concept of a microfabricated device with 3D hy-
drodynamic focusing that will be used to analyze blood cell populations. It
is comprised of a hydrodynamic focusing region that manipulates cell posi-
tion and an electrical interrogation region that counts individual cells. The
electrical interrogation region is designed after the aforementioned Coulter
principle. A low-frequency (50 kHz) AC voltage signal is applied across
parallel, coplanar micro electrodes, resulting in parabolic current lines that
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Figure 3.1: Concept of electrical microcytometer with 3D focusing
mechanism. (a) Chip-level view of the 3D hydrodynamic focusing and
electrical sensing region (not drawn to scale). (b) The 2D sheaths force
particles in the sample stream to flow in a single-file manner and the (c) 3D
sheath ensures the particles flow consistently close to the sensing electrodes.
(d) Size comparison of chip to a quarter dollar. From [133] - Reproduced by
permission of The Royal Society of Chemistry.
extend upwards toward the top of the channel. A cell or other particle pass-
ing through this region will either enhance or block current, depending on the
relative conductivity of the particle to the surrounding medium. This will
temporarily change the effective impedance of the sensing region, resulting in
an impedance pulse with a width corresponding to the particle translocation
time. In this study, cells are treated as non-conducting spheres at 50 kHz,
which is well below the characteristic frequency, fC , of a cell’s membrane
(> 2 - 3 MHz) [95, 132]. Cell passage will increase the impedance of the
sensing region similar to the polystyrene particles also used in this investiga-
tion. Therefore, particle size (or conversely, the volume of conductive buffer
displaced by the particle) will dominate the impedance pulse amplitude.
Hydrodynamic focusing is a simple but elegant mechanism used in flow
cytometry to ensure accurate population analysis by forcing particles to flow
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in a single-file and spatially consistent manner through the sensing region.
This reduces the possibility of coincidence events, where multiple particles
simultaneously pass through the sensing region, and decreases signal inaccu-
racies from variance in particle translocation position [134]. Hydrodynamic
focusing relies on the concept of laminar fluid flow where a fluid’s viscous
forces dominate its inertial forces, creating a predictable and stable flow in
which multiple streams flow adjacently with little or no mixing. The low
Reynolds number associated with microscale fluidic channels creates an ideal
environment for laminar flow, even at relatively high fluid velocities (in our
case, up to 26 cm·s−1 with a total flow rate of 100 µL·min−1). We take ad-
vantage of this property to ensure cells and other particles flow in a single-file
manner and consistently in close proximity to the sensing electrodes. Fig-
ure 3.1(b) illustrates how we first force particles into a single-file line via
lateral sheath flows. Although this 2D focusing mechanism greatly reduces
the probability of coincidence events, the system still suffers inaccuracy from
the variance of pulse amplitude from particles passing through the sensing
region at varying heights [107]. To solve this problem, we subsequently use a
third sheath to vertically confine the sample stream close to the sensing elec-
trodes, completing the 3D focusing mechanism (Fig. 3.1(c)). This increases
the impedance pulse signal-to-noise ratio by forcing cells to pass through the
highest current line density nearest the electrodes. It also better represents
the size distribution of a particle population by eliminating the variance in
particle translocation height (e.g., larger particle passing farther from elec-
trodes may block the same amount of current as a smaller particle passing
closer to the electrodes). Therefore, one can confidently assume pulse height
is directly proportional to particle size.
An optimal sheath-to-sample flow rate ratio (R) is necessary to create a
sample stream core that is the approximate dimensions of the cells or other





where FSHEATH and FSAMPLE are the sheath and sample infusion flow rates,
respectively. Specifically, R2D represents the flow rate ratio of the laterally
confining sheaths (split from same inlet) to the sample, while R3D represents
the flow rate ratio of the vertically confining sheath to the sample. We use
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simulations to optimize R2D and R3D for the enumeration of helper T cell
concentrations and confirm the results experimentally.
3.3 Materials and Methods
3.3.1 Microcytometer Fabrication
Electrodes Layer
The substrate containing the stimulating/sensing electrodes was fabricated
using standard photolithography and metal lift-off techniques (Fig. 3.2). A
4” Si wafer was piranha cleaned (H2O2:H2SO4, 1:1) and baked on a hotplate
at 120 ◦C for 15 minutes before wet oxidation at 1150 ◦C to obtain a SiO2
thickness of 0.6 µm (not shown in figure). AZ-1518 positive photoresist (AZ
Electronic Materials, Charlotte, NC) was spun on the wafer at 4,000 rpm
for 40 s, soft baked on a hotplate at 90 ◦C for 5 minutes, aligned with the
electrodes mask and exposed for 20 s under a Canon PLA501F 4” mask
aligner (Canon Corp., Tokyo, Japan). The photoresist was then developed
in AZ Developer (AZ Developer:DI water, 1:1) for 1 minute, rinsed thor-
oughly with DI water for 2 minutes, dried with N2, and hard baked at 110
◦C for 2 minutes (Fig. 3.2(a)). The wafer was submerged in buffered HF acid
(BHF; 6:1) to etch 300 nm of the exposed SiO2 and create recesses for the
electrodes (Figure 3.2(b)). After thorough rinsing with DI and N2 drying,
electrodes were created by depositing a 30 nm adhesion layer of Ti and subse-
quent 270 nm layer of Pt using an Airco FDC 1800 electron beam evaporator
(Airco-Temescal, Berkeley, CA) (Figure 3.2(c)). The wafer was then placed
in acetone overnight to remove the underlying photoresist and lift off the
unnecessary metal, resulting in the desired recessed electrode pattern (Fig.
3.2(d). Wafers were diced using a Disco DAD-6TM dicing saw (Disco Hi-Tec
America, Raleigh, NC). The recessed electrodes ensured optimal bonding of
the fluidic layer (described below) by eliminating the abrupt step height of
the electrodes.
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Figure 3.2: Fabrication process flow for both electrical sensing (left) and
microfludics (right) layers, covalently coupled by oxygen plasma bonding of
the PDMS and SiO2 surfaces (not drawn to scale). From supplemental




The microfluidic channels were created by a standardized and rapid technique
using a thick negative photoresist (SU-8; Microchem Corp., Newton, MA)
and a biocompatible polymer, Polydimethylsiloxane (PDMS; Dow Corning,
Midland, MI). A 4” Si wafer was piranha cleaned and baked at 120 ◦C for
15 minutes before spinning on SU-8 negative photoresist to a thickness of 30
µm. After soft-baking (65 ◦C for 3.5 minutes, then 95 ◦C for 9 minutes),
the wafer was exposed for 22 s under the 5” mask aligner and submerged
in SU-8 Developer for 4 minutes, rinsed with isopropyl alcohol, and hard
baked at 120 ◦C for 20 minutes (Fig. 3.2(e)). A positive mold of the 32
µm-high channels was created by pouring uncured PDMS (10:1 ratio of pre-
polymer to curing agent) onto the negative SU-8 mold and polymerizing it
for 8 hours at 65 ◦C (Fig. 3.2(f)). After curing, PDMS dies were cut out,
peeled off, and holes corresponding to the sheath inlet, sample inlet, and
output were punched out using a customized syringe needle (Fig. 3.2(g)).
A hermetic seal between the PDMS and substrate was formed by oxidizing
both with O2 plasma (200 W, 1 Torr, 35 s) in a barrel etcher followed by
quick alignment of channels to electrodes and bonding (Fig. 3.2(h)). Cured
PDMS dies were cut out and holes corresponding to the 2D and 3D sheath
inlets, sample inlet, and outlet were punched out using customized syringe
needles. A hermetic seal between the PDMS and substrate was formed by
oxidizing both with O2 plasma in a barrel etcher followed by quick alignment
of channels to electrodes and bonding. The plasma creates silanol groups on
the PDMS which makes it hydrophilic, enabling it to covalently bond with
the SiO2 layer on the substrate [135]. Microbore tubing was inserted into
the three inlets and sealed with epoxy to create a fluidic pathway between
the chip and three Harvard syringe pumps (Harvard Apparatus, Holliston,
MA), enabling independent control over each inlet infusion rate. Tubing was
also inserted into the waste port to ensure proper containment of biological
waste.
3.3.2 Electrical Impedance Sensing Setup
Figure 3.3 illustrates the experimental setup used to hydrodynamically ma-
nipulate and electrically interrogate cell and particle populations. The SR
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850 lock-in amplifier (Stanford Research Systems, Inc., Sunnyvale, CA) was
used to apply a 4 V (rms) internally-referenced 50 kHz sinusoidal signal across
the resistor R and the platinum electrodes (14 µm wide, 7 µm gap). The
value of R was chosen to match the impedance value of the channel sensing
region at 50 kHz in order to facilitate the highest sensitivity when a cell or
particle perturbs it. An Agilent 4284 LCR meter (Agilent Technologies, Inc.,
Palo Alto, CA) was used to find the impedance spectrum of the electrodes
in PBS for the 102 to 106 Hz frequency range, and an R value of 10 kΩ was
obtained. Real (X) and Imaginary (Y) impedance signals were exported from
the lock in amplifier and recorded in binary format on a computer running NI
LabVIEW via a PCI-6221 DAQ card (National Instruments, Austin, TX).
Matlab (The MathWorks, Natick, MA) was used to convert the NI binary file
into a text format to be read in by the Axon Clampfit 10 software (Molecu-
lar Devices, Sunnyvale, CA). Clampfit was used to adjust the baseline of the
impedance signal, filter out excess noise, and analyze the impedance pulses
using the threshold search method. This method only records a pulse when
its amplitude is at least the same as the trigger level (in our case, set as a
multiplicative factor of the standard deviation of the noise of the baseline
signal without cells or particles). Three syringe pumps were used to inde-
pendently control the sample, 2D sheath, and 3D sheath inlet flow rates in
order to facilitate and investigate the 3D hydrodynamic focusing of particles
and cells. A sensitive Pixera Penguin 600CL CCD camera (Pixera Corpora-
tion, San Jose, CA) coupled to a Nikon Eclipse E600FN microscope (Nikon
Instruments, Inc., Melville, NY) was used to observe cells and beads passing
through the sensing region, ensuring particles were being focused and that
impedance pulses were from particle passage.
3.3.3 Simulations of 2D and 3D Focusing of Sample Stream
The FLUENT Computational Fluid Dynamics simulation package (ANSYS,
Lebanon, NH) was used to find the optimal flow rate ratios between the
sample inlet and each of the 2D and 3D sheath inlets. Experiments, described
below, were performed to evaluate the accuracy of the 2D and 3D focusing
simulations.
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Figure 3.3: Experimental setup: syringe pumps control sample and sheath
flows through the sensing region, which is connected to the external circuit
via micro-manipulators (not shown). From [133] - Reproduced by
permission of The Royal Society of Chemistry.
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3.3.4 2D Focusing of Sample Stream of Trypan Blue
The optimal R2D was obtained experimentally by independently varying the
infuse rates of the 2D sheath and sample inlet syringe pumps. Trypan Blue
dye was infused into the sample inlet to distinguish the sample flow stream
from the sheath flow streams. The sample stream width was precisely mea-
sured by analyzing micrographs taken using a digital video camera coupled
to a microscope. This analysis was performed on a chip with a glass substrate
to enhance the contrast of the sample stream via microscope backlight. No
3D sheath inlet was punched into the PDMS microfluidics layer.
3.3.5 3D Focusing of Polystyrene Particles
The optimal 3D sheath flow rate ratio was experimentally found by focusing
7.32 µm polystyrene microparticles (Bangs Laboratories, Inc., Fishers, IN)
by varying R3D and observing the change in the average and distribution of
impedance pulse heights. R2D was locked at the optimal ratio found in the 2D
Trypan Blue experiment. The total flow rate was locked at a constant value
to ensure constant bead velocity through the sensing region for all 3D flow
ratios because it was found that the average pulse heights would decrease for
increasing bead velocities (unpublished data). The shorter pulses in the time
domain from faster bead velocities result in a broader spectrum of frequency
components that are lower in amplitude; eventually, the higher frequency
components are clipped out by the lock-ins low pass filter. The microbeads
were diluted in phosphate buffered saline (PBS), sonicated for 5 minutes to
reduce bead aggregates, and infused into the sample port at a flow rate of 4
µL·min−1 with a total flow rate (2D sheath + 3D sheath + sample) of 100
µL·min−1.
3.3.6 CD4+ T-Lymphocyte Concentration Comparisons
It is imperative that the microfabricated chip can reliably provide cell counts
that are comparable to the industry standard method of flow cytometry. In
this study, we compared our device to the Becton Dickinson LSR II Flow
Cytometer (Becton Dickinson, Franklin Lakes, NJ) by analyzing varying di-
lutions of cultured 8E5/LAV cells, a human lymphoblastic cell line from
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ATCC (Manassas, VA). Cells were cultured two to three times a week in
RPMI-1640 media (ATCC) with 10% fetal bovine serum (Fetalplex, Gemini
Bio-Products, West Sacramento, CA) and kept in a 5% CO2 incubator at
37 ◦C. Various dilutions of the lymphoblasts were created by the following
method. Approximately 10 mL of 8E5/LAV cell suspension was spun down
into a pellet using an Eppendorf 5810R refrigerated centrifuge (Eppendorf
International, Hamburg, Germany) at 4 ◦C and 200 x g for 10 minutes. The
pellet was resuspended in PBS + 1% bovine serum albumin (BSA), pelleted
a second time, and resuspended in 1 mL PBS + 1% BSA to obtain a high
concentration of cells (5 x 106 mL−1). A dilution series was then created to
give concentrations ranging from 103 to 5 x 106 cells·mL−1. Cells were kept
on ice during the entire experiment. Each dilution was then injected into the
sample inlet via syringe pump at a rate of 4 µL·min−1 with the 2D and 3D
sheath pumps infusing PBS at their respective optimal rates. Cell concen-
tration was found by dividing the number of pulses by the known amount
of sample volume flown during a 5 minute time period (20 µL total volume
flown). The BD LSR II flow cytometer was then used to obtain the con-
centration of aliquots from the same dilutions. A known volume of a known
concentration of FITC fluorescent beads (Bangs Laboratories) was mixed
with each cell dilution. The beads were gated on the FITC channel with
an event stop value of 10,000 total beads. Cellular events were gated based
on their forward scattering (FSC) and side scattering (SSC) characteristics.
Cell concentrations were calculated by the ratio of cellular events to bead
events, multiplied by the known concentration of counting beads.
3.4 Results and Discussion
3.4.1 Optimal Flow Ratios for 2D and 3D Focusing of
Particles
A 3D representation of the fabricated 200 µm wide and 32 µm high mi-
crochannels was constructed using hexahedral cells1 (∼175,000) in the Gam-
bit mesh generation software (ANSYS) and imported into FLUENT. A vol-
1To avoid ambiguity, the “cell” referenced in this section refer to discrete volumes used
in finite element modeling, unless otherwise noted.
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ume of fluid (VOF) multiphase model was constructed assuming laminar,
incompressible, immiscible, and isothermal flows as well as a no-slip condi-
tion at all sidewalls. The optimal R2D was obtained by performing multiple
simulations with R2D ranging from 1 to 16 with the 3D sheath flow velocity
set to 0. After 2,500 iterations, the sample stream width, WS, was deter-
mined by measuring the width of cells which contain at least a 50% volume
fraction of the fluid from the sample fluid.2
Experiments were performed to compare WS dependence on R2D from
the simulation results using Trypan Blue dye to distinguish the sample flow
stream from the sheath flow streams. 50% (v/v) Trypan Blue and DI water
were infused into the sample and sheath inlet ports, respectively. Infusion
rates for both sample and 2D sheath pumps were varied to match the flow rate
ratios in the simulations. Micrographs were taken 30 s after changes in R2D
to ensure the system was stable. WS values were obtained by comparing the
dyed stream to the known channel width. Figure 3.4 illustrates the positive
correlation between the sample stream and the flow rate ratio. A lower
flow rate ratio results in more sheath volume at the channel junction, which
displaces the sample stream and causes it to become thinner. A R2D ratio of
8 gives a WS of 12.3 µm, which proves to be the optimal focusing condition
for the cultured lymphoblasts. This is similar to the simulated results of 12
µm for the same R2D ratio, as shown in Fig. 3.5(a). Figure 3.5(h) shows the
decaying exponential dependence of WS on R2D and the strong agreement
between the experimental and simulated results. This consistency ensures
that cells of particular size can be predictably focused into a single-file line
at the corresponding flow rate ratio.
The optimal R3D was obtained through simulations by locking R2D at 8,
and varying R3D from 1 to 16. Figure 3.5(h) illustrates the decaying ex-
ponential dependence of sample stream height, HS, on R3D. Figure 3.5(f)
shows that an R3D of 8 gave the optimal HS of ∼10 µm, creating a sample
stream core with the same dimensions of blood cells. This size ensured cells
and particles would stay in close proximity to the sensing electrodes but was
large enough to keep them within the sample flow stream. Experiments were
performed to test the accuracy of these simulations as well as the reliability of
our 3D focusing mechanism. Polystyrene beads were injected into the sample
2The volume fraction of a cell is the percentage of cell volume that contains the phase
of interest.
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Figure 3.4: Micrographs of 2D focusing region with Trypan blue sample for
various R2D values. From supplementary materials from [133] - Reproduced
by permission of The Royal Society of Chemistry.
inlet at identical R2D and R3D values to those tested in FLUENT, and 5 min-
utes of impedance data was recorded (20 µL). Clampfit was used to record
and analyze pulses that were at least four times the standard deviation of the
baseline noise. Figure 3.6(a) illustrates how bead impedance pulses become
more uniform with R3D = 8, (iii), versus no 3D focusing, (ii), showing that
the beads were indeed flowing closer to the electrodes at a higher consistency.
This can be quantitatively reflected in the increase in mean and decrease in
standard deviation of the pulse amplitude for a duration of 4 s from (ii) to
(iii). Figure 3.6(b) shows the percentage change, %∆µZ , in average pulse
height for varying R3D values and the corresponding percent change in stan-
dard deviations, %∆µZ , for the entire 5 minutes of analysis. %∆µZ is the
normalized difference between average pulse height amplitudes for R3D > 0





%∆σZ is calculated in the same way, but replacing µX and µ0 with σX and
σ0, respectively. The positive correlation between pulse amplitude and R3D
for R3D = 1 to 8 shows that the beads were successfully being manipulated
to flow closer to the sensing electrodes and block a higher percentage of cur-
rent. It was found that R3D = 8 resulted in the largest increase of average
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Figure 3.5: (a) FLUENT simulation of 2D hydrofocusing of the sample
stream for R2D = 8, giving an optimal sample stream width of 12 µm. (b -
g) Height profile of sample stream for R3D values of 0, 1, 2, 4, 8 16,
respectively; profile was taken parallel to the Y axis, as denoted in (a). (h,
top and right axes) Comparison between experimental (open circles) and
simulated (solid triangles) results for WS for various R2D values; dash-dot
line represents exponential fitting of simulated data (R2 = 0.992). (h,
bottom and left axes) Sample stream height dependence on R3D from
simulations with labels linking points to corresponding simulations in (b -
g); dashed line represents two-phase exponential association fitting (R2 =
0.999). Adapted from [133].
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pulse amplitude (44.4%) and largest decrease in pulse amplitude standard
deviation (15.4%) versus no 3D focusing. R3D = 16 resulted in a decrease in
mean amplitude and increase in standard deviation most likely because the
sample stream height was too small (∼6 µm in simulations, Fig. 3.5(g)) to
consistently contain the 7.32 µm particles. Its 30.8% increase in standard
deviation over no 3D focusing (R3D = 0) could be from the fact that many
particles could not stay within the sample stream and were forced into the
sheath at varying heights above the electrodes. Figure 3.6(c) compares the
pulse height distributions between beads undergoing no 3D focusing and op-
timal focusing (R3D = 8). The differences between the pulse distributions
show that the optimal 3D focusing of the particles results in a better repre-
sentation of particle size distribution. In the case of no 3D focusing, the pulse
distribution is of decaying exponential nature. Optimal focusing results in a
Gaussian distribution, which is expected for the discrete-sized microparticles
with a mean diameter. This eliminates pulse amplitude ambiguity caused by
variance in particle translocation height above the sensing electrodes. Figure
3.6(d) shows the pulse duration histogram for no 3D focusing and optimal
3D focusing. Optimal 3D focusing gives a larger average duration because
particles are flowing closer to the electrodes, where the field line distribution
covers more distance in the direction of particle flow. The 39.9% decrease in
standard deviation at optimal focusing conditions further supports that the
beads were translocating at a more consistent height above the electrodes.
3.4.2 T Cell Concentration Comparison
T cell counts using the electrical microcytometer were compared against the
BD LSR II flow cytometer for concentrations ranging over three orders of
magnitude (103 to 2 x 106 cells·mL−1) with the majority of concentrations
within the critical range of < 500 cells·µL−1 for HIV/AIDS diagnostics. 20
µL of each sample was analyzed by the microcytometer under optimal 3D
focusing conditions (R2D = R3D = 8). Clampfit was used to obtain each sam-
ple concentration by denoting a cellular event as a pulse that was at least five
times the standard deviation of the baseline noise. As a control, aliquots from
the same samples were then analyzed by the LSR II flow cytometer. Figure
3.7 compares the LSR II data, (a), with that of the microcytometer, (b). The
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Figure 3.6: Effect of 3D focusing of 7.32 µm polystyrene particles on
electrical analysis. (a) (i) Baseline impedance signal (no beads), (ii) signal
with beads and no 3D focusing (R3D = 0) with pulse amplitude statistics
for 4 s duration, and (iii) signal with beads and optimal 3D focusing (R3D=
8) with pulse amplitude statistics. (a, inset) Magnification of a single
impedance pulse and the concept of threshold analysis using a trigger that
is four times the standard deviation of the noise in (i); pulse duration is
calculated from the intersection of the pulse with the trigger, while pulse
magnitude is simply the maximum height within the pulse duration. (b)
Percent change in mean pulse magnitude, %∆µZ (triangles, solid line), and
standard deviation, %∆σZ (squares, dash-dot line), relative to R3D = 0 for
various R3D values. Number of triggered events (R3D value in parentheses):
n = 5,199 (0), n = 17,157 (1), n = 11,106 (2), n = 11,869 (4), n = 13,355
(8), and n = 3,457 (16). (c) Pulse height distribution comparison between
R3D = 0 and R3D = 8; statistics shown are from raw data; curve fitting is
used to show how the distribution drastically changes from decaying
exponential for R3D = 0 (R
2 = 0.95) to Gaussian for R3D = 8 (R
2 = 0.97).
(d) Pulse duration (relative to 4x trigger level) distribution comparison
between R3D = 0 and R3D = 8; statistics shown are from Gaussian curve
fittings (R2 = 0.94 for R3D = 0 and R
2 = 0.92 for R3D = 8). For both (c)
and (d), an outline of the R3D = 0 distribution is shown when it is
overlapped by the R3D = 8 distribution. From [133] - Reproduced by
permission of The Royal Society of Chemistry.
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FSC histogram in Fig. 3.7(a) shows the cell size distribution found using the
flow cytometer, which can be compared to the pulse height histogram of the
electrical microcytometer in (b). There is a noticeable difference between the
two histograms in that the FSC histogram contains a secondary peak, which
denotes live cells. As previously mentioned, in impedance spectroscopy, cells
are treated as non-conducting spheres at frequencies well below fC . Frequen-
cies higher than fC effectively short the capacitance of the cell membrane
via relaxation mechanisms (β-dispersion) [95], which allows for the investi-
gation of the internal electrical characteristics of the cells such as cytoplasm
conductivity and DNA content that could give more insight into whether a
cell was alive or dead. In our case, the cells are treated as non-conducting
spheres. Therefore, it was necessary to gate whole cells in the LSR II data
for a fair comparison with the data from the electrical counter, as illustrated
in the inset of Fig. 3.7(a).
The following is our logic in gating whole cells for the flow cytometry data.
In flow cytometry, the magnitude of forward scattering depends proportion-
ally on cell size and refractive index, while side scattering depends on the
complexity of the cells interior (e.g., granularity) [134]. A whole cell that is
dead or dying will have a compromised membrane, allowing surrounding me-
dia to enter, which effectively reduces the refractive index of the cell and the
level of forward scattering. Side scattering will roughly remain unchanged
between living and dead/dying cells because cellular contents still remain
intact inside the membrane. Therefore, whole cellular events are gated on
the entire FSC range and the limited SSC range ( ∼375 arbitrary units) as
depicted in regions 1 and 2 in the inset of Fig. 3.7(a).
The inset of Fig. 3.7(b) represents the relationship between impedance
pulse height and pulse width (measured with respect to 5x trigger) for the
microcytometer. It is interesting to note that we observed two different pop-
ulations for cells analyzed by the electrical microcytometer, which could not
be distinguished by the aforementioned pulse height histogram. The events
in region 1 show a strong positive correlation between the peak amplitude
and duration, which is expected for non-conducting spheres. However, the
events in region 2 show a higher variance in duration over a smaller am-
plitude range. We postulate that these are dead or dying whole cells with
compromised membranes or ionic channels. These cells cannot be modeled
as non-conducting particles, as electrical conduction can take place within
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Figure 3.7: Comparison between the analysis of aliquots from the same
sample of helper T cells by flow cytometer and electrical microcytometer.
(a) LSR II flow cytometer analysis; FSC histogram relates cell size
distribution while the inset FSC vs. SSC scatter plot illustrates the two
sub-populations of whole cells: living (region 1) and dead/dying (region 2).
(b) Electrical microcytometer analysis; pulse amplitude histogram shows
cell size distribution; inset scatter plot shows relationship between cell
translocation time and peak amplitude, and distinguishes between live
(region 1) and dead/dying (region 2) cells. The percent of live whole cells
was calculated by dividing the number of events in region 1 by the total
number of whole cells (regions 1 and 2). (c - h) Micrographs of focused
helper T cells illustrating their large size variation: (c) healthy cell (8.7 µm
in diameter), (d) dead/dying cell (18.2 µm), (e) multiple cells flowing in a
single-file manner, and clumps of cells as (f) doublets, (g) triplets, and (h)
quadruplets. White scale bars are 75 µm. From [133] - Reproduced by
permission of The Royal Society of Chemistry.
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the cell, reducing the effective impedance of the cell. The large variance in
duration in this region can be explained by the fact that the cells were un-
dergoing apoptosis and increased in size. This will increase the translocation
time of the cells, but will have little effect on pulse amplitude because of the
cells’ compromised membranes. Using this theory, we found that the fraction
of live T cells found by the microcytometer matched closely with that of the
LSR II flow cytometer for a aliquots from the same sample (40.7% vs. 41.2%,
respectively). Figure 3.7(c - h) illustrates how cell size can vary from 8.7 µm
with a healthy T cell (c), to over twice as large during apoptosis (d), or even
larger via clumping of multiple cells (f - h).
Figure 3.8 shows the correlation of 13 concentration values found from
the electrical microcytometer and the LSR II flow cytometer. Each point
represents one particular dilution that was measured by both methods. The
microcytometer proved to perform well for the whole range of concentrations
tested, especially in the critical concentration range of < 500 cells·µL−1 (n =
11; R2 = 0.95), even considering that measurements were taken from different
aliquots of the same dilution and includes inherent pipetting error.
3.5 Conclusions
We have investigated a microfabricated AC impedance analysis system for the
electrical counting of CD4+ T lymphocytes for point-of-care blood analysis.
The two-stage 3D focusing mechanism was easily fabricated using a single
microfluidics layer, and ensured cells and particles flowed in a single-file line
and consistently close to the sensing electrodes. This not only enhanced the
sensitivity of the devicegiving CD4+ T lymphocyte counts comparable to an
industry standard flow cytometer—but ensured accurate representation of
the size distribution of the population, which can help differentiate among
different cell types in heterogeneous populations and aid in understanding cell
growth cycles in homogenous populations. In addition, we found that it has
the capability to differentiate between live cells and those with compromised
membranes, providing the possibility of on-chip live/dead cell counts. A
simple-to-use handheld device can be realized via a simplified chip or IC-
based lock-in amplifier and a miniaturized pumping system. This design will
provide an inexpensive and reliable back end to a totally autonomous blood
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Figure 3.8: Concentration comparison between the electrical counter and
the LSR II flow cytometer for the full range of the 13 concentrations
analyzed (10 to 2,000 cells·µL−1). The dash-dot line is a linear regression
for the 11 samples (R2 = 0.95) within the critical range (< 500 cells·µL−1)
and indicates good correlation between the two methods. The dashed line
denotes 1:1 correlation between both analysis methods. From [133] -
Reproduced by permission of The Royal Society of Chemistry.
cell counter which selectively isolates and subsequently counts a specific cell




FOR CD4+ T LYMPHOCYTES
4.1 Introduction
The previous chapter showed that it is feasible to obtain accurate counts for
homogenous populations of cultured CD4+ T lymphocytes using electrical
impedance sensing in a microfabricated biochip [133]. However, a next major
step toward a practical point-of-care (PoC) device was needed to selectively
enumerate the T cells among the various cell types found in blood. This
chapter describes one method in obtaining an absolute CD4 T cell count
using a differential counting method with two electrical impedance sensors.
Specifically, we have developed a microfabricated biochip that enumerates
CD4+ T lymphocytes from leukocyte populations obtained from partially-
processed human blood samples (erythrocytes are lysed off-chip) using elec-
trical impedance sensing and immunoaffinity chromatography. T cell counts
are found by obtaining the difference between the number of leukocytes be-
fore and after depleting CD4+ T cells with immobilized antibodies in a cap-
ture chamber. This differential counting technique has been validated to
analyze physiological concentrations of leukocytes with an accuracy of ∼9
cells·µL−1 by passivating the capture chamber with bovine serum albumin.
In addition, the counter provided T cell counts which correlated closely with
an optical control (R2 = 0.997) for CD4 cell concentrations ranging from
approximately 100 to 700 cells·µL−1. We believe that this approach can
be a promising method for bringing quantitative HIV/AIDS diagnostics to
resource-poor regions in the world.
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4.2 Principle
Figure 4.1(a) depicts the microfabricated differential counting device that
uses affinity chromatography, electrical impedance sensing, and a reverse-
flow method to selectively enumerate CD4+ T cells. The main feature of
the chip is its large capture chamber, which is conjugated with anti-human
CD4 antibody to selectively isolate and deplete all CD4+ T cells from the
heterogeneous leukocyte population, which we have described previously [51].
Monocytes also express the CD4 antigen and bind to the capture region, but
can be removed by the application of a controlled shear stress, as monocytes
contain an order of magnitude less CD4 surface antigen than T cells [51,136,
137]. The electrical sensors are designed to count individual cells using the
Coulter principle, where the passage of a cell perturbs the electrical current
within an orifice, creating a distinct impedance pulse. The chip contains two
such counters, both configured to measure the relative impedance change
caused by the passage of a cell. Specifically, each counter is comprised of three
electrodes, configured so that the impedance signal between electrode pairs
B and C is subtracted from the signal between pairs A and B (4.1(b, right
panel)). This self-referencing design is valuable in impedance spectroscopy
in microfluidics [107,138]—and is especially useful in our case, as it identifies
which direction cells are flowing within the chip. A single cell entering the
chip through the entrance port creates an up-down pulse pair, while cells
exiting back out of the entrance port create down-up pulse pairs (Fig. 4.1(b-
c, right panel)).
Figure 4.1(b-d) illustrates the reverse-flow differential counting method
used to obtain accurate and objective cell counts. Red blood cells from
whole blood samples are lysed off-chip, and a pure leukocyte population
is injected into the chip’s entrance. All white blood cells are counted as
they pass through the entrance counter and enter a chamber functionalized
with CD4 antibody. This capture chamber depletes CD4+ T cells from the
leukocyte population (Fig. 4.1(b)). Flow direction is reversed once cells are
detected at the exit counter, and uncaptured or non-specifically bound cells
are washed back out of the chip’s entrance after being enumerated again by
the entrance counter (Fig. 4.1(c)). Figure 4.1(d) depicts a completed exper-
iment in which the capture chamber contains only specifically bound CD4+
cells. The differential count depicts the number of captured CD4+ T lym-
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Figure 4.1: Principle of electrical differential counting of CD4+ T cells. (a)
Graphically-rendered image depicting the chip’s geometry, specifically its
two electrical counters and capture chamber. (b-d) Cross-sectional views of
the chip during an experiment: (b) forward flow direction to obtain total
leukocyte count at the entrance counter, (c) reverse flow direction and
enumeration of uncaptured cells after leukocytes reach the exit sensor, and
(d) finished experiment after all unbound leukocytes are washed from the
capture chamber. The concentration of CD4+ cells can be obtained simply
by normalizing the differential count by the known sample volume (d, right
panel). The right panels of (b) and (c) illustrate how cell flow direction at
the entrance counter can be determined by the change in pulse signature
polarity, with the pulse signature changing from up-down (b) to down-up
(c) in time. From [139] - Reproduced by permission of The Royal Society of
Chemistry.
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phocytes by obtaining the difference between the forward and reverse counts.
Actual helper T cell concentrations can simply be found by normalizing this
difference to the volume of sample flown into the chip.
Although this application is focused on CD4+ T cell enumeration for
HIV/AIDS diagnostics, it can be expanded to analyze other cell types simply
by choosing different capture antibodies for the particular cell surface antigen
of interest.
4.3 Materials and Methods
4.3.1 Channel and Sensor Design
Each counter was comprised of a 15 µm-wide and 15 µm-high microchan-
nel that funneled the cells over three 10 µm-wide platinum electrodes (with
10 µm spacings). The counting channel dimensions were chosen to be large
enough to facilitate leukocyte passage without clogging (leukocytes have an
average diameter of ∼13 µm) [140], but small enough to ensure the cells
flowed past the electrodes in a single-file manner with small variation in pas-
sage height to ensure consistent enumeration of cells [107,133]. The counting
electrodes’ dimensions were chosen to provide adequate spatial resolution (50
µm) and to create a sensing region volume of ∼11 pL (50 µm x 15 µm x 15
µm), both to ensure coincident events would not occur for leukocyte con-
centrations up to ∼9 x 104 cells·µL−1, well above the 4 11 x 103 cells·µL−1
physiological range found in humans [11].
The 50 µm height of the capture region was chosen to provide a large
enough sample volume of ∼7 µL for an accurate depiction of a patient’s
health and to ensure proper shear stresses at the fluid-wall interface for opti-
mal CD4+ T cell capture. According to Cheng et al., a shear stress greater






can be used to estimate the shear stress at the walls of a rectangular mi-
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crofluidic channel of a constant width, ω1, where µ is the dynamic viscosity
of the fluid, Q is the volumetric flow rate, and h is the height of the chan-
nel [141]. This shows the sensitive, inverse-squared relationship between the
channel height and the shear stress at the chamber’s floor and ceiling. If the
capture chamber remained the same height as the counter channels (15 µm),
the capture chamber would give a shear stress of over 5.5 dyn·cm−2 at Q
= 5 µL·min−1, which would be over the aforementioned 3 dyn·cm−2 upper
boundary. However, a 50 µm capture chamber height significantly reduces
the average shear stress to 0.5 dyn·cm−2, greatly increasing the interactions
between the cells’ surface antigens and the immobilized Ab, which facilitate
cell capture. The 34 mm capture chamber length ensured sufficient interac-
tion time (∼80 s at sample flow rate of 5 µL·min−1 for flowing in a single
direction).
Three-dimensional hydrodynamic focusing was desired, as it may result in
an increase in impedance pulse signal-to-noise ratio and lessen the possibility
of clogging [133]. However, it would have effectively increased the entrance
flow rate (∼125 µL·min−1 for a 5 µL·min−1 cell sample flow rate), resulting
in a capture chamber shear stress of 11.1 dyn·cm−2, which is well beyond the
maximum to facilitate CD4 T cell capture. In addition, the cell passage time
through the 15 µm x 15 µm counter pore at this flow rate would result in
transition times faster than 90 ns, which is well below the minimum transi-
tion time of ∼2 µs that can be resolved using the lock-in amplifier described
in the experimental section. As a result, samples were filtered before infusion
into the chip to prevent clogging the 15 µm counting pores. It was found that
the 15 µm counting pore height was small enough to ensure cells passed con-
sistently close to the coplanar sensing electrodes to create accurate particle
size distributions [133].
4.3.2 Differential Counter Fabrication
Fabrication of the differential counter is illustrated for one counter region in
Fig. 4.2(a-g).
The electrical sensing layer was fabricated using the standard metal lift-off
process. A 4” glass wafer (Pyrex 7740) was first spin-coated with LOR2A
liftoff resist (Microchem Corp., Newton, MA), soft-baked at 183 ◦C for 5
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minutes and then coated with Microposit S-1805 photoresist (Rohm and Haas
Electronic Materials, Marlborough, MA). After another soft-bake at 110 ◦C
for 90 s, the wafer was aligned to the electrodes mask on a Quintel Q7000
mask aligner and exposed for a total dose of 2.8 mJ·cm−2. The wafer was
then placed on a 110 ◦C hotplate for a 60 s post-exposure bake before being
immersed into Microposit MF CD-26 developer (Rohm and Haas Electronic
Materials) for 80 s and rinsed with DI water for 2 minutes (Fig. 4.2(a)).
The wafer was then de-scummed in an O2 plasma system for 20 s before
being placed in a CHA SEC-6000 evaporator (CHA Industries, Fremont,
CA) for the deposition of 25 nm of Ti adhesion layer, followed by a 75 nm Pt
conduction layer (Fig. 4.2(b)). The undesired metal was lifted off by placing
the wafer in a 70 ◦C bath of Microchem Remover PG for 15 minutes, creating
the necessary conduction paths for the counters (Fig. 4.2(c)).
The multi-height fluidics layer was created by fabricating a negative image
of the desired channels using Microchem SU-8 25 photoresist. SU-8 25 was
spun on a 4” Si wafer to a height of 15 µm, and was pre-baked in two
steps for 2 minutes at 65 ◦C and then 95 ◦C for 5 minutes. The wafer
was then aligned and exposed to a mask defining all of the fluidic channels,
including the capture region, counters, sample inlet and outlet, and antibody
functionalization ports (Fig. 4.2(d)). A second layer of SU-8 was spun on to
obtain a total thickness of 50 µm for the entire wafer, and was pre-baked first
at 65 ◦C for 5 minutes and then 95 ◦C for 15 minutes. The wafer was then
exposed to a second mask that only defined the capture chamber, allowing it
to have a height of 50 µm, compared to the other fluidic regions of 15 µm in
height. The wafer was developed in Microchem SU-8 developer for 2 minutes
at room temperature, rinsed with isopropyl alcohol, and hard-baked at 125
◦C for 15 minutes (Fig. 4.2(e)). Poly(dimethylsiloxane) (PDMS), 1:10 ratio
of curing agent to base, was poured over the negative mold and allowed to
cure overnight at 65 ◦C (Fig. 4.2(f)). The polymerized mold was peeled off,
and ports were punched for all inlets and outlets using a blunt syringe needle.
A sealed fluidic chip was completed by aligning and bonding the electrode
sensing layer to the fluidics layer after oxygen plasma activation in a bar-
rel etcher (Fig. 4.2(g)). Teflon microbore tubing was used to make fluidic
connections among the chip, valves, and syringe pumps.
Figure 4.2(h) compares the footprint of the completed chip to a U.S. dime,
suggesting that the device could be manufactured as a single-use, disposable
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Figure 4.2: (a - g) Microfabrication process flow for the electrical
differential counter chip. (h) Fabricated chip compared to the size of a U.S.
dime (scale bar length is 10 mm). (i) Micrograph of an entrance counter
region, depicting the three-electrodes setup, narrow counter channel, and 50
µm-high capture chamber (scale bar length is 100 µm). From [139] -
Reproduced by permission of The Royal Society of Chemistry.
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chip. Figure 4.2(i) is a micrograph of the entrance counter region.
4.3.3 Obtaining Purified Leukocytes from Whole Blood
Red blood cells were lysed before flowing samples through the differential
counter chip, as the concentration of erythrocytes would be too high to an-
alyze at the desired flow rates and could also introduce additional counting
error. On the day of the experiment, 4 mL samples of whole blood from
healthy donors were collected in EDTA-coated Vacutainer tubes (BD Bio-
sciences, Franklin Lakes, NJ). Twelve mL of lysis solution (0.12 % (v/v)
formic acid and 0.05% (w/v) saponin in DI) was added to 1 mL of whole
blood and incubated for 6 seconds with agitation. Lysis was immediately
stopped by the addition of quenching solution (5.3 mL of 0.6% (w/v) sodium
carbonate and 3% (w/v) sodium chloride in DI) [117]. The solution was
centrifuged for 5 minutes at 200 x gravity at room temperature, supernatant
was aspirated, and the leukocyte pellet was resuspended in 5 mL PBS + 1%
(w/v) bovine serum albumin (BSA). The suspension was centrifuged again
and resuspended in 1 mL PBS + 1% BSA, giving the physiological concentra-
tion of white blood cells. The volume of resuspension PBS was also varied to
provide different leukocyte concentrations. The saponin/formic acid lysing
method was chosen because it proved to be the most rapid and effective
erythrocyte lysis technique and ensured cell sample concentrations were low
enough to be successfully analyzed by the electrical counter (see 4.3.5). How-
ever, this aggressive lysing method has been known to differentially damage
the membrances of leukocyte subtypes with possible loss of viability [117].
Flow analysis showed that the saponin/formic acid lysis agent did decrease
the total leukocyte concentration when compared to a commercially avail-
able solution (BD Pharm LyseTM, BD Biosciences), but T lymphocyte and
monocyte populations were not affected. This held true even for varying the
duration of incubation in the lysis solution (3 s to 18 s). Leukocyte vital-
ity was preserved by resuspending the cells in a PBS + 1% BSA solution
immediately after halting the lysis process with the quenching solution.
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4.3.4 Experimental Setup and Reverse-Flow Differential
Counting Technique
Figure 4.3 illustrates the experimental setup and process used to differentially
count CD4+ T cells. The process can be split into two segments: forward
flow (Fig. 4.3(1)) and reverse-flow analysis (Fig. 4.3(2)). A Harvard Appa-
ratus (Holliston, MA) PicoPlus syringe pump injected a constant stream of
leukocytes into the chip through the entrance counter at 5 µL·min−1 to cre-
ate a forward count of all leukocytes. The enumerated cells entered the CD4
capture chamber and were depleted of CD4+ T cells. Forward flow contin-
ued until cells were detected at the exit counter. At this time, flow direction
was reversed by switching the entrance and exit valves and by initiating the
PBS + 1% BSA solution wash pump at 5 µL·min−1. The unattached leuko-
cytes were washed back out the capture chamber and entrance counter to be
enumerated, creating a reverse count. The total number of captured CD4+
T lymphocytes could be simply calculated by subtracting the reverse count
from the forward count.
Counting was performed using a Zurich Instruments (Zurich, Switzerland)
HF2LI dual lock-in amplifier which injected a 5 V (rms) 1.1 MHz AC signal
into the entrance and exit counters (VOUT 1 and VOUT 2, respectively).
Relative impedance was measured using three microelectrodes set up in a
Wheatstone bridge configuration, balanced with 10 kΩ resistors (R) and a
68 pF capacitor. For each counter, the voltage signal across each resistor was
subtracted (i.e., V2 – V1, or V4 – V3 ) using a differential preamplifier before
entering the lock-in’s input. An increased sensitivity and stable impedance
signal were two of the benefits of this balancing bridge method, but the major
advantage of the three-electrode configuration was that one could precisely
and accurately determine when the forward counting stopped and reverse
counting started, as already described.
The bridge potential difference signals for the entrance and exit counters
were input into the HF2LI, and the impedance magnitude and phase angle (R
and θ, respectively) were output to a computer for real-time observation and
recording of data at a 200 kHz sampling rate using a National Instruments
(Austin, TX) PCI-6351 DAQ card and Lab-VIEW software. The data was
imported into and analyzed with Clampfit software. Impedance pulses were
counted using a threshold detection method, and forward and reverse counts
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Figure 4.3: Experimental setup and process for electrical differential
counting of CD4+ T cells. A dual lock-in amplifier is used to inject an AC
signal and monitor its change through the chip’s counter regions, which are
balanced by a Wheatstone configuration. Process: (1) the cells pump
injects leukocytes into the chip (forward direction) to be enumerated at the
entrance counter; (2) after cells are sensed at the exit counter, both valves
are switched to reverse flow direction and the PBS wash pump purges the
capture chamber of uncaptured cells, which are enumerated again by the
entrance counter. From [139] - Reproduced by permission of The Royal
Society of Chemistry.
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Figure 4.4: Impedance data of the entrance counter for the entire duration
of a reverse-flow differential counting experiment. The data can be
separated into four regimes: (i) no cells present, (ii) cells beginning to enter
the chip’s entrance, (iii) just after reversing flow and counting cells exiting
back out the entrance, and (iv) near the end of purging the capture
chamber of uncaptured cells. Magnifications of the impedance signal during
forward (v) and reverse flow (vi) show how pulse signature polarity can be
used to ensure when reverse counting begins. From [139] - Reproduced by
permission of The Royal Society of Chemistry.
were compared.
Another computer connected to a digital camera on a Nikon Eclipse E600FN
microscope (Nikon Instruments, Inc., Melville, NY) was used to observe cell
passage through the channels as well as cellular interactions with the capture
chamber’s walls.
Figure 4.4 shows an example of the reverse-flow differential counting method
from actual experimental data. Flow reversal caused impedance pulses to in-
vert polarity from down-up (v) to up-down (vi), exhibiting a straightforward
method to differentiate between cells entering and exiting the chip.
4.3.5 Maximum Pulse Density Limit
It is imperative that the differential counter can analyze physiological con-
centrations of white blood cells (∼1 x 104 cells·µL−1) flowing at the desired
rate of 5 – 10 µL·min−1. This flow rate range would provide as rapid sample
analysis as possible, given the limitations of (1) creating a capture cham-
ber shear stress < 3 dyn·cm−2, (2) ensuring the capture chamber volume is
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large enough to contain an adequate sample volume (≥ 5 µL), (3) creating
a capture chamber (and chip) footprint that would be amenable to PoC ap-
plications (smaller than a microscopy slide, ∼75 mm x ∼25 mm), and (4)
ensuring the pulses are not attenuated by the lock-in amplifier’s low pass
filter (in our case of AC analysis). In the last case, as flow rate is increased,
impedance pulses become shorter in duration and contain mostly frequency
components that exceed the filter’s bandwidth. These components are at-
tenuated, resulting in diminished pulses that cannot be detected above the
baseline noise level.
A maximum pulse density (pulses·s−1) must be found to test whether the
electrical counters can accurately count physiological concentrations of leuko-
cytes at the aforementioned flow rate range. Some limiting factors for accu-
rate counting in any electrical cytometer are (1) the concentration of cells
in the sample, (2) the speed in which they flow through the sensor, and (3)
the measurement system’s sampling frequency. As the concentration of cells
increases at a constant flow rate, the duration between passage events de-
creases. Eventually, the concentration becomes high enough where two cells
will be in the same sensing region, creating coincidence events that cause
two impedance pulses to overlap. For a finite sampling frequency–even if the
cells are not coincident within the sensing region–a high enough velocity will
eventually cause overlap of the pulses from two subsequent cell passages.
Hence, we found the maximum pulse density by flowing increasing concen-
trations of blood cells into the chip until noticeable pulse overlap occurred
(i.e., an up-down or down-up pulse signature was not completed before an-
other cell passed through the sensing region).
4.3.6 Direct-Flow Differential Technique
The described reverse-flow differential counting technique was implemented
in response to problems found using a simpler flow-through method, where
flow was constant in one direction and both entrance and exit sensors were
used to quantify the number leukocytes before and after depletion of CD4+
T cells, respectively (Fig. 4.5). The difference in the electrical characteristics
between each counter and its respective external circuitry made it impossible
to objectively compare the counting results between both counters. Although
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Figure 4.5: Direct-flow differential sensing method. White blood cell
populations were flowed directly from chip entrance to exit. The differential
count was obtained by subtracting the exit count from the entrance count.
The difference in counter sensitivities prevented this as a feasible method to
obtain CD4+ T lymphocyte counts.
both counters could detect cell passage, their sensitivities differed enough to
make subsequent analysis subjective. For example, the average impedance
pulse height at the entrance counter may be lower than that found at the exit
counter for the same population of cells or beads with the capture chamber
passivated from specific and non-specific adsorption. Ideally, both counters
would have the same sensitivity and produce the same average impedance
pulse heights for identical populations, resulting in a differential count of
zero. However, using the same threshold trigger level (determines at what
height an impedance pulse is a cell) would result in the non-real result of a
larger exit count than entrance count—a negative differential count. Scaling
the trigger level based on average pulse height, noise level, and other variables
proved unsuccessful and subjective, precluding further application.
The reverse-flow differential counting method would remove the ambiguity
in electrical analysis and lessen the counting error by using the entrance
counter alone to enumerate cells entering and exiting the chip. Because only
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one sensor is being used, the same threshold trigger level can be used for
both the forward and reverse counts, resulting in a more straightforward
and objective method to obtain differential counts. The exit counter would
only be used as a qualitative means to determine when to reverse fluid flow
direction to prevent cells from being lost through the chip’s exit and to
initiate reverse counting.
4.3.7 Reverse-Flow Differential Technique Validation
Experiments were designed to evaluate the plausibility of the reverse-flow
differential counting technique and to quantify its inherent error. This can
be found by passivating the capture chamber from any cellular interactions—
specific and nonspecific—and performing differential counts of leukocyte pop-
ulations. Ideally, a passivated capture chamber would result in equal forward
and reverse counts (a differential count of zero), but error may come from
imperfections in the passivation layer, cell disruption inside the capture cham-
ber, and the electrical analysis itself.
The capture chamber was passivated by flowing in phosphate buffered
saline (PBS, pH 7.4), with 1% BSA (A3059-50G; Sigma-Aldrich, St. Louis,
MO) and incubating for at least one hour at room temperature to prevent
the non-specific adsorption of cells. BSA is a well-known protein for surface
passivation, and readily binds to the hydrophilic glass substrate at pH 7.4.36
The passivated chip was then evaluated using the reverse differential counting
technique, described above, for various leukocyte dilutions.
4.3.8 Capture Chamber Modification for CD4+ T
Lymphocytes
Other experiments were performed to enumerate CD4+ T lymphocytes in
the heterogenous leukocyte populations by selectively immobilizing them in
the capture chamber, which was functionalized with CD4 antibody.
Purified mouse antibody to human CD4 (MHCD0400) from Invitrogen,
diluted (1:10) in PBS, was flown through a newly fabricated chip until the
entire capture chamber was filled. Flow was stopped, and the solution was
allowed to incubate at room temperature for 30 minutes, followed by two
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more filling plus incubation cycles. A solution of PBS + 1% BSA was used
to wash away unbound CD4 antibody and block any unconjugated sites from
the nonspecific binding of cells. Chamber functionalization was performed
either immediately before flowing leukocyte samples or the day before with
the functionalized chip stored overnight at 4 ◦C.
4.3.9 CD4+ T Lymphocyte Count Comparison with Optical
Control
An optical counting method using image processing was implemented to eval-
uate the electrical microcytometer chip’s differential counting technique. Im-
mediately after electrical differential counting was finished, the chip’s entire
capture region was sequentially imaged using an Olympus (Tokyo, Japan)
IX81 inverted microscope with phase contrast under a total magnification
of 64. Images were merged using standard imaging software, and cells were
automatically enumerated in ImageJ to find the actual number of cells that
were captured. This count was then compared with the electrical differential
count.
4.3.10 Cell Capture Efficiency
A BD Biosciences LSRII flow cytometer was used to quantify the efficiency
of the chip in capturing CD4+ T lymphocytes. Two leukocyte populations
were analyzed: cells before flowing into the chip and cells that have exited the
chip after a differential counting experiment. Alexa Fluor R© 488-conjugated
mouse antibody to human CD4 (MHCD0420) was purchased from Invitro-
gen. Phycoerythrin-Cy7 (PE-Cy7
TM
)-conjugated mouse antibody to human
CD14 (25-0149-42) and peridinin chlorophyll protein-cyanine 5.5 (PerCP-
Cy5.5
TM
)-conjugated mouse antibody to human CD3 (45-0037-42) were pur-
chased from eBioscience (San Diego, CA). Both populations were stained
with a cocktail of the above labels by following the manufacturer’s suggested
protocols, rinsed with centrifugation (200 x g, 5 minutes), and resuspended
in PBS for flow analysis to compare the percentages of CD4+ T lymphocytes
(CD3+CD4+CD14-) in both populations.
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4.3.11 Cell Capture Purity
After optical control micrographs were obtained, the captured cells were flu-
orescently labeled to examine their phenotype and to understand the capture
purity of the system (i.e., the ratio between CD4+ T lymphocytes captured
and total cells captured). Alexa Fluor R© 488-conjugated mouse antibody to
human CD4 (MHCD0420), allophycocyanin (APC)-conjugated mouse an-
tibody to human CD14 (MHCD1405), and 4’,6-diamidino-2-phenylindole
(DAPI, D21490) were purchased from Invitrogen (Carlsbad, CA). The CD14
antibody was used to determine which CD4+ cells were monocytes, which
express both the CD4 and CD14 surface proteins. DAPI was used to de-
termine which cells were nucleated, in the case un-lysed erythrocytes were
nonspecifically captured. A 1:20 cocktail of the above three fluorophores was
created in PBS and flown into the chip at 2.5 µL·min−1 for a total volume
of 50 µL. Flow was stopped and the mixture was allowed to incubate for 30
additional minutes. This was followed by a 5 µL·min−1 wash with PBS + 1%
BSA to ensure unbound labels were purged from the chip. Fluorescent mi-
crographs of selected areas of the chip were taken to create a representative of
the entire population using the Olympus IX81 with appropriate fluorescent
filter sets at a total magnification of 320.
4.4 Experimental Procedures
4.4.1 Maximum Pulse Density Limit
Varying dilutions (1:1000 to 1:100) of whole blood were injected into a chip at
a constant flow rate of 5 µL·min−1 to test the pulse density limits (pulses·s−1)
of the differential counter. Flow direction was not reversed (kept in forward
direction), and pulses were only analyzed for the entrance counter. Pulse
density was calculated by normalizing the total number of pulses found by
the number of fixed time windows that were applied at random points in the
raw data.
Figure 4.6 compares the cell concentration found using the chip (calculated
by the number of pulses for a known volume flown) versus the calculated
concentration of each sample dilution, assuming the concentration of whole
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Figure 4.6: Maximum pulse density characterization. Concentration
calculations were based on the number of pulses·s−1 for a known flow rate.
Error bars represent the standard deviations obtained from measurements
of 9 (1:1000), 14 (1:500), 25 (1:200), and 23 (1:100) duration windows.
From [139] - Reproduced by permission of The Royal Society of Chemistry.
blood was 5 x 106 cells·µL−1. At a 5 µL·min−1 flow rate, the chip could
handle the 1:200 dilution of whole blood (∼2.5 x 104 cells·µL−1), but failed
to count every pulse individually for the 1:100 dilution (∼5 x 104 cells·µL−1)
because of pulse merging. The maximum pulse density the chip could handle
was 2,236 cells·s−1, equivalent to a concentration of 2.68 x 104 cells·µL−1 at
a flow rate of 5 µL·min−1. While in some pathologic conditions physiological
leukocyte counts can exceed this threshold, the vast majority of leukocyte
counts will be lower. This maximum pulse density also confirms that effective
lysis of erythrocytes is necessary before sample entry to avoid cell counting
error.
A possible explanation for the discrepancy between the theoretical (9 x 104
cells·µL−1) and the observed concentration maxima (2.68 x 104 cells·µL−1) is
the theoretical calculations assumed an even distribution of cells in the sam-
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ple volume. However, cells may not be evenly distributed at the microscale,
as they could travel in packets that result in coincidence events (multiple
cells in the sensing region). This is likely with the higher concentrations
(i.e., 1:100) and effectively reduced the maximum cell concentration that the
electrical counters could handle.
The sampling frequency (115.2 kHz was used in this particular experiment)
was not a limitation, as cell velocity through the sensing region (370 mm·s−1
for Q = 5 µL·min−1) was not high enough to cause two pulse signatures
to overlap from consecutive cell passages. Cell translocation time through
the sensing region was 135 µs, or ∼15 data samples. This was well above
our estimated minimum of 5 samples needed to resolve the passage of a
cell and to distinguish between two different cells—as long as they were not
simultaneously within the sensing region. (This estimated minimum sample
number was determined by assuming distinct cell passage could be resolved
if impedance signal values were recorded at the (1) baseline immediately
before cell passage, (2) first peak (positive- or negative-going), (3) baseline
between peaks, (4) second peak (opposite the polarity of the first peak), and
(5) baseline after both peaks.)
4.4.2 Aggregate Shearing Mechanism
The reverse-flow differential counting technique should ensure much smaller
error than its direct-flow counterpart by using a single counter to enumer-
ate white blood cells entering and exiting the chip. However, preliminary
passivated capture chamber experiments showed a large discrepancy existed
between entrance and exit counts. Figure 4.7 illustrates a typical result for
a negative control experiment. Ideally, the entrance and exit sums should
be equivalent at the end of the experiment, but have a difference of over
∼3,500. It is interesting to notice that the exit count is higher than the
entrance count, which is true for the 1:1 dilution of white blood cells, but
not as dominant in lower leukocyte dilutions. Figure 4.8 shows the relation-
ship between the white blood cell concentration and the difference between
the exit and entrance counts for various trigger levels. A trigger level is the
voltage threshold that determines whether an impedance pulse is a cell, and
is set manually in Clampfit. It is a common convention to base the trig-
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ger level off of the standard deviation of the baseline signal’s noise (with no
cells present). In the case of this experiment, a trigger level of ten times
the standard deviation (SD) of the noise was the minimum threshold that
could be used to ensure baseline noise pulses were not counted as cellular
events. The threshold level for the entrance and exit counters is identical. A
noticeable trend is the less diluted samples intersect the X-axis (Entrance -
Exit = 0) at higher threshold values (67 x SD for 1:1; 40 x SD for 1:2; 20
x SD for 1:5) in the direction of increasing trigger level value (left to right).
This, combined with the fact that the exit count is higher than the entrance
count, can explain the large discrepancy in the entrance and exit counts.
Cell aggregates form more frequently as the concentration of the purified
leukocytes increases because there is more interaction between cell surfaces.
These aggregates pass through the entrance counter port and its relatively
high shear stresses (1,320 dyn·cm−1) separate the aggregates back into in-
dividual cells, which are then counted by the exit counter. An aggregate is
counted as a single entity by the entrance counter, but can become three or
more entities by the time it reaches the exit counter. The entrance and exit
counts only become equal when the threshold level is large enough to not
count smaller entities such as single cells, and only counts larger objects that
remain physically after passing through the entrance counter.
The aggregation of leukocytes prevents a true evaluation of the differen-
tial counter and can be remedied by larger dilutions. However, diluting has
several drawbacks, most importantly, analyzing only a fraction of the cells
needed to provide a more robust helper T cell test and requiring a much
larger chip volume. Therefore, it is necessary to have the physiological con-
centration of white blood cells enter the chip, and can possibly still be allowed
using a microfabricated 10 µm x 13 µm PDMS/glass pore, or “shearer”, to
separate cell aggregates before the chip entrance. Figure 4.9(a) shows the
results after repeating the passivated experiment for 1:1 diluted leukocytes.
The shearer proves to decrease the amount of aggregates before entering the
differential counter chip (X-intercept at 9 x SD vs. 12.5 x SD for cell sam-
ples injected directly into the chip without the shearer). Figure 4.9(b) shows
the difference in cell size (pulse amplitude) and cell passage duration when
using the shearer. The population undergoing shear before making it to the
entrance counter is a tighter distribution at lower pulse duration with similar
pulse height amplitude as the un-sheared population because the larger ag-
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Figure 4.7: Representative entrance and exit count for the passivated
capture chamber experiment. The larger difference count may be attributed
to the aggregation of the more concentrated white blood cell solutions.
Figure 4.8: Relationship between white blood cell concentration and the
discrepancy between the entrance and exit counts. Increasing trigger
threshold levels eventually results in a matched entrance and exit count, as
depicted by arrows.
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gregates block the impedance sensing region longer. The amplitude does not
change much because even the single cells are large enough to block most of
the electrical current passing between the sensing electrodes. Figure 4.9(c)
illustrates the size and passage duration similarities of cells that have been
sheared prior to and counted at the entrance sensor and cells that did not
undergo pre-chip shearing, but pass through the entrance counter pore and
are counted at the exit counter. This shows that the entrance counter indeed
is shearing aggregates into smaller entities, performing the same job as the
pre-chip shearer. It is therefore necessary to have the shearing unit placed
before the chip to ensure most aggregates are separated into single cells.
4.4.3 Reverse-Flow Differential Technique Validation
Figure 4.10(a) illustrates the results for 14 experiments on the analysis of
leukocyte populations using the reverse differential counting method with a
passivated capture chamber. Leukocyte sample dilutions ranged from 0.25 to
2 times the physiological concentration to understand the inherent error of
the device and technique for a range of leukocyte counts. The percent error
decreased for larger forward counts (i.e., leukocytes entering the chip), which
is desirable for clinical situations where samples will contain physiological
concentrations of leukocytes. The main reason for this was that the absolute
counting error remained roughly constant for the entire forward count range.
(The percent error here is the absolute counting error normalized by the
forward count, while the absolute counting error is the absolute difference
from the ideal differential count of zero.)
Figure 4.10(b) illustrates the accumulated forward and reverse counts dur-
ing the experiment highlighted in Fig. 4.10(a). This demonstrates how the
reverse count eventually leveled off and became close to the forward count,
resulting in an absolute counting error of 71 cells that equates to a 1.2%
error.
Table 4.1 quantifies the data in Fig. 4.10(a), and affirms that larger leuko-
cyte counts (> 2,000 cells) resulted in a smaller percent error (∼1.2%). The
absolute counting error for this range of forward counts was ∼46 cells. The
significance of this small error can best be expressed by normalizing it to the
estimated 5 µL injected sample volume, resulting in a concentration accuracy
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Figure 4.9: (a) Effects of shearer on differential cell counts at various
trigger levels. (b) The reduction of aggregates by the shearer are
demonstrated by the localization of cellular events at lower pulse durations
at the entrance counter, compared to the wider range of durations found
without using a shearer module. (c) The pulse amplitude/duration
distributions are similar for cells counted by the entrance counter after the
shear module and cells counted at the exit counter after passing through
the entrance counter (with no shearer module).
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Figure 4.10: Analysis of reverse differential counting for a passivated
capture chamber. (a) Percent error decreases exponentially (dashed line, R2
= 0.57) as the number of leukocytes entering the chip (forward count)
increases. (b) Cumulative counts of forward and reverse-flow regimes for
the particular experiment highlighted in (a). Error is calculated by
normalizing the differential count (absolute difference between the forward
and reverse counts) to the forward count. From [139] - Reproduced by
permission of The Royal Society of Chemistry.
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of ∼9 cells·µL−1. This not only validates the differential counter as a plausi-
ble CD4+ T cell enumeration method, but opens the possibility of analyzing
patients with advanced AIDS, who may have CD4+ T cell concentrations <
50 cells·µL−1.
Table 4.1: Error analysis of electrical differential counting of leukocytes
using a passivated capture chamber. x denotes sample mean. From [139] -
Reproduced by permission of The Royal Society of Chemistry.
Est. conc.
Abs. counting accuracy
Error (%) error (cells) (cells per µL)
x SD x SD x SD
All WBC 2.91 3.93 44.2 31.3 8.84 6.26
WBC < 2,000 7.25 5.37 38.8 25.0 7.76 5.00
WBC > 2,000 1.18 1.02 46.4 34.5 9.28 6.90
Although the capture chamber volume was ∼7 µL (Fig. 4.1(a)), we can
only estimate that approximately 5 µL of sample entered the chamber before
flow was reversed to prevent the loss of cells. This is because cell sample
diffusion resulted in a lower concentration of cells reaching the exit counter
before the more concentrated cell population completely filled the chamber.
Estimation was made by observing the portion of the capture chamber filled
with the concentrated cell population.
The counting error was caused mainly by non-specific adsorption of cells
onto the chamber surface, despite passivating the capture chamber with BSA.
Passivation using more incubation time and/or PBS with a pH closer to
BSA’s isoelectric point of 5 would substantially decrease this error and further
emphasize the accuracy of this enumeration technique [142]. Another possible
source of error may be dead/dying cells rupturing under the high shear rates
found in the counter channel during forward counting, and not having the
opportunity to be captured or counted again during the reverse counting
phase.
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4.4.4 CD4+ T Lymphocyte Count Comparison: Optical vs.
Electrical
Fourteen purified leukocyte samples of varying dilution (0.5 to 2 times the
physiological leukocyte concentration) were analyzed using a capture cham-
ber conjugated with CD4 antibody. Figure 4.11(a) shows the results of the
CD4+ T cell counting experiments and the close correlation (y = 0.994x, R2
= 0.997) between the electrical differential method and the optical control
experiments.
Figure 4.11(b) illustrates the cumulative forward and reverse counts dur-
ing an experiment, showing how the absolute number of helper T cells was
calculated. This particular experiment was finished within 7 minutes, as
the reverse count levels off at this point. The average counting time for 12
experiments was 10±1.8 minutes, which can easily be shortened by using
higher flow rates. The two other experiments were not included in the aver-
age because their average flow rates differed from the majority, affecting the
analysis time.
Figure 4.11(c) shows Bland-Altman comparison analysis between the elec-
trical differential and optical counting methods. A bias of only -9 cells con-
firms the accuracy of the electrical differential counting method for the entire
range of enumerated CD4+ T cells. One reason for the negative bias (larger
optical counts than electrical counts) could be that leukocytes traveling in
aggregates were counted as one entity during the forward count, were then
separated by the high shear forces of the entrance counter, and then were
counted individually during reverse counting. This would result in a lower
electrical CD4+ T cell count and a negative bias when compared to the
optical count.
Figure 4.11(d) shows how the percent error relates to the total number of
CD4+ T cells counted. (The percent error here is defined as the absolute
difference in optical and electrical counts, normalized by the optical count.)
Assuming that 5 µL of sample was flown into the chip, the data can be
separated into three important CD4+ T cell concentration regimes for AIDS
diagnostics. For less than 1,000 cells captured on the chip (5 µL sample at
200 cells·µL−1, the clinical definition of AIDS), the average error was 4.5%
(n = 3). This shows to have high accuracy; for example, a patient with an
actual CD4+ T cell concentration of 100 cells·µL−1 would have a counting
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Figure 4.11: Reverse-flow differential counting of CD4+ T lymphocytes. (a)
Comparison of electrical differential counting method and the optical
controls. A linear fit (R2 = 0.997) is not shown, as it is would be
indistinguishable from the y = x correlation standard. (b) Cumulative
counts of forward and reverse-flow regimes for the particular experiment
highlighted in (a). The absolute number of captured CD4+ T cells was
found simply by subtracting the reverse count from the forward count. The
dotted line denotes a completed analysis (where reverse counting levels off)
duration of approximately 7 minutes. (c) Bland-Altman analysis of the
data in (a). The dash-dot lines denote upper and lower levels of agreement
(ULA and LLA, respectively). The dashed line shows a bias of 9 cells
toward the optical method. (d) Counting error decreases as the total
number of captured CD4+ T cells increases. Listed statistics are for three
regimes demarcated by dashed lines: 0 to 1,000 captured helper T cells (0
to 200 cells·µL−1, assuming 5 µL of sample flown into chip), n = 3; 1,000 to
1,750 (200 to 350 cells·µL−1), n = 5; and greater than 1,750 (> 350
cells·µL−1), n = 6. From [139] - Reproduced by permission of The Royal
Society of Chemistry.
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Figure 4.12: Composite phase contrast image of entire 34 mm-long capture
chamber after a differential counting experiment. The bottom three panels
are magnifications of the regions denoted in the main figure. Error bar
lengths are 500 µm, and grayscale intensity was inverted to enhance
visualization of captured cells (dark spots). From the supplementary
of [139] - Reproduced by permission of The Royal Society of Chemistry.
error of only ±4.5 cells·µL−1. The device has also shown to be even more
accurate for the regimes surrounding the clinically critical threshold of 350
cells·µL−1 (1,750 cells captured), which has been shown to be an optimal
condition to start ART [5].
Figure 4.12 shows a composite phase contrast image of the entire capture
region that was used to obtain the optical control count for a particular
experiment. The largest density of cells was located near the midpoint of
the chamber’s length (inset 2), while a smaller density was found near the
entrance (inset 1). The cells would have had little time to interact with the
antibody layer just upon entering the chip compared to the interaction time
from reaching the center of the chip. The low capture density near the exit
(inset 3) can be explained by the fact that a smaller concentration of cells
leading the entire population reached the exit counter first, causing reversal
of the flow before higher concentrations could reach the end of the chip.
One cause of these leading cells could be that they were traveling at or near
the center of the microbore tubing (or the center of the capture chamber’s
height), where they would travel at approximately twice the velocity of the
other cells, which were traveling at the average flow velocity under laminar
flow conditions.
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4.4.5 CD4+ Capture Efficiency
Flow cytometry analysis for 8 chips showed that 60.2±18% of CD4+ T cells
were immobilized in the capture chamber. A major reason for this low cap-
ture efficiency may be that cells entering into the chip later do not have
enough time to interact with the antibody before flow reversal. In addi-
tion, the low shear stress used during the experiments (0.5 dyn·cm−2) may
also cause a loss in capture efficiency. Cheng et al. have shown that shear
stresses between 1 and 3 dyn·cm−2 will ensure adequate CD4+ T cell capture
(∼95%), while efficiency sharply drops off outside of this zone [51]. However,
they relied on erythrocytes flowing in the center of the capture chamber to
effectively push the leukocytes toward the chamber walls, facilitating more
leukocyte-antibody interactions. In our case, erythrocytes must be lysed to
accurately enumerate leukocytes, but this removes the leukocyte margina-
tion mechanism. Although most leukocytes were able to come into contact
with the chamber’s floor by sedimentation, other leukocytes traveled near
the center of the 50 µm-high channel at higher velocities and away from
interactions with its walls. Simply reducing the capture chamber’s height
would not only increase the shear stress to within the desired range, but also
ensures cells would interact with the chamber’s walls. In addition, a covalent
surface chemistry using linkers could be used to ensure proper CD4 antibody
fragment antigen-binding (Fab) region orientation for optimal cell capture.
Additional error may have been introduced simply by the fact that a small
sample volume (5 µL) was collected for flow analysis. Some practical is-
sues are cells lost by non-specific adsorption to tubing during collection and
cells lost during flow cytometry analysis preparation (fluorescent staining and
washing).
4.4.6 CD4+ capture purity
Figure 4.13 depicts the analysis of three areas of a chip’s capture region
as an example of fluorescence analysis for quantification of captured cell
purity. The percentage of captured cells being leukocytes was calculated
by dividing the number of DAPI-positive cells by the number of cells found
in the bright field image. The percentage of captured cells being CD4+ was
calculated by dividing the number of Alexa Fluor R© 488-positive (CD4+) cells
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Figure 4.13: Example of selective fluorescence analysis of captured cells
shown in bright field images for three different areas of the chip’s capture
region. ImageJ threshold analysis was used to define cells; false coloring
was used to discriminate among the three fluorophores used: DAPI (blue;
nucleated cells or white blood cells), Alexa Fluor R© 488 (green; CD4+;
present on helper T cells or monocytes), and PE (red; CD14+; present on
monocytes). Scale bars represent 200 µm. From the supplementary of [139]
- Reproduced by permission of The Royal Society of Chemistry.
by the number of DAPI-positive cells. The percentage of captured cells being
monocytes was calculated by dividing the number of PE-positive (CD14+)
cells by the number of Alexa Fluor R© 488-positive cells. ImageJ software was
used to determine the grayscale threshold level which defined the presence
of a cell. False coloring was used to illustrate the different fluorescent labels
used in the experiments.
Three chips were analyzed for CD4+ T cell capture purity after complet-
ing electrical differential counting experiments. In all chips, it was found
that all captured cells were leukocytes (DAPI+) expressing the CD4 antigen
(AF488+), confirming the high specificity of the surface chemistry for CD4+
cells. It was found that 81.7% of captured cells were CD4+ T lymphocytes,
with monocytes comprising the remaining portion. According to Cheng et
al., monocyte capture increased for shear stresses < 0.7 dyn·cm−2, a regime
in which our chip was operating (0.5 dyn·cm−2) [51]. One of the chips had a
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CD4+ T cell capture purity of 56.5% because flow was temporarily stopped
before reversing flow direction. This effectively decreased shear stress even
further, allowing more monocytes to be captured. The other two chips had
no such stoppage, and showed an average capture purity of 94.3%, which
agrees with our previous work [51]. Although relatively small, the percent-
age of captured monocytes can still cause a positive bias for patients CD4+ T
cell counts below 200 cells·µL−1. One solution for this problem is to create a
monocyte depletion chamber conjugated with CD14 Ab immediately before
the entrance to the entrance counter and main capture chamber [53].
4.5 Conclusions
We have demonstrated as a proof of concept that a differential cell counter
device using the reverse-flow technique and cell immunoaffinity depletion is a
viable method to electrically enumerate CD4+ T lymphocytes from purified
leukocyte populations from donor blood samples. Our microfabricated device
and detection approach resulted in a short testing time of 10 minutes, had an
accuracy (9 cells·µL−1) that allows for lower detection limits, and correlated
closely with an optical standard (R2 = 0.997), demonstrating its capability
to analyze patients in all stages of HIV infection. Its microfabricated nature
suggests it may be an inexpensive, simple, and portable alternative to current
flow cytometric practices that would enhance the penetration of CD4+ T cell
tests into resource-poor regions.
Several advancements to the current design are necessary to create a com-
plete PoC AIDS diagnostics device for whole blood samples. An on-chip ery-
throcyte removal/lysis module is needed to eliminate off-chip sample prepa-
ration steps. Also, an on-chip sample metering system is necessary to ac-
curately ensure a known amount of blood is injected into the chip and for
comparison to other CD4+ T cell counting methods. Furthermore, an opti-
mized capture chamber design and surface chemistry would provide greater




FOR CD4+ T LYMPHOCYTES WITH
SAMPLE PREPARATION MODULE
5.1 Introduction
In the previous chapter, it was demonstrated that CD4+ T lymphocytes
could be accurately enumerated using a microfabricated sensor that used only
electrical interrogation coupled with an antibody-coated capture region. This
is significant, as it does not require the bulky, expensive, and fragile optics
and fluorescent labeling implemented by other reduced-scale CD4+ T cell an-
alyzers. However, this previous design requires off-chip sample preparation to
create a purified population of leukocytes via erythrocyte lysis and centrifu-
gation. These off-chip steps are impractical for resource-poor regions, which
may not have laboratory equipment, personnel, or laboratories to perform
such steps. This chapter details the methods to develop the necessary on-
chip sample preparation module to realize an integrated, stand-alone CD4+
T cell counter that can handle whole blood as an input.
5.2 Principle
Figure 5.1 shows the newest version of the electrical differential counting chip
which can handle whole blood samples. This chip builds upon the reverse-
flow differential counting principle where white blood cells are counted before
(forward count) and after the depletion of CD4+ T cells (reverse count), with
the absolute CD4+ T cell count being the difference between the forward
and reverse counts [139]. A multilayer fluidics network is necessary to ensure
accurate spatio-temporal control of the injected blood cells and a small chip
footprint.
The addition of an erythrocyte lysis module is critical to ensure accurate
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counts, as the sheer number of erythrocytes (∼1,000 times average leuko-
cyte concentrations) would require large sample dilutions—increasing analy-
sis time drastically—and would inherently increase the probability of count-
ing error. As an example of the latter point, 1 µL of blood from a patient may
have 500 CD4+ T cells, 5,000 leukocytes, and 5 x 106 erythrocytes. With no
erythrocyte lysis, only ∼0.01% of the counted cells would be captured. This
small change could be easily lost in the noise of sources of error, such as the
nonspecific adsorption of erythrocytes to the capture chamber. On the other
hand, erythrocyte lysis would result in a 10% difference between forward and
reverse counts in this example, which we have shown to be detectable [139].
The lysis module selectively ruptures the membranes of the erythrocytes
through diffusive mixing of the lysis solution (saponin + formic acid) with
the centered blood stream [118, 143]. Figure 5.2(a) shows how the blood
sample stream is focused between two lysis streams to enhance the diffusion
effects, while the 65 µm-tall serpentine mixing region, Fig. 5.2(b), ensures
complete diffusion and enough lysis time to rupture all erythrocytes but keeps
leukocytes intact (∼6 s). The 110 µm-tall quenching module supplies a con-
centrated solution of salts and sodium carbonate to both sides of the mixture
to quickly halt lysis and give the saponin from the lysing solution enough time
to fully disassociate erythrocyte membranes—creating a debris-free, purified
population of leukocytes before electrical analysis at the counting region (Fig.
5.2(c)). The quenching process has been shown to take ∼10 s [143].
The counting region is similar to our previous work and is comprised of
a 15 x 15 µm2 channel with 15 µm-wide platinum electrodes with similar
gaps, resulting in a sensing volume (∼17 pL) small enough to ensure cells
are counted individually and with little cell passage height variance over
the coplanar sensing electrodes [139]. Figure 5.2(d) shows two leukocytes
passing through the counter region. The main purpose of the three-electrode
system is to determine whether cells are entering or exiting the chip after
flow reversal [139]. The new chip lacks the second (exit) counter of the
previous design because an external metering system has been added that can
accurately deliver a known volume of sample to the chip. Equally important,
a large (∼500 µL) holding coil has been added to the chip’s exit to ensure
no cells are lost before all the sample is metered and flow reversal starts.
The capture region selectively captures CD4+ T cells via CD4 antibodies
immobilized on the chamber walls. Each of the 20 mm long, 2 mm wide
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Figure 5.1: Electrical differential counter chip for whole blood samples (3
cm x 4 cm footprint). The lysing region contains all three fluid inlets,
denoted by color described in the inset legend. The capture region includes
the sole chip outlet, which is connected to a 500 µL exit holding coil to
prevent the loss of leukocytes before flow direction reversal. The lysis
mixture contains whole blood and the lysis buffer, while the quench
mixture contains whole blood, lysis buffer, and quenching buffer. The
lighter shades of red illustrate the progressive dilution of the blood sample
after being processed through each module.
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Figure 5.2: Micrographs of the various regions shown in Fig. 5.1. (a)
Focusing of blood sample by lysis buffer sheaths to decrease diffusion time
necessary to lyse the erythrocytes. (b) Serpentine mixing channels in the
lysing region. As the blood sample flows from left to right, the
erythrocytes’ membranes progressively rupture until they release their
hemaglobin, resulting in transparent “ghosts”. (c) Mixing channels in the
quenching region, showing only leukocytes (some highlighted with arrows).
(d) Two leukocytes passing through the counting region. (e) Fluorescent
micrograph of CD4+ T lymphocytes (green) and monocytes (red) that were
captured in one of the chambers in the capture region. False coloring was
used to simulate actual fluorescence color. Scale bars: (a) – (c), 400 µm;
(d), 300 µm; (e), 150 µm.
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capture chambers are of equal height, which depends on the desired capture
chamber shear stress and the total flow rate of the three chip inlets (70 –
208 µm). Because of the increase of total flow rate from the on-chip lysis
and quenching modules (∼20x sample flow rate), a binary network of chan-
nels is used to equally divide the sample flow into eight identical capture
chambers to ensure channel shear stress is low enough to allow enough in-
teractions between the cells and the immobilized antibodies on the chamber
walls. A single 16 mm-wide capture would not have given desired results,
as the very low height-to-width ratio would cause the chamber to collapse
during fabrication. It would also balloon up when pressurized during experi-
ments, creating a capture channel height much more than the desired height
(this was even noticed sometimes with the 4 mm-wide capture chamber in
the previous chapter). Finally, it was observed that even with a 4 mm cap-
ture chamber from last chapter’s experiments, cells would generally flow in
the center of the channel, missing a majority of possible interactions with
immobilized antibodies not in the center of the channel’s width. This would
only be perpetuated with a wider capture chamber. The 2 mm width has
proven to solve or lessen the aforementioned problems. Figure 5.2(e) shows
fluorescently labeled CD4+ T lymphocytes (green) and monocytes (red) im-
mobilized in one of the capture chambers.
5.3 Materials and Methods
5.3.1 On-Chip Sample Preparation
Erythrocytes were first lysed for durations between 2 and 10 s upon entering
the chip by using a 0.12% (v/v) formic acid and 0.05% (w/v) saponin in DI
solution. Lysis was quickly quenched using a 0.6% (w/v) sodium carbonate
and 3% (w/v) sodium chloride in DI solution or a solution of concentrated
PBS with 0.6% (w/v) sodium carbonate. The blood sample, lysing, and
quenching solutions are each flown at particular rates to ensure similar mix-
ture ratios as noted in the literature [143]. The ratio between the blood
sample and lysis solution flow rates was always locked to 1:12, respectively.
The ratio between the blood sample and 3% (w/v) sodium chloride quench-
ing solution was set to 1:5.3, while it was 1:6.3 for the concentrated PBS
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Figure 5.3: Microfabrication processes for creating the electrodes (a–c) and
fluidics (d–e) layers. Both layers were exposed to O2 plasma before aligning
and permanently bonding them (f). Different channel heights were used to
ensure proper cell residence time (lysing and quenching), counting accuracy
(counter), and capture chamber shear stress (capture).
quenching solution.
5.3.2 Counter Fabrication
Figure 5.3 illustrates the fabrication methods used to create the aforemen-
tioned differential counter chip, which is comprised of an electrodes layer and
a multi-level fluidics layer.
Platinum electrodes were created by standard lift-off processes, as previ-
ously described [139]. Briefly, a negative of the electrodes pattern (15 µm
widths and gaps) was patterned on a 4” glass (Pyrex 7740) wafer using a dou-
ble layer liftoff recipe using LOR2A lift off (Microchem Corp. Newton, MA)
and Microposit S-1805 (Rohm and Haas Electronic Materials, Marlborough,
MA) resists. An EV420 mask aligner (Electronic Visions, Inc., Rockledge,
FL) was used to align and expose the wafer, and the resist was developed
with Microposit CD-26 developer (Fig. 5.3(a)). An SEC-6000 evaporator
(CHA Industries, Fremont, CA) was used to first deposit a 25 nm Ti adhe-
sion layer, followed by a 75 nm Pt conduction layer (Fig. 5.3(b)). Undesired
metal was subsequently lifted off using Microchem Remover PG to create the
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electrode geometry (Fig. 5.3(c)). Individual chips were diced using a Disco
DAD-6TM dicing saw (Tokyo, Japan).
The multi-level fluidics layer was created using standard rapid microfluidic
prototyping using Microchem SU-8 negative photoresists and Poly(dimethyls-
iloxzane) (PDMS). A negative master was constructed on a 4” Si wafer using
four successive iterations of the standard SU-8 recipe, with all soft bake and
post-exposure bake durations and temperatures being similar to those sug-
gested in the SU-8 product sheets. SU-8 was spun to a height of 15 µm
and exposed using the EV420 mask aligner to define the counting and filter
regions and provide a base for the other regions. A 55 µm layer was then
spun on and exposed to define the 70 µm-tall capture region. 30 µm of SU-8
50 was deposited to define the 100 µm lysis region, followed by a 50 µm layer
to create the 150 µm quenching region (Fig. 5.3(d)). Development in SU-8
developer was deferred until all four layers were created. After development
and rinsing the mold with IPA, a 1:10 curing agent to base mixture of PDMS
was poured over it and cured for at least 15 minutues at 150◦ C to create the
fluidic channels (Fig. 5.3(e)). The fluidic inlets and outlet were cored out of
the PDMS mold using a custom hole punch.
Devices were assembled by aligning and permanently bonding the electrodes-
glass and PDMS layers after exposing both to O2 plasma (Fig. 5.3(f)). Mi-
crobore tubing was inserted into the inlets and outlet to connect to the fluidic
control system, described below. Figure 5.4 shows a finished chip, which has
a 3 cm x 4 cm footprint.
5.3.3 Experimental Setup
Figure 5.5 illustrates the setup used to evaluate the differential counter
device. An Eksigent Nanoflow LC pump (Dublin, CA) is used to infuse
the lysing, quenching, and PBS carrier and washing solutions into the chip
with accurate and consistent flow rates. A Rheodyne MHP7980-500-1 valve
(Rohnert Park, CA) is used to load a blood sample into a 10 µL holding coil
(via syringe) and then direct PBS through the coil to inject the blood sam-
ple into the chip. Air bubbles are injected into the holding coil immediately
before and after the blood sample to ensure no diffusion into and dilution
from the adjoining buffer solutions. Inside the chip, the erythrocytes are
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Figure 5.4: Completed microfluidic chip after PDMS/glass bonding.
lysed, leukocytes are electrically counted, and CD4+ T cells are captured in
the capture region. These processes continue until 10 µL of sample has been
injected into the chip, providing the forward count. A valve with a 500 µL
holding coil contains any uncaptured leukocytes that have exited the chip to
ensure no loss of cells during forward flow. Once the 10 µL sample is injected
into the chip, both valves are switched to reverse the flow direction and wash
all cells out of the 500 µL holding coil and the chip’s capture and counting
regions to obtain the reverse count. Figure 5.6 graphically summarizes the
processes performed in the microfluidic chip to obtain an electrical differen-
tial count. Experiment durations range from 12 to 35 minutes, depending on
the total flow rate in the chip, which in turn depends on the capture chamber
height and the desired capture chamber shear stress.
A Zurich Instruments (Zurich, Switzerland) HF2LI lock-in amplifier was
used to simultaneously inject 303 kHz and 1.7 MHz AC signals (both at
5 V (rms) amplitude) into the chip’s center counting electrode. Relative
impedance was obtained by creating a Wheatstone bridge circuit with 10 kΩ
resistors [139]. The voltage difference between the two Wheatstone branches
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Figure 5.5: Experimental setup
Figure 5.6: Flow graph of processes performed in the differential counter
chip. The chip waste is used for subsequent characterization of the chip’s
capture performance. Experiment durations may range from 12 to 35
minutes, depending on the total flow rate of the chip, which depends on the
capture chamber height and the desired shear stress.
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was found using a differential preamplifier (Zurich Instruments) and input
into the HF2LI, which provided the impedance magnitude (R) and phase
(θ) that was recorded at a 500 kHz sampling rate in LabVIEW on a com-
puter with a PCI-6351 DAQ card (National Instruments, Austin, TX). A
customized Matlab program was used to analyze pulses at a high through-
put, providing differential counting data in the form of various scatterplot
relationships. For example, the low frequency impedance (at 303 kHz) can
be plotted against the electrical opacity, which is the ratio of high frequency
(at 1.7 MHz) to low frequency impedances [102].
The following is the reasoning behind the chosen interrogation frequen-
cies. The 303 kHz (low frequency) signal was used to differentiate among
leukocytes based on cell size. At this frequency, cells act as non-conducting
spheres that completely block the electrical current in the volume of conduc-
tive fluid they displace. This creates impedance pulses that are proportional
to a cell’s volume [95,132]. As a result, the lymphocytes (7 – 8 µm diameter)
can be distinguished from the larger granulocytes and monocytes (≥ 10 µm
diameter). The 1.7 MHz interrogation frequency (high frequency) has been
shown to further differentiate among the leukocytes and between cells and
debris [117, 118, 122]. At this frequency, the change in impedance from cell
passage is less about cell size and more about the cell membrane capaci-
tance, which is shown in Fig. 2.9(b). Cells with different membrane surface
morphologies (e.g., roughness, folds, wrinkles, blebs, etc.) will have differ-
ent membrane surface areas, resulting in different membrane capacitances.
For example, monocytes have extensive ruﬄing and pronounced folds in their
membranes, which would increase their surface area, leading at an increase in
membrane capacitance [144]. This could distinguish them from neutrophils,
which may have less prominent ruﬄes and folds. Equation 5.1 shows how
the impedance from a capacitor Zcap is inversely proportional to capacitance
(C) at a particular frequency (ω), and how a larger capacitance would result





Gawad et al. extend this concept to calculating cell impedance using the
equivalent circuit model for a cell in Fig. 2.9(a) to simulate changes in a
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Figure 5.7: SPICE simulation of the impedance of a cell, showing how
modifying cell characteristics changes the total impedance of the cell. Of
particular interest is the 10% increase in cell membrane capacitance, which
causes a decrease of impedance, which is maximum around 1.7 MHz.
From [145] - Reproduced by permission of The Royal Society of Chemistry.
cell’s impedance after increasing its membrane capacitance [145]. According
to their results in Fig. 5.7, this change creates a decrease in cell impedance
which is maximum around 1.7 MHz. This may be why Holmes et al. were
able to differentiate between neutrophils and monocytes at a frequency of
1.7 MHz, as they show that the opacity of the monocytes is less than the
neutrophils (Fig. 2.12(a)) [117].
A Nikon Eclipse E600 FN microscope (Nikon Instruments, Incl. Melville,
NY) coupled with a Phantom v310 high speed camera (Vision Research,
Wayne, NJ) was used to verify the chip’s proper operation, including ery-
throcyte lysis, debris filtering, leukocyte counting, and CD4+ T cell capture.
5.3.4 Blood Sample Acquisition
Blood samples were obtained from volunteers using an informed consent pro-
cess approved by the UIUC Institutional Review Board. Blood was col-
lected via venipuncture in EDTA-coated BD Vacutainers R© (BD Biosciences,
Franklin Lakes, NJ), and kept on sample rotisserie at room temperature until
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needed for experiments. The blood samples were used within 24 hours for
all chip experiments and external controls.
5.3.5 Passivated Capture Chamber Analysis
With the addition of the lysing, quenching, and filtering modules and a mod-
ified capture chamber geometry, it was important to re-evaluate the reverse-
flow differential counting method. Possible error could come from the delayed
loss of cells from the shock of the rapid lysis process or from the relatively
long cell residence time in the blood/lysis/quenching mixture. This mixture
contains a much lower blood protein concentration (∼1:20 dilution) than
found in vivo, which may adversely affect the leukocytes’ vitality.
Differential counting experiments were performed with capture chambers
passivated from all cellular interactions to find the inherent counting error
of the system via comparison to the ideal differential count of zero (equal
forward and reverse counts) [139]. Capture chambers were passivated for at
least 2 hours using a 1% BSA in PBS (pH 4.3) blocking solution. A pH
of 4.3 was chosen to facilitate optimal BSA adsorption to the glass surface
via electrostatic interactions between the positively-charged glass (isoelectric
point of 1.5 to 3.5) and negatively-charged BSA (isoelectric point of 4.7).
BSA more readily (30 - 60 times more than glass) adsorbs to the PDMS
surfaces for a wide pH range with its smaller surface charge capacity and
high hydrophobicity [146].
A 1% BSA in PBS (pH 7.4) solution was used to wash away the block-
ing solution immediately before performing the reverse electrical differential
counting protocol with whole blood samples, which was described earlier in
this section. Percent error was determined by finding the difference between
the forward and reverse counts, and normalizing the result by the forward
count [139].
5.3.6 Erythrocyte Lysis and Quenching Time Optimization
Ledis et al. developed the initial protocol for rapid, debris-free erythrocyte
lysis using a 0.12% (v/v) formic acid and 0.05% (w/v) saponin in DI solution,
and noted that lysis times should not be longer than 10 s, but preferably
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6 s or less [143]. Lysis times longer than 10 s would adversely affect the
vitality of the leukocytes. They also noted that the lysis process needed to be
quenched for at least 10 s to ensure all erythrocytes and their membranes were
completely disassociated by the saponin detergent. Van Berkel et al. were
the first to implement this lysing and quenching technique in a microfluidic
environment, which gave them more precise control of the lysis time, which
was set to 6 s [118]. They did not mention the quenching time that they
used.
Experiments were performed to observe the efficacy of erythrocyte lysis
and leukocyte viability for a range of exposure times in the aforementioned
lysis solution in a microfluidic environment. 10 µL whole blood samples
were injected into the chip, with the blood sample and lysis solution flow
rates adjusted to ensure proper flow ratio (1:12) and exposure time in lysis
regions of known volume. The lysis process was rapidly neutralized by the
quenching solution for durations that would ensure the erythrocyte ghosts
were completely disassociated by the saponin detergent before reaching the
counting region, which electrically analyzed the purified leukocytes using
the aforementioned dual frequency interrogation method. Total leukocyte,
lymphocyte, granulocyte, and monocyte concentrations and their respective
ratios to each other were compared with controls found using a Sysmex XE-
5000 hematology analyzer at the Carle Foundation Hospital Laboratory in
Urbana, IL.
Experiments were also performed to find the minimum quench duration to
create a debris-free leukocyte solution. Quenching time was varied by adjust-
ing the volume of microfluidic tubing between the output of the quenching
region and the input of the counter region. The blood, lysing solution, and
quenching solution flow rates and ratios were kept constant. The quenched
solution was interrogated with the dual frequency method at the counter re-
gion, and the resultant impedance data were analyzed to see whether erythro-
cytes were successfully lysed (i.e., no interference from unlysed erythrocytes
in determining accurate leukocyte counts) for a specific quenching duration.
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5.3.7 Capture Chamber Modification for CD4+ T
Lymphocyte Capture
Selective capture of CD4+ T lymphocytes from leukocytes was attained by
coating the capture chamber region via simple adsorption with CD4 anti-
body before electrical differential experiments. Specifically, purified mouse
antibody to human CD4 (clone 13B8.2; IM0398, Beckman Coulter, Inc.,
Brea, CA) was diluted 1:20 in pH 7.4 PBS and then injected into the cap-
ture region chambers. The solution was then incubated for 30 minutes before
a second infusion and subsequent incubation period of at least 30 minutes.
The chips were either used immediately after the final incubation period, or
stored in a 4 ◦C refrigerator for experiments that would be performed on the
same day as antibody coating. The antibody solution was washed out with
pH 7.4 PBS immediately before counting experiments.
5.3.8 CD4+ T Lymphocyte Count Comparison
It is imperative to compare the differential counter chip’s CD4+ T cell counts
to the “gold” standard of flow cytometry to see whether the chip would be
a viable alternative in resource-poor regions. 10 µL whole blood samples
were evaluated using the electrical differential counting technique with on-
chip erythrocyte lysis and quenching. Control counts were found using a
Beckman Coulter FC-500 flow cytometer at the Carle Foundation Hospital
Laboratory in Urbana, IL.
5.3.9 CD4+ T lymphocyte Capture Efficiency Analysis
Capture efficiency analysis was used to evaluate the chip’s ability to capture
CD4+ T lymphocytes at various capture chamber shear stresses. This is
necessary to understand possible errors between the electrical differential
counts and the various control counts, as poor capture efficiencies would
result in chip counts that are much lower than those from control counts.
For example, a capture efficiency of 25% would result in electrical counts
that are four times less than the control counts, assuming capture purity is
100%.
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Figure 5.8 illustrates the capture efficiency analysis protocol. Two popu-
lations were analyzed for the percent of CD4+ T cells (out of total lympho-
cytes) from the same blood source: (1) 10 µL whole blood samples that went
through on-chip lysis and quenching, but were collected in a tube immedi-
ately after the quenching process and (2) 10 µL whole blood samples that
went through the entire reverse differential counting process with capture
chambers coated with anti-CD4 antibody (also including) on-chip lysis and
quenching. Both populations were collected in tubes already containing a 1%
BSA in PBS (pH 7.4) solution and immediately centrifuged (200 x g, 5 min-
utes) and resuspended in 200 µL of the BSA solution. This dilution of chip
waste in the BSA solution was necessary, as it was found to increase leukocyte
vitality. Omitting this dilution step resulted in total loss of all leukocytes.
Both samples were labeled with a cocktail of Alexa Fluor R© 488-conjugated
mouse antibody to human CD4 (MHCD0420, Invitrogen, Carlsbad, CA),
phycoerythrin-Cy7 (PE-Cy7
TM
)-conjugated mouse antibody to human CD45
(25-0459-42, eBioscience, San Diego, CA) and peridinin chlorophyll protein-
cyanine 5.5 (PerCP-Cy5.5
TM
)-conjugated mouse antibody to human CD3
(45-0037-42, eBioscience) using the manufacturer’s suggested protocols to
fluorescently isolate the CD4+ T lymphocytes (CD45+CD3+CD4+). The
CD45 label was used to enhance the isolation of the lymphocytes from the
other leukocytes, based on the lymphocytes’ unique side scatter and CD45
receptor density characteristics. After labeling for 30 minutes, 1% BSA in
PBS (pH 7.4) was added to each sample before washing (200 x g, 5 minutes)
and resuspending the cells in the BSA solution before flow analysis using a
Guava EasyCyte Plus flow cytometer (Guava Technologies, Inc., Hayward,
CA). The times listed in Fig. 5.8 are to give an idea of the time the leukocytes
have been outside their optimal environment in whole blood.





where ξpop1 and ξpop2 are the fractions of total lymphocytes that are CD4+
T lymphocytes measured from the aforementioned populations (1) and (2),
respectively. These populations can be explicitly described by the equation
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Figure 5.8: Process flow graph for the capture efficiency analysis protocol.
Times listed are to give an idea on the time the leukocytes have been





where XCD4Tcell is the sum of all CD4+ T lymphocyte events and Xother is
the sum of all other lymphocyte events.
Population (1) in Fig. 5.8 could have been obtained from flow cytometry
at Carle Foundation Hospital Laboratory; however, we wanted both popu-
lations (1) and (2) to share as many steps as possible for the most accurate
comparison. For example, the Carle reference laboratory would have first
labeled the CD4+ T cells with fluorescent antibodies and then lysed the
erythrocytes off-chip (using different lysing chemicals than described in this
chapter) before flow cytometry analysis.
5.3.10 CD4+ T lymphocyte Capture Purity Analysis
Capture purity analysis was used to evaluate the chip’s sensitivity in captur-
ing CD4+ T cells—where a true positive event would be a captured CD4+
T cell and a false negative event would be the capture of any other cell. This
capture purity is another important factor in the chip’s counting accuracy
when compared to control counts. For example, a capture purity of 50%
would result in electrical cell counts that are twice those found using the
control method, assuming capture efficiency is 100%.
Figure 5.9 illustrates the capture purity analysis protocol. After CD4+
T cell capture experiments were completed, captured cells were labeled in a
1% BSA in PBS (pH 7.4) solution containing Alexa Fluor R© 488-conjugated
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Figure 5.9: Process flow graph for the capture purity analysis protocol.
Durations are given to give an idea on how long the leukocytes have been
outside their ideal environment in whole blood before analysis. Since the
fixing step preserves cell morphology, the actual crucial duration should be
between 47 and 70 minutes.
mouse antibody to human CD4 (MHCD0420, Invitrogen), allophycocyanin
(APC)-conjugated mouse antibody to human CD14 (MHCD1405, Invitro-
gen), and 4’,6-diamidino-2-phenylindole (DAPI, D21490, Invitrogen). The
labeling solution consisted of antibody concentrations that were 1:30 of their
respective stock solutions and a 1 µM DAPI concentration. The labeling so-
lution was incubated in the capture chambers for at least 30 minutes before
being washed out with fresh 1% BSA in PBS (pH 7.4) solution. Cells were
then fixed with a 1% paraformaldehyde (PFA) in PBS (pH 7.4) solution for 15
minutes before being washed with fresh 1% BSA in PBS (pH 7.4). Cells were
fluorescently imaged using an Olympus IX81 inverted microscope (Tokyo,
Japan) with total magnification of 200x with the appropriate filter sets. Mi-
crographs along the entire length of several of the eight capture chambers
were taken to represent the entire captured population. ImageJ software was
used to obtain the percentage of CD4+ T cells (DAPI+CD4+CD14-), mono-
cytes (DAPI+CD4+CD14+), and other leukocytes (DAPI+CD4-CD14-) out
of total captured cells. Figure 5.9 lists the estimated duration of the capture
purity analysis protocol to give an idea of how long the leukocytes have been
out of their optimal environment in whole blood before imaging. However,
the duration up to fixation is the most crucial, as the fixing step preserves
cell morphology. A more accurate assumption would therefore be 47 – 70
minutes.
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5.4 Experimental Results and Discussion
5.4.1 Passivated Capture Chamber Analysis
Whole blood samples were analyzed using the reverse differential counting
method with a passivated capture chamber. Sample volumes from 0.5 µL to
10 µL were used to vary the total number of leukocytes that passed through
the chip. Lysing and quenching were performed on-chip using lysing (0.12%
(v/v) formic acid and 0.05% saponin in DI) and quenching (0.6% (w/v)
sodium carbonate and 3% (w/v) sodium chloride in DI) buffers that have
been previously shown to work in the microfludic environment [118]. Input
flow rates were adjusted to ensure ∼6 s lysis times.
Figure 5.10 illustrates the high error found between the forward and reverse
counts (average absolute error: x¯ = 36.8%, n = 8)1. The majority of the
points lie well above the x axis, showing many cells were lost between forward
and reverse counting. Capture chambers were inspected to ensure minimal
non-specific binding of leukocytes occurred. One possible reason for this
large error is the lysing/quenching mixture does not create an amenable
environment for leukocyte vitality for the minimum of 10 minute residence
time, resulting in cell death/lysis before being counted again during reverse
flow direction. This was supported by the fact that the lysis/quenching
solution mixture had a pH of 6.7 and an osmolarity of ∼400 mOsm, which
are far from the ideal in keeping the leukocytes alive for extended periods (in
vivo conditions are a pH of 7.4 and osmolarity of 300 to 330 mOsm).
Experiments were designed to confirm whether the counting error was
from a quenching solution, which did not fully neutralize the lysis process
and provide the cells with an amiable osmotic environment. Erythrocytes
were lysed off-chip using the same lysis and quenching solutions as before;
however, the leukocyte pellet was washed with and resuspended in a 1% BSA
solution in PBS (pH 7.4) before being injected into the chip (bypassing the
lysis and quenching modules). Fig. 5.11 shows how the error drastically
drops (x¯ = 4.2%, n = 9), showing the important role the quenching solution
has in ensuring leukocyte vitality for the entire cell residence time in the
counter chip.
A new quenching solution was formulated to provide an optimal environ-
1x¯ and s represent the sample mean and sample standard deviation, respectively.
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Figure 5.10: Percent error for electrical differential counts with passivated
capture chambers using 0.12% (v/v) formic acid and 0.05% saponin in DI
lysis and 0.6% (w/v) sodium carbonate and 3% (w/v) sodium chloride in
DI quenching solutions. The sample mean and standard deviation were x¯ =
36.8% and s = 27.0%, respectively, and were calculated by taking the
absolute of each percent error beforehand (n = 8).
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Figure 5.11: Percent error for electrical differential counts with passivated
capture chambers using off-chip lysis and resuspension in 1% BSA PBS (pH
7.4) solution. The sample mean and standard deviation were x¯ = 4.2% and
s = 2.6%, respectively (n = 9). Outliers were removed with a 99.99%
confidence, assuming a T distribution. Logarithmic data fitting (dashed
line) was used as the most accurate depiction of %error over a range of
forward counts. (R2 = 0.69).
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Figure 5.12: Percent error for electrical differential counts with passivated
capture chambers using 0.12% (v/v) formic acid and 0.05% saponin in DI
lysis and 0.6% (w/v) sodium carbonate in 2.1x PBS quenching solutions.
The sample mean and standard deviation were x¯ = 3.0% and s = 3.0%,
respectively (n = 20).
ment for the leukocytes after on-chip lysis and quenching. The solution
was comprised of concentrated PBS (∼2.1x) and sodium carbonate (∼0.6%
(w/v)), which resulted in a pH of 7.4 and an osmolarity of 324 mOsm after
mixing with lysing solution and blood—with the ratios of 1 part blood, 12
parts lysing solution, and 6.3 parts quenching solution. The phosphate buffer
in the PBS would ensure that the pH would be stable for storage and during
experiments, which may not be true for the previous quenching solution that
lacked buffer capacity.
Reverse differential counting experiments with passivated capture cham-
bers were performed with the new quenching solution, resulting in a much
lower counting error (x¯ = 3.0%, n = 20) (Fig. 5.12). Figure 5.13 shows
how this error is comparable to using the off-chip lysis methods used in the
previous chapter and this chapter, which suggests that the electrical differ-
ential counting chip with integrated on-chip lysis and quenching modules is
a plausible device to obtain CD4+ T cell counts.
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Figure 5.13: Comparison of absolute %errors using different quenching
techniques. The “Quench 1” label denotes on chip lysis and quenching with
0.6% (w/v) sodium carbonate and 3% (w/v) sodium chloride in DI
quenching solution (n = 8); “Off-Chip Lysis” denotes standard off-chip
lysis/quench followed by wash/resuspension in 1% BSA PBS (pH 7.4)
solution (n = 9); “Off-Chip Lysis, Ch. 4” denotes error from reverse
differential counting with passivated capture chambers from the previous
chapter (n = 14); “Quench 2” represents on-chip lysis and quenching with
0.6% (w/v) sodium carbonate in 2.1x PBS quenching solution (n = 20).
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5.4.2 Erythrocyte Lysis and Quenching Time Optimization
Figure 5.14 illustrates how on-chip lysis duration affects the population dis-
tribution of the leukocytes. Each scatterplot compares the low frequency
impedance (303 kHz) to the opacity—the ratio of the high frequency impedance
at 1.7 MHz to the low frequency impedance—for a particular lysis time. The
low frequency impedance level is proportional to the size of a cell, while
the electrical opacity gives information about a cell’s membrane that is in-
dependent of cell size [103, 107, 117]. It can be seen that as lysis time
increases, a portion of the granulocytes/monocytes population transitions
from its original population (2 s), to between the lymphocytes and granu-
locytes/monocytes population (4 – 6 s), to its final position which partially
overlaps the smaller-sized portion of the lymphocyte population (8 – 10 s).
Holmes et al. noted that short-term exposure of leukocytes to saponin dur-
ing lysis can damage the membranes of some leukocytes subsets [117]. Also,
it is well known that saponin is used to permeabilize cells’ cytoplasmic and
nuclear membranes by solubilizing membrane cholesterol, but does not af-
fect cell morphology or membrane antigen expression [147]. This may ex-
plain the aforementioned transition: some granulocytes’ and/or monocytes’
membranes become progressively more permeabilized as the lysis time in-
creases. Eventually, the membranes become fully permeabilized, forming the
third population of cells, shown in Fig. 5.14(e). At 303 kHz, the perme-
abilized cells cannot be represented as non-conducting particles anymore, as
electrical conduction takes place through the cell, resulting in smaller 303
kHz impedance (a 64% decrease between the granulocyte/monocyte pop-
ulation and the permeabilized population in Fig. 5.14(e)). The 1.7 MHz
impedance also decreased (42%) for similar reasons, but not to the same
extent as at 303 kHz—which explains the 63% increase in the permeabi-
lized population’s opacity. One possible explanation is the fact that the high
frequency impedance would already be electrically interrogating unpermeabi-
lized cells’ interiors. This is unlike low frequency interrogation, where cells
block all electrical conduction and the impedance is directly proportional to
the volume of fluid that is displaced by each cell.
We group the granulocyte and monocyte populations together because we
cannot electrically distinguish the two. Holmes et al. have shown that the
two populations have similar low frequency impedance characteristics (cell
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size), but the monocytes’ opacity was slightly less than the granulocytes,
allowing them to differentiate the two populations (Fig. 2.12). We do not
observe this difference, but assume the monocytes are included with the
granulocyte population. Our coplanar electrode configuration may prevent
us from seeing this slight difference in opacity, as their vertical (top-bottom)
electrodes configuration may remove possible error caused by cells passing
the electrodes at varying heights—creating a more sensitive system [107,117].
Figure 5.15 shows the recovery of leukocytes and leukocyte subpopulations
for a range of on-chip lysis durations. Recovery percentage is based on the
ratio of the chip concentration to the control concentration. The granulo-
cytes/monocytes were gated similarly to the dashed areas in the inset of Fig.
5.15, which includes the permeabilized population. Lymphocyte gating is
shown by the solid ellipse of the same inset. The total leukocyte recovery of
55 – 65% for all durations shows considerable leukocyte loss, which can be
attributed to the loss of granulocytes/monocytes—a population which has
already been shown to be affected by the lysis process (Fig. 5.14) and com-
prises the majority of total leukocytes (∼67%, n = 15). For example, at a lysis
time of 2s, the 36% loss of granulocytes/monocytes contributes to 24% total
leukocyte loss, while the 51% lymphocyte loss contributes 17% to the total
loss. The decrease in granulocytes/monocytes and increase in lymphocytes
starting at 4 s is most likely from the permeabilized granulocytes/monocytes
population overlapping and being gated with the lymphocytes population.
This results in false positives for lymphocyte counts and an apparent loss of
of cells in the granulocytes/monocytes population.
This aggressive lysing method lyses all erythrocytes within seconds, which
is optimal for a microfluidic point-of-care platform. Gentler lysing methods
may give a higher leukocyte recovery, but can take up to 15 minutes and,
from our experience, are not as successful in removing enough erythrocytes to
provide accurate leukocyte analysis using the electrical differential counting
technique. However, is the rapid lysing technique deleterious for the CD4+ T
cells? We have used flow cytometry to compare CD4+ T cell recoveries for the
aforementioned rapid lysis technique (performed off-chip) and a commercial
method (Becton Dickinson Pharmlyse
TM
). We found that although there was
a loss of 20% of total leukocytes compared to the Pharmlyse
TM
, the rapid
lysis technique showed only a loss of 1% CD4+ T cells (n = 4). Although
the lysing dynamics may be different in the microfluidic environment, it is
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Figure 5.14: Low frequency impedance (303 kHz) vs. opacity (|Z| @ 1.7
MHz / |Z| @ 303 kHz) scatterplots showing the effects of microfluidic lysing
duration on the granulocyte/monocyte population. (a) – (e) represent 2, 4,
6, 8, and 10 s lysing times, respectively. A distinct third population of
permeabilized granulocytes/monocytes can be seen for 10 s lysis duration.
The vertical lines in the inset low frequency impedance histograms show
the estimated mean of the permeabilized population’s movement toward
the lower impedance regime from 2 s to 10 s. The horizontal lines in the
inset opacity histograms show the estimated mean of the same population
during its rise in opacity from 2 s to 10 s.
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Figure 5.15: Recovery percentages for varying lysis durations for leukocytes
and leukocyte subpopulations. The solid, dotted, and dashed lines denote
total leukocyte, lymphocyte, and granulocyte/monocyte recovery,
respectively. n = 6 for the 2 s data, while n = 3 for all the other lysing
durations. The inset shows an example of how lymphocytes and
granulocytes/monocytes were counted in a low frequency impedance (x
axis) vs. opacity (y axis) scatterplot for a 6 s lysis duration. The solid
ellipse denotes lymphocyte gating, while the two dashed areas denote the
total granulocyte/monocyte populations. It is assumed that the third
population is permeabilized granulocytes and monocytes.
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possible that even if 50% of leukocytes are lost after lysis, all of CD4+ T
cells may have been successfully recovered, given that in our experiments the
average percent of total leukocytes that were CD4+ T cells was 13% (from
15 different donor samples).
Figure 5.16 shows how quenching duration affects the quality of the electri-
cal signal and the ability to accurately count leukocytes. Quenching times of
7.5 s and 11.3 s do not allow the saponin to completely disassociate the ery-
throcyte fragments or ghosts that were created from the exposure to formic
acid [117]. These ghosts still create an appreciable change in impedance when
they pass through the counter, resulting in a baseline noise level which masks
many leukocytes. The low frequency impedance pulse histograms shown in
Fig. 5.16(b) and (d) show that the erythrocyte debris dominates all counts.
Complete erythrocyte lysis and debris removal seem to occur between 11.3
s and 15.4 s, as the pulse signal-to-noise ratio in Fig. 5.16(e) is similar
to that found by analyzing leukocyte populations that were prepared using
off-chip techniques, which includes lysing, quenching, and washing twice via
centrifuge. In addition, the baseline noise at 15.4 s is similar to that found
for the longer quench durations in Fig. 5.16(g) and (i). The histograms
shown in Fig. 5.16(f), (h), and (j) show how the erythrocyte debris peak at
the far left of the distribution at 15.4 s decreases as quenching time is in-
creased until it is completely removed at 48.3 s, showing only the lymphocyte
and granulocyte/monocyte populations. Therefore, the minimum quenching
time should be approximately 48 s to ensure that all erythrocyte debris is
removed, ensuring adequate separation from the electrical noise and that no
debris is falsely counted as leukocytes. Figure 5.17 shows micrographs of
the counter region for the same quenching experiments, confirming that a
considerable amount of debris exists for 7.5 s, is lessened at 11.3 s, and is
completely removed at 48.3 s.
5.4.3 CD4+ T Lymphocyte Capture Efficiency
Figure 5.18 shows flow cytometry data using the aforementioned labeling pro-
tocol to isolate the lymphocytes and CD4+ T lymphocytes. Figure 5.18(a)
shows how total lymphocytes are gated based on their unique side scattering
vs. CD45 fluorescence intensities. Figure 5.18(b) breaks down the lympho-
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Figure 5.16: Impedance signals (a, c, e, g, i) and resultant pulse height
histograms (b, d, f, h, j) for various quenching times of whole blood
samples. Histograms were created by analyzing impedance data using a
threshold level of 0.22 V. The plots in (a), (c), (e), (g), and (i) are 200 ms
snapshots of the electrical data that was analyzed to create their respective
histograms. Impedance pulse plots were plotted at the same scale for pulse
height and baseline noise comparison.
112
Figure 5.17: Micrographs of the counting channel at different quenching
times of whole blood samples. Erythrocyte debris is noticeable for 7.5 s (a),
lessens at 11.3 s (b), and is absent at 48.3 s (c). Flow direction is from left
to right in all micrographs. Arrows signify the position of leukocytes along
the channel. Scale bars are 200 µm.
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Figure 5.18: Flow cytometry analysis of lymphocytes from on-chip
processed whole blood. (a) The lymphocyte population was isolated via its
unique side scattering vs. CD45 intensities. (b) CD4+ T lymphocytes were
isolated through the presence of CD3 and CD4 antigens within the
lymphocyte population gated in (a).
cytes gated in (a) into different lymphocyte subpopulations. Populations
of interest include CD4+ T lymphocytes (CD3+CD4+, upper right quad-
rant), T lymphocytes (CD3+, upper two quadrants), and all lymphocytes
(all quadrants). The fraction of lymphocytes that are CD4+ T lymphocytes
is calculated based on the number of upper right quadrant events divided by
the events in all quadrants (i.e., Eq. 5.3).
Figure 5.19 shows how the capture efficiency increases with decreasing
shear stresses and plateaus at 0.333 dyn·cm−2 with a maximum of 44.5%
efficiency at 0.088 dyn·cm−2. The average efficiency for the plateau is 41.9%,
which is somewhat lower to what we found in the off-chip lysis methods from
the previous chapter (60.2%). The following are possible explanations for
this discrepancy.
1. The capture efficiencies in this chapter may actually be similar to those
in the previous chapter, but non-idealities from the differential counting
experiments and subsequent capture efficiency analysis itself may be
generating artifacts that result in seemingly lower capture efficiencies.
(a) The nonspecific capture of lymphocytes other than CD4+ T lym-
phocytes would generate error in calculating capture efficiency.
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Figure 5.19: CD4+ T cell capture efficiency for various capture chamber
shear stresses. Corrections for the capture of lymphocytes that are not
CD4+ T lymphocytes, described in the text, resulted in an increase of 2.5,
1.8, 2.6, 1.1, and 0.9 percentage points for 0.088, 0.167, 0.333, 0.667, and 1
dyn·cm−2, respectively. These corrections are reflected in this figure.
Iterations: 0.088 dyn·cm−2, n = 6; 0.167 dyn·cm−2, n = 5; 0.333 – 1
dyn·cm−2, n = 3.
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This nonspecific capture would lower the number of Xother events
in Eq. 5.3, increasing the fraction of CD4+ T cells that were not
captured by the chip (ξpop2, Eq. 5.2), resulting in a lower calcu-
lated capture efficiency (η, Eq. 5.2) than reality. Adjustments
to Fig. 5.19 were made to compensate for this error, assuming
all CD4- leukocytes had equal opportunity to be nonspecifically
captured. The capture of these other lymphocytes was estimated
by knowing the percent of these cells compared to all leukocytes
(via flow cytometry control) and the percent of nonspecific cap-
ture of CD4- leukocytes for a particular capture chamber shear
stress (see 5.4.4). Multiplying these two terms gives the fraction
of other lymphocytes that were captured, and that should be added
to Xother in Eq. 5.3 to ensure the most accurate capture efficiency
analysis. This resulted in an average increase of 1.8% in capture
efficiency for all shear stresses, which far from covers the discrep-
ancy between the capture efficiencies found in this chapter and
the previous chapter.
(b) Another possible source of error is that the on-chip lysis process
and larger cell residence times using the methods in this chapter
may cause damage to the lymphocytes that are not CD4+ T lym-
phocytes, causing delayed death before being analyzed by flow cy-
tometry. With respect to the capture efficiency calculations, this
would create the same effects as if these lymphocytes were non-
specifically captured in the capture chambers, resulting in a lower
capture efficiency than it truly is. No corrections can be made
for this error using the aforementioned capture efficiency analysis
protocol, as this protocol relies solely on the ratios of cells. It is
possible to compensate for this in future experiments by adding a
known number of fluorescent counting particles to the samples be-
fore flow cytometry analysis to find the absolute concentrations of
the lymphocytes and lymphocyte subsets. Comparing the concen-
trations between the population of cells that were simply lysed and
quenched and the population of cells that went through the entire
differential capture process would show how many lymphocytes
were actually lost from the differential counting process. Other
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possible solutions to this source of error are listed in 5.4.5.
2. Several suggestions for why the on-chip sample processing results in a
lower capture efficiency than the off-chip method stem from the fact
that the methods described in the previous chapter in preparing the
purified leukocyte population vary significantly compared to the on-
chip lysis sample preparation that is described in this chapter. Both
methods lysed erythrocytes and quenched the lysis process using similar
chemicals and lysis times, but the similarities end there. For the off-chip
lysis method, the remaining leukocytes were washed twice in a 1%BSA
in PBS (pH 7.4) solution, resuspended in the same solution, and stored
on ice for at least 30 minutes before capture experiments. On-chip lysis
and quenching resulted in a purified leukocyte population suspended in
PBS (pH 7.4) containing saponin, the products of neutralizing formic
acid with sodium bicarbonate, and erythrocyte debris. These purified
leukocytes could make it into the capture region in as little as 30 s after
lysis. Some suggestions:
(a) The erythrocyte debris may be interfering with antigen-antibody
binding dynamics. Although the erythrocyte debris is undetectable
optically via microscope and electrically via impedance analysis,
its presence at the molecular level cannot be neglected, and may
partially block the interactions between the helper T cells’ CD4
receptors and the immobilized CD4 antibodies on the chamber
floors.
(b) The lysis solution may cause hypotonic swelling of the leukocytes,
partially damaging or removing microvilli which contain the CD4
antigens on their tips [148]. This would hinder antigen-antibody
interactions, as the microvilli are known to aid in cell adhesion to
surfaces in vitro and in vivo circumstances [148,149]. This may not
happen to all CD4+ T cells since a portion of them are captured.
A possible explanation for this is that some of the cells are exposed
to the lysis solution longer during the initial diffusive mixing of
blood and lysis solution, which is relatively slow in the laminar
flow regime. If this damage is temporary, the cells processed off-
chip may have enough time to recover before passing through the
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capture chambers—a luxury the on-chip processed cells do not
have.
(c) The presence of saponin, commonly used to permeabilize living
and fixed cells for internal labeling studies, may cause problems
with cell antigen expression, effectively reducing the number of
captured cells. However, multiple sources have shown that lym-
phocyte surface antigen functionality was not impeded by the pres-
ence of saponin and that this permeabilization is reversible if the
saponin is washed away [147,150].
3. Another reason for the differences between the capture efficiencies found
in this chapter and the previous chapter could be that we used different
antibody clones at different concentrations. The concentration of anti-
body used to coat the capture chambers was 20 µg·mL−1 in the previous
chapter, while half the amount was used in this chapter’s experiments
(10 µg·mL−1). This could understandably lessen the antigen-antibody
interaction time and probability, resulting in fewer cells captured.
4. Another possible source of error is the capture chamber length in the
design in this chapter is shorter than in the previous chapter (20 mm
vs. 34 mm), possibly not allowing as much time for capture. Capture
chamber length had to be reduced to fit the additional modules and
create a chip with a reasonable footprint for fabrication throughput
purposes. However, the reverse flow technique effectively increases the
capture chamber length by 100% to 40 mm, which is similar to capture
chamber lengths used elsewhere for single flow direction capture of
CD4+ T lymphocytes [51,52,64].
With respect to the last point, it is possible that some cells are not making
contact with the capture chamber floor to facilitate capture. Therefore, it is
imperative to ensure the sedimentation process has enough time to cause the
lymphocytes to reach the floor of the capture chambers to interact with the
immobilized CD4 antibody. We can obtain an estimate of the sedimentation
velocity of lymphocytes with the equation [151]
w =




where ρp and ρf are the densities of lymphocytes (1.075 g·mL−1, [152]) and
suspending medium (1.01 g·mL−1), respectively. The suspending medium
was assumed to have a density similar to that found in a 1x concentration
of PBS (pH 7.4). The radius of the lymphocytes, r, is estimated to be 3.9
µm, which was determined from the average lymphocyte volume found by
Zipursky et al. [152]. The dynamic viscosity of the suspending medium,
µ, was empirically found to be 1.33 cP by measuring lysed and quenched
whole blood using a viscometer in our laboratory. The acceleration due to
gravity is denoted as g. Using the aforementioned equation and values, the
sedimentation velocity of lymphocytes was found to be 1.62 µm·s−1.
Cell residence time in the chamber, tRES, is based on the average fluid





where LC is the chamber length (20 mm), WC is the effective capture re-
gion width (2 mm x 8 chambers = 16 mm), HC is the capture region height
(varies), and QT is the sum of the sample, lysis, and quenching solution volu-
metric flow rates (varies). At a shear stress of 0.167 dyn·cm−2, cell residence
time in the capture chamber is approximately 86 s in either the forward or
reverse flow direction. Multiplying this time by the previously calculated
sedimentation velocity would result in a downward vertical displacement of
∼140 um for lymphocytes. Given that 115 µm tall capture chambers were
used for the 0.167 dyn·cm−2 shear stress experiments, all lymphocytes should
settle to the floor of the capture region well before exiting it because their
settling distance would be over 1.21 times the height of the chamber.
Figure 5.20 summarizes the fraction of a chamber’s height settled by lym-
phocytes for all shear stresses. The fraction was found by dividing the sed-
imentation displacement distance by the height of the chamber. These cal-
culations allow for proper comparison between different shear stresses, as
several capture chamber heights and different flow rates were used to obtain
the specific shear stresses and to reduce leukocyte residence time in the chip
to avoid cell loss. It is interesting to note that the fractions found for both
0.088 and 0.333 dyn·cm−2, which had relatively high capture efficiencies, are
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Figure 5.20: Relationship between ratio of capture chamber height settled
by lymphocyte sedimentation and shear stress (solid line, left y-axis), and
the relationship between the average capture chamber fluid flow velocity
and the shear stress (dashed line, right y-axis). Capture chamber heights
used for particular shear stresses were 208 µm for 0.088 dyn·cm−2, 115 µm
for 0.167 and 0.333 dyn·cm−2, and 70 µm for .667 and 1 dyn·cm−2.
below unity and are similar to those found at the higher shear stresses, which
had much lower capture efficiencies. This may mean that the lymphocytes
are already near the floor of the chambers when they enter, reducing the dis-
tance necessary to settle to the floor. This is possible, given the leukocytes
were funneled down toward the floor of the 15 µm counting channel, and may
have remained near the floor of subsequent taller channels.
Since the cells most likely are making it to the surface of the capture
chamber for all tested shear stresses, another main factor determining CD4+
T cell capture is the velocity of the cells along the chamber floor. At smaller
shear stresses, the slower rolling velocity of the cells on the capture chamber
floor allows more interaction time with the immobilized antibodies, increasing
the probability of capture. The average chamber flow velocities used in the
capture experiments are depicted in Fig. 5.20, showing that the lower average
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flow velocities correlate with the shear stresses which gave the highest capture
efficiencies, and that at velocities above 0.45 mm·s−1 the cells do not have
enough interaction time with the CD4 antibodies. It is not to be implied that
the calculated average chamber flow velocity is the actual rolling velocity of
the cells on the surface of the chip, but that the latter is directly proportional
to the former.
Even if the capture efficiency was similar to the previous chapter (60.2%),
it would still be considerably lower than what Cheng et al. reported (above
90%) because it lacks the leukocyte margination effect that is caused by
the presence of the erythrocytes [51, 139]. Whereas their method depends
on the erythrocytes to push the leukocytes against all chamber walls, our
method depends on sedimentation to cause the leukocytes to land and then
roll along the floor of the capture chambers. The capture efficiency could be
enhanced by using covalent chemistry to ensure the proper orientation of the
antibodies’ antigen binding regions, ultimately increasing interaction time
and probability between the CD4+ T cells and the immobilized antibodies.
Moon et al. have used such a chemistry for capturing CD4+ T lymphocytes
that were rolling along the floor of the capture chamber, but were still only
able to obtain a 70.2% capture efficiency [60].
Capture efficiency could further be improved by decreasing the chamber
height to be similar to the size of the cells to force more cell-surface in-
teraction, but the effective width of the capture region would have to be
prohibitively large to ensure low shear stresses at sample flow rates to keep
the diagnostic duration below 15 minutes. For example, to have 10 µm-high
capture chambers and to operate at 0.167 dyn·cm−2 to have 10 µL of blood
analyzed within 10 minutes, the effective width of the capture channel re-
gion would have to be over 4.75 m wide, which is obviously impractical for
any situation, much less for point-of-care applications. Microposts coated
with antibodies have been shown to increase the efficiency of capturing rare
circulating tumor cells [153]. The increase in surface area using a similar
micropost design in the capture chamber may help increase the capture ef-
ficiency of CD4+ T cells. For example, microposts can be spaced closely
together (e.g., ∼10 µm) to force the lymphocytes to interact with the pillar
surfaces, while the chamber height can be large enough to ensure that the
combination of low enough shear stress and a small chip footprint are possi-
ble. This could also increase the capture purity, as higher shear stresses can
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be used because of the guaranteed surface interactions with the posts. These
higher shear stresses, especially starting at 1 dyn·cm−2, could decrease the
nonspecific capture of CD4- leukocytes and the capture of monocytes [51].
5.4.4 CD4+ T Lymphocyte Capture Purity
Figure 5.21 gives the percent of total captured cells for each cell type of
interest for a range of shear stresses. The increase in capture purity of CD4+
T cells with shear stress is mostly attributed to the decrease in nonspecific
capture of CD4 negative leukocytes (monocytes are weakly CD4+). This is
supported by the fact that at a shear stress of 0.088 dyn·cm−2, nonspecific
capture of other leukocytes dramatically increases to 54%, resulting in a
CD4+ capture purity of only 32%. At such a low shear stress, the leukocytes
are rolling so slowly on the channel floor that they have enough time to
attach to the glass surface via their integrin receptors. Although monocytes
have an order of magnitude less CD4 surface antigen than CD4+ T cells, Eq.
5.4 shows that their larger size (r = 5.03 µ, [152]) ensures they will settle to
the chamber floor 1.6 times faster than lymphocytes, having ample time to
interact with the CD4 antibodies at all shear stresses [51, 136, 137]. This is
supported by the fact that the percent of captured cells being monocytes is
similar for all shear stresses (x¯ = 18.4%, s = 3.7%.).
The capture purity for the previous chapter was ∼82% at 0.5 dyn·cm−2,
which is considerably larger than what was found in this chapter (∼60%,
estimated for the same shear stress). The main reason for this discrepancy
is the fact that the leukocytes were in a 1% BSA solution in the previous
chapter, acting as a blocking agent to prevent nonspecific capture of leuko-
cytes. No blocking agent was present in this chapter’s capture experiments.
The percent of other leukocytes captured at this shear stress in this chap-
ter’s data is ∼20%. Assuming blocking would prevent all nonspecific capture,
the estimated capture purity would be around 80%, which would match the
previous chapter’s data.
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Figure 5.21: Percent of total captured cells vs. capture chamber shear
stress for all CD4+ cells, CD4+ T cells, monocytes, and other leukocytes.
The “All CD4+ cells data” is obtained by adding the monocytes and CD4+
T cell percentages. CD4+ T cell capture purity peaks at 73% at 1
dyn·cm−2, slightly decreases to an average of 63% (s = 1.9%) for 0.167 –
0.667 dyn·cm−2 before further decreasing to 32% for 0.088 dyn·cm−2.
Iterations: 0.088 dyn·cm−2, n = 6; 0.167 dyn·cm−2, n = 7; 0.333 dyn·cm−2,
n = 11; 0.667 dyn·cm−2, n = 10; 1 dyn·cm−2, n = 4.
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5.4.5 CD4+ T Lymphocytes Comparison: Electrical
Differential Counting vs. Flow Cytometry Control
Sixteen blood samples were analyzed using the electrical differential counting
technique to find the concentration of CD4+ T lymphocytes. Nine of the
blood samples were diluted using their own plasma to provide a range of
CD4+ T cell counts (1:2 to 1:20 dilutions). These results were compared
to the flow cytometry control, obtained from the Carle Foundation Hospital
Laboratory. A chamber shear stress of 0.167 dyn·cm−2 was used for these
capture experiments because its relatively high capture efficiency (Fig. 5.19)
and purity (Fig. 5.21) should provide the most accurate representation of
the actual CD4+ T cell concentration. A shear stress of 0.333 dyn·cm−2
could have also been used, but it was assumed that the capture efficiency at
0.167 dyn·cm−2 would be the same or greater because the cells would have
more opportunity to interact with the immobilized antibodies on the capture
chamber floors at the slower flow speeds—despite the minor dip in its capture
efficiency.
Figure 5.22 shows the low frequency impedance vs. opacity scatterplots
for forward (a) and reverse (b) counts for a particular capture experiment.
It also shows how the total number of leukocytes were gated for both counts.
The reverse counting gate was slightly modified to follow the contour of the
permeabilized cells to avoid counting the noise that is not present in the
forward counts. The source of the noise could be debris from leukocytes that
died and ruptured in the capture chambers or exit holding coil.
Figure 5.23 compares the electrical differential counting method to the flow
cytometry control for all 16 iterations, showing good correlation between the
two methods (y = 1.068x, R2 = 0.946). Multiple repetitions were analyzed
using the chip for the same donor sample, and showed high repeatability, es-
pecially for the lower CD4+ T cell concentrations. The high correlation with
the “golden standard” of flow cytometry and high repeatability suggests that
this electrical differential counting method with on-chip sample preparation
is a viable technology to provide portable and rapid CD4+ T cell counts for
patients in resource-poor regions.
This high correlation was not expected, given that the capture efficiency
and purity were approximately 42% and 63% for this shear stress regime.
Equation 5.6 relates the flow cytometry CD4+ T cell concentration control
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Figure 5.22: Low frequency impedance vs. opacity scatter plots of a CD4+
T lymphocyte capture experiment. Capture chamber shear stress was 0.167
dyn·cm−2. The dashed boxes indicate the gates used to determine the total
leukocyte counts for the forward (a) and reverse (b) flow directions.
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Figure 5.23: Comparison between CD4+ T cell concentrations from the
flow cytometry control and the electrical differential counting method (n =
16). The dashed line represents perfect correlation between the two analysis
methods. The solid line represents a linear fit of all 16 points (y = 1.068x,
R2 = 0.946). Outliers were removed with a 99.99% confidence, assuming a
T distribution. Average cell concentration and standard deviation are given
for repetitions in chip analysis for the same sample. The number in
parentheses denotes how many iterations were performed, which can be
difficult to differentiate because of datapoint density.
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(Tctl) to the electrical differential count (Tchip) through the capture purity
(α), capture efficiency (η, Eq. 5.2), and CD4+ T cell recovery after erythro-





It is assumed that β is unity because of our previous investigations (5.4.2).
Given the aforementioned capture efficiency (42%) and purity (63%), Tchip/Tctl
would be 0.67, which means that, on average, chip counts should be 33% less
than the control counts. However, Fig. 5.23 shows that, on average, chip
counts are ∼7% larger than the control counts (based on the slope of the
linear fit).
The author believes that this discrepancy is primarily caused by the errors
in obtaining the capture efficiency, which are detailed in 5.4.3, reasoning 1,
with emphasis on (b). As shown in Fig. 5.8, the capture efficiency protocol
requires many steps where cells can be lost or damaged. The duration the
leukocytes are exposed to the lysis/quenching mixture before being diluted
in the waste vial for population (1) is less than a minute. The leukocytes in
population (2), however, may be in the mixture for over 35 minutes. This
time difference between the two populations supports the idea that the vi-
tality of population (2) is substantially less than (1). In addition, the total
time between leukocytes leaving their optimal environment in whole blood
and actual efficiency analysis in the flow cytometer is also a concern, as the
cells in population (2) are out of their optimal environment for over 75 min-
utes, most likely affecting their vitality. Fixing the cells could sustain their
morphology, but this step would have been performed after fluorescent label-
ing of the cells—which is already at the end of the efficiency analysis protocol
and would have added several more processing steps.
In contrast, capture purity analysis has proven to be a more reliable pro-
cess. It directly obtains the capture purity of cells by imaging a single pop-
ulation of leukocytes that were captured on chip. In contrast, the capture
efficiency experiments compares two different populations of leukocytes that
went through a different number of steps of different total durations, most
likely with different vitalities. This leads us to believe that α in Eq. 5.6 is
an accurate representation of capture purity.
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With α being a good representative of capture purity, the feasibility that
CD4+ T cell recovery after lysis is unity (β = 1), and given the high corre-
lation between the chip and control counts (y = 1.07x, or Tchip ≈ Tctl), the
only variable unaccounted for is capture efficiency (η). In fact, if the capture
efficiency was indeed 60% as found in the previous chapter, Eq. 5.6 would
result in a Tchip/Tctl of 0.95. This would complement the 1.07 ratio that is
observed from the chip vs. control counting data in Fig. 5.23.
Capture efficiency experiments can be improved to better ensure the afore-
mentioned errors are minimized and/or compensated for. Some suggested
modifications are listed below.
1. Fluorescent counting beads can be used to obtain the absolute con-
centrations of the lymphocytes and lymphocyte subsets during flow
cytometry analysis, giving vital information regarding how many lym-
phocytes were lost (5.4.3).
2. Experiments need to be modified to ensure that the vitality of the
lymphocyte (and leukocyte) population is maintained throughout the
entire differential counting and capture efficiency analysis processes.
This may be done by optimizing the capture chamber height to ensure
a shear stress of 0.167 dyn·cm−2 at the fastest total flow rate possible
(60 µL·min−1, based on the pumping system’s maximum infusion rates)
to ensure cell duration in the chip’s non-ideal environment is minimal.
3. BSA could be added to the quenching solution to simulate the same
on-chip conditions found in the previous chapter, possibly increasing
the vitality of the cells.
4. Capture efficiency experiments could also be run that negate the reverse
flow step to also shorten cell residence time in the chip and also quantify
the capture efficiency of performing a single pass through the capture
chambers (it could be possible that only one pass would be needed).
5. Decreasing on-chip lysis time below 2 s may improve lymphocyte (and
total leukocyte) recovery, allowing lymphocytes to remain alive longer
in the non-ideal, on-chip environment.
6. Obtaining capture efficiency more directly by analyzing the captured
cells in the same manner as used in capture purity analysis may re-
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duce error. Captured cells can be fluorescently tagged with CD3+ and
CD4+ antibodies, and the ratio of the CD3+CD4+ helper T cells to
total T cells (CD3+) can be compared to the same ratio found using
the flow cytometry control of the same blood sample source.
5.5 Conclusions
In this chapter, we have evaluated an electrical differential counter with
an on-chip sample preparation module to evaluate whole blood samples for
CD4+ T lymphocyte concentration. We found that erythrocyte lysis is quick
and rigorous, leading to leukocyte casualties. However, preliminary experi-
ments have shown that the CD4+ T cells were not affected by off-chip lysis
and quenching, as they showed high recovery (99%). Lysis times less than
2 s may result in higher leukocyte recovery, allowing the differential counter
chip to accurately provide the total lymphocyte and granulocyte/monocyte
concentrations in addition to the CD4+ T lymphocyte concentration. We
found that the quenching solution described in the literature [118, 143] did
not maintain leukocyte vitality for the required residence times in the chip
(≥ 12 minutes), but modified the solution using concentrated PBS to ensure
correct and stable pH and osmolarity. The optimal quenching time was found
to be ∼48 s to disassociate all erythrocytes, ensuring a debris-free leukocyte
solution. The chip’s capture purity and efficiency were characterized for dif-
ferent capture chamber shear stresses, and the optimal shear stress of 0.167
dyn·cm−2 was used to obtain CD4+ T cell concentrations that correlated
well with the “gold standard” of flow cytometry. The on-chip lysis of ery-
throcytes and subsequent immunocapture of the remaining leukocytes is not
found in the literature, and requires more detailed characterization between
capture efficiency and the resultant chip counts. Efforts should be made to





This chapter briefly discusses future steps that should be taken to better
characterize, improve on, and expand the current differential counter design.
6.1 Further Evaluation of Current Differential Counter
6.1.1 Erythrocyte Lysis Duration
In 5.4.2, it was found that approximately 40% of total leukocytes were lost af-
ter on-chip erythrocyte lysis, preventing an accurate depiction of total leuko-
cytes, lymphocytes, and granulocytes/monocytes, which is helpful supple-
mentary information to the CD4+ T cell count. Even though initial exper-
iments have shown that CD4+ T cell vitality is not affected by the lysis
protocol, it is still possible that other lymphocytes are being affected (i.e.,
partial damage and delayed death), resulting in a capture efficiency that is
lower than it actually is (5.4.3).
Several modifications can be made to investigate this topic. The minimum
lysis time can found by reducing lysis duration until just before unlysed
erythrocytes are observed at the counter channel. This can be evaluated by
looking at the counter region under microscope with the aid of a high speed
camera, or by observing the low frequency impedance vs. opacity scatter
plots for a noticeable erythrocyte population. The lysis and/or quenching




More iterations of capture efficiency experiments are necessary to fully under-
stand the correlation between the chip’s differential count, capture efficiency,
lysis recovery, and capture purity. Equation 5.6 has related these terms and
shows a discrepancy between the expected and actual relationship between
the chip and control counts. It is the author’s belief that the actual cap-
ture efficiencies are higher than depicted in Fig. 5.19 for the reasons stated
in 5.4.3. Mainly, the nonspecific capture or delayed death/lysis of lympho-
cytes other than the CD4+ T lymphocytes is causing the capture efficiency
calculations to result in lower capture efficiencies.
Counting efficiency experiments can be modified to quantify the aforemen-
tioned losses of lymphocytes, ensuring an accurate depiction of the capture
dynamics of the chip. Specifically, adding a known number of fluorescent
counting beads to the labeled solutions would provide the concentrations of
total lymphocytes and CD4+ T lymphocytes, rather than simply the ratio
between the two populations. The concentrations can be compared between
samples that were not injected into the capture chamber and the those that
went through the entire differential counting process to see if any lympho-
cytes, other than CD4+ T cells, were lost. Another solution to reduce error
is to perform capture efficiency analysis more directly by using the same
methods from the capture purity protocol. This entails fluorescently tagging
all captured T cells with CD3 antibodies in addition to labeling all captured
CD4+ T lymphocytes with CD4+ antibodies. The ratio of CD3+CD4+
helper T cells to the total number of CD3+ T cells can be compared to the
same ratio obtained from flow cytometry. Other proposed solutions are listed
in 5.4.5.
Improving lymphocyte vitality would also help ensure more accurate re-
sults. Further optimization of lysis time and/or lysis/quenching solution
formulations may help preserve lymphocytes (and other leukocytes) dur-
ing the entire differential counting experiment and subsequent capture effi-
ciency analysis (6.1.1). Reducing cell residence time in the non-ideal saponin,
protein-diminished environment found on-chip should also increase cell vital-
ity. This can be done by increasing the total flow rate (blood sample + lysis
solution + quenching solution) for faster processing times, given the capture
chamber’s height is increased to maintain the optimal shear stress of 0.167
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dyn·cm−2.
6.1.3 HIV Patient Testing
It is necessary to test whether the differential counter can accurately provide
CD4+ T cell counts for HIV/AIDS patients in addition to HIV- patients. In
Chapter 5, low CD4+ T cell concentrations were created by diluting whole
blood before injecting it into the chip. In this case, the ratio between helper
T cells and total leukocytes remained the same (8 – 22% range, x¯ = 12%,
s = 4%; n = 15). In HIV+ patients, this ratio may be much lower, given
the selective depletion of the CD4+ T cells. We may need to confirm the
counting accuracy because the ratio of leukocytes that were nonspecifically
captured to the CD4+ T lymphocytes would increase.
HIV+ patient samples will be obtained from willing participants of the
Champaign-Urbana Public Health District (Champaign, IL) using an in-
formed consent process approved by the University of Illinois Institutional
Review Board. These samples will be analyzed by the differential counter
chip and control counts will be obtained from Carle Foundation Hospital
Laboratory (Urbana, IL).
6.2 Improvements on Current Differential Counter
6.2.1 Surface Chemistry
In this dissertation, CD4 antibodies have been immobilized to the capture
chamber walls by simple adsorption. A more robust protocol, such as the
silane surface chemistry already described, would ensure that a higher num-
ber of Fab regions are available to interact with helper T cell surface antigens,
increasing the chip’s capture efficiency [51,60,141,154]. It could also increase
the chip’s capture purity, as the presence of silane and linkers should pro-
vide a more even and robust coverage over chamber surfaces, more effectively
preventing nonspecific binding of other leukocytes.
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6.2.2 Enhancing Cell and Chamber Surface Interactions
Moon et al. have used the aforementioned silane surface chemistry to capture
CD4+ T cells by allowing them to roll along the chamber floor (similar to the
capturing methods in Chapters 4 and 5), but only achieved a 70.2% capture
efficiency, which is far less than what Cheng et al. obtained from flowing
whole blood through their capture chambers (> 90%) [51, 60]. This is be-
cause the latter capture method relies on erythrocytes to push the leukocytes
toward the walls of the capture chamber, ensuring high quality interactions
with the immobilized CD4 antibodies. In our case, the necessary step of
lysing the erythrocytes before counting prevents us from taking advantage of
this phenomenon.
Moon et al. said that increasing the capture chamber’s length may increase
the interaction time between the cells and capture chamber floor, resulting in
a higher capture efficiency [60]. However, our reverse flow method allows the
cells to interact with the 20 mm capture chamber twice, effectively creating
a 40 mm capture chamber length—which is much longer than their 24 mm
capture chamber in which they flow their cells through only once. With this
fact, it may possible that cells need this mechanical pressure to fully engage
the cells’ surface antigens with the antibodies on the chamber walls.
A capture chamber of small height (∼10 µm) could be used to do this, as
it is similar in height to the average size of the lymphocytes. However, as al-
ready mentioned in 5.4.3, the resulting chip’s footprint would be prohibitively
large to ensure proper capture chamber stress and analysis times.
Nagrath et al. used microposts coated with antibodies to increase the
efficiency of capturing rare circulating tumor cells (CTCs) [153]. Adams et al.
used a series of sinusoidal capture channels to also isolate CTCs from blood
samples [124]. Stott et al. used a herringbone design to create microvortices
that enhanced the cell-to-surface interactions [155].
We plan to use an approach similar to Nagrath et al. by placing microposts
into the capture chamber to not only create more surface area for cell-to-
surface interactions, but to mechanically press the cells against the antibody-
coated posts. Figure 6.1 illustrates this idea, where leukocytes are forced
against and squeezed between pillars, capturing the CD4+ T cells. Figure
6.2 shows preliminary COMSOL simulations of shear stresses in a capture
region with pillars. Optimal shear stresses may be more similar to those used
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Figure 6.1: Illustration showing leukocytes passing through a capture
region comprised of vertical pillars (top-down view). The arrow denotes
flow direction. All leukocytes are temporarily squeezed between pillars
coated with CD4 antibodies. CD4+ T lymphocytes are captured while the
other leukocytes were allowed to pass through the array. Shear stress would
be controlled to prevent the capture of monocytes (weakly CD4+) and the
nonspecific capture of other leukocytes.
by Cheng et al. (1 – 3 dyn·cm−2), as all leukocytes will be pushed between
the pillars similarly to the way the erythrocytes forced the leukocytes to the
capture chamber walls [51]. Pillar diameter, height, and spacing will need to
be optimized to (1) create optimal shear stress at a particular total flow rate,
(2) ensure the back pressure generated from the capture chamber is below
the maximum to ensure no leaking, and (3) ensure successful and consistent
pillar formation (i.e., the height-to-diameter ratio is crucial).
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Figure 6.2: COMSOL simulation of shear stresses in a capture chamber
arrayed with pillars. The arrow denotes flow direction. Pillar diameter,
spacing, and height are 20 µm, 10 µm, and 50 µm, respectively. Capture
chamber length, width, and height are 300 µm, 150 µm, and 50 µm,
respectively. Flow velocity was chosen to match the flow velocity in the
chip design from Chapter 5 at the maximum total flow rates allowed by the
pumping system (60 µL·min−1), provided the velocity was scaled down
because the differences in capture chamber width and height between this
simulation and the capture chamber design from Chapter 5.
135
6.2.3 Revisiting the Single Flow Direction Method
CD4+ T cell counting duration could be halved if a single flow direction was
used with electrical counters at both the entrance and exit of the capture
chamber. Initial investigations in Chapter 4 showed that this method would
not work, as the two counters would have different sensitivities—making it
impossible to choose an objective impedance threshold level that determined
which pulses were leukocytes. However, the dual frequency interrogation
method described in Chapter 5 and elsewhere has shown it is possible to
isolate populations based on their shape in the low frequency impedance vs.
opacity scatterplots [117, 118]. As a result, entrance and exit counts can be
gated separately with the confidence that all leukocytes were accounted for
in each case.
A major benefit for the single flow direction method besides shorter anal-
ysis time is the fact that the leukocytes’ on-chip residence times will be less,
resulting in a healthier cell population for exit counts and for subsequent
characterization (e.g., capture purity and capture efficiency).
6.3 Expansion of Differential Counter Concept
The advantage of the differential counting approach is that it can be easily
adapted to count other cell types simply by changing the immobilized an-
tibodies in the capture chambers. Capture chambers and counters can be
multiplexed to provide multiple cell counts in a single chip. This would truly
harness the power of working in the microfluidic domain: different screen-
ings could be performed simultaneously, reducing total testing time and cost.
Figure 6.3 shows how this idea can be implemented to obtain a complete cell
count (CBC) on a chip by using different antibodies specific to particular
white blood cell subsets. A CBC is a common and important screening tool
which provides physicians with a general assessment of a patient’s health to
help direct them to further testing and/or treatment. The chip depicted in
Fig. 6.3 also includes an erythrocyte and platelet counting region that first
dilutes the blood sample to electrically count these cells, which are at much
higher densities than leukocytes [118]. Fewer chambers would be needed
if dual frequency impedance interrogation was used, as lymphocytes could
be easily distinguished from granulocytes (neutrophils, eosinophils, and ba-
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Figure 6.3: Concept of CBC on a chip using the electrical differential
counting technique. Whole blood samples are split between two branches.
Branch A performs erythrocyte lysis and subsequent differential counts of
leukocyte subsets. Branch B dilutes the blood sample to count the
erythrocytes and platelets. Modified from [156]. c© 2011 IEEE.
sophils) simply from the forward (entrance) counts.
The first major step to realize and test the feasibility of this concept is
to start with analyzing two cell types simultaneously. CD4+ T lymphocytes
and CD8+ T lymphocytes (suppressor T cells) were chosen, as their counts
and ratio are also an important HIV/AIDS diagnostic. Figure 6.4 shows
an actual mask design that will be used to create the fluidics and electrical
sensing components of the CD4/CD8 chip. The same lysis and quenching
methods would be used as described in Chapter 5. After quenching, the
purified leukocyte population would be split between two separate counter
and capture chamber networks. One set of capture chambers would be coated
with CD4 antibodies, while the other would be coated with CD8 antibodies.
The branching mechanism may create extra counting error if downstream
fluidic resistances are not identical between the two counter/capture net-
works. This non-ideal situation would cause the flow to split unevenly be-
tween the two branches, resulting in counting error because the assumption
that identical sample volumes were analyzed by each counter would not be
true.
On-chip flow rate metering can be used to compensate for this error by
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Figure 6.4: CD4/CD8 differential counter design. Whole blood samples
undergo the same on-chip erythrocyte lysis and quenching steps before
equally splitting the flow between two separate counters and capture
chamber networks. The chip’s dimensions are 3 cm x 4 cm.
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determining the ratio of flow rates between the two networks in addition
to how much sample volume was flown through each counter. Collins and
Lee have shown that the admittance across microfabricated electrodes in
microfluidic channels for ionic solutions varies linearly with flow rate [157].
We used the configuration shown in Fig. 6.5(a) to simultaneously count
leukocytes and measure flow rate after on-chip lysing and quenching. Figure
6.5(b) verifies this linear relationship, suggesting that this method can be
used to compensate for the aforementioned flow error and provide accurate
CD4/CD8 counts.
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Figure 6.5: (a) Electrical configuration to simultaneously count cells and
measure volumetric flow rate. (b) Comparison between the voltage of V2
and known flow rates. The relationship is linear, as shown by the linear




EXTRACTION OF BIOLOGICAL CELLS
Pauly and Schwan’s investigations into the dielectric properties of cellular
suspensions have led to the following equations which can be used to estimate
the cellular dispersion phenomena [96,103,158]. This was accomplished using















(1 + 2p)2 + 2(1− p)1








1 + 2p(σ2 − σ1)/(σ2 + 2σ1)
1− p(σ2 − σ1)/(σ2 + 2σ1) (A.4)
0 and σ0 are the permittivities and conductivities measured at the low
frequency limit and ∞ and σ∞ are the permittivities and conductivities
measured at the high frequency limit, respectively. r is vacuum permittivity
(8.85 x 10−14 F/cm), p is the volume fraction of the cells, D is the cell
diameter, and CM is the cell membrane capacitance. 1 and σ1 are the
permittivities and conductivities of the suspension media, respectively.
These foundational relationships can be used to obtain the cytoplasm per-
mittivity (2) and conductivity (σ2) [103,145,161]:
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2 = 1
(−2 + p)1 + (2 + p)∞
(1 + 2p)1 − (1− p)∞ (A.5)
σ2 =
(2 + p)2(σ∞ − σ1)
(1 + 2p)(2 + p)− 2(1− p)2(σ∞/σ1) (A.6)
The membrance capacitance can also be extracted; using the Hanai-Asami-






1− (1− p)3/2 (A.7)
fc is the characteristic (or mid-point) frequency of the β-dispersion phe-
nomenon, which is caused by the charging of the capacitive cell membrance







σ1(2 + p) + σ2(1− p)
)
(A.8)
Qualitatively, at low frequencies, the cell’s membrane can polarize in enough
time to create a counter field to the externally applied field, effectively shield-
ing the cell’s inner contents. As the applied frequency is increased, the mem-
brane’s charge/discharge response begins to lag, and eventually fails to keep
up with the external field. As in the case of a capacitor at high frequen-
cies, the membrane’s reactance becomes negligible and is effectively shunted.
This allows the total potential to be across the cell’s cytoplasm, effectively
polarizing its nuclear envelope and organelles. At even higher frequencies,
the nuclear envelope itself is shunted, resulting in another dispersion, and the
nucleus is electrically interrogated [164]. Therefore, it is possible to electri-
cally interrogate different components of a cell simply by varying the applied
frequency.
In addition, fc can be used to find the effective permittivity () and con-
ductivity (σ) of the entire cell (combined membrane and cytoplasm) for an
arbitrary frequency:
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